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Summary
Infection of rat embryo (RE) cells with herpes simplex virus type 2 (HSV-2) 
inhibits the methylation of newly synthesised cellular DNA. This hypomethylation 
may be an important step in the transformation of cells by HSV-2 as various cell 
strains also show reduced levels of methylation in comparison to the parent RE 
cells. The mechanism of HSV infection induced hypomethylation and in addition, 
the relationship between this hypomethylation and the hypomethylation of 
transformed cell strains was investigated during the course of this work.
DNA methylase activity, as measured in an in vitro assay, is unaltered 
following HSV-2 infection. There is no increase in the rate of degradation of the 
methyl group donor, SAM and the ratio of SAM/SAH is also unaltered in infected 
cells. Moreover, cellular DNA in infected cells retains the ability to accept methyl 
groups. These results suggest, therefore, that despite the inhibition of DNA 
methylation, RE cells infected with HSV-2 appear to retain all the factors necessary 
for DNA methylation to take place.
The possibility that HSV infection inhibits DNA methylase activity in vivo by 
altering the intracellular ionic environment was investigated. However, we were 
unable to mimic infection induced hypomethylation by treating cells with high (0.24 
M) concentrations of NaCl or with a variety of ionophores.
Immunofluoresence studies using anti-methylase antibodies showed that DNA
methylase concentrates around the nuclear periphery following infection with HSV-
2. This is in contrast to the sites of DNA replication which are distributed
throughout the nucleus and this differential distribution leads us to speculate that the
inhibition of DNA methylation following infection occurs as a result of DNA
methylase being distanced from its substrate, newly synthesised DNA. In support
of this theory we have demonstrated that a viral mutant which does not cause an
inhibition of DNA methylation when infected into RE cells similarly does not cause
the redistribution of DNA methylase. The mechanism of this redistribution is still
x i i i
unknown but wc hypothesise that DNA methylase may migrate to the nuclear 
periphery by association with cellular chromatin which undergoes nuclear 
marginadon and condensation at early times after infection.
RE cells can be transformed with the Bgl II n fragment of HSV-2 and these 
cloned cell strains have a genome-wide reduction in the level of methylation as 
compared to the parent RE cells. However, we have no evidence for inhibition of 
methylation within 48 hours following the transfection of RE cells with the Bgl II n 
or neighbouring fragments. This suggests that an inhibition of methylation is not 
the primary event in the transformation ofRE cells by fragments of HSV-2 
although it may be important in the maintenance of the transformed state.
xiv
Chapter 1 Introduction
1.1 DNA Methylation
1 .1 .1  The Presence of 5-MethyIcytosine in DNA
1 .1 .1 .1  Modified Bases in DNA
The presence of the modified bases, 5-methylcytosine (m5C) and N6- 
methyladenine (m ^A ) (see figure 1.1) in DNA, was first observed over thirty years 
ago by Hotchkiss, (1948), Wyatt, (1951) and Dunn and Smith, (1958). Since these 
initial findings, such bases have been found to occur in the genomes of almost all 
prokaryotes and eukaryotes to a greater or lesser extent.
NH-
O x
H
5-m ethylcytosine
H CH3 
\  /
N
N
H
N ^-m ethyladenine
Figure 1.1 5-MethyIcytosine and N^-M ethyladenine
Prokaiyotic DNA contains both m6A and m5C. A third modified base N4- 
methylcytosine, the product of modification by the Ben I methylase, has also been 
found in certain bacteria (Janulaitis et ai, 1983). The DNA of certain lower 
eukaryotes, such as protozoa, also contain both m5C and m^A whereas the DNA of 
higher eukaryotes contains only m5C. The frequency of occurrence of mSC in 
eukaryotes varies greatly with species. In vertebrates, 2-8% of all cytosines are 
methylated but in plants this figure may be as high as 40%. In contrast, the level of 
DNA methylation in insects is much lower for example, the level of m5C is 0.95%
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in locusts (Wyatt, 1951) and 0.17% in mosquitoes (Adams etal., 1979b). Only the 
DNA of certain nematodes (Simpson et al., 1986), yeast, fungi (reviewed by Magill 
and Magill, 1989) cellular slime moulds (Smith and Ratner, 1991) and surprisingly 
Drosophila (Pollack et al., 1984) have been shown to contain negligible levels of 
m5C.
Methylated bases have also been detected in the DNA of several viruses. Many 
types of bacteriophage have been shown to contain levels of m5C or m^A in their 
genomes comparable to that of their bacterial host In contrast to this post replicative 
modification of bases, all the cytosine residues in the Xanthomas bateriophage, XP- 
12, are replaced by m5C incorporated directly into DNA (Kuo and Tu, 1976). 
Similarly, hydnoxymethylcytosine completely replaces cytosine in the DNA of T- 
even phages.
With the exception of frog virus 3 DNA (Wills and Granoff, 1980), DNA 
isolated from intact virions and free intracellular viral DNA from animal viruses 
does not contain m^C. Animal virus DNA, however, may become methylated when 
integrated into the host chromosome e.g adenovirus (reviewed by Doerfler, 1991) 
or during latency and this will be discussed further in section 1.2.6.
1 .1 .1 .2  The Distribution of 5-MethyIcytosine
In animals, the highest proportion of m5C occurs in the CpG dinucleotide with 
approximately 70% of such dinucleotides methylated. In plants m5C is also found 
in the trinucleotide sequence CpNpG where N represents any base. The distribution 
of m5C in these sequences, however, is far from random.
At the cellular level, there are tissue-specific differences in the levels of m5C as 
measured in total genomic DNA from various tissues in the same organism 
(Vanyushin et al., 1970,1973a and b; Ehrlich et al., 1982; Gama-Sosa et al.,
1983). Tissue-specific levels of methylation have also been observed in the vicinity
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of a number of specific genes, for example, in chicken and human globin genes 
(reviewed in Adams and Burdon, 1985). These tissue-specific differences were the 
first indications as to possible functions of DNA methylation which will be 
discussed later. In a more recent study Kochanek et al., (1990) demonstrated that 
the DNA methylation status of the genes encoding human necrosis factor a  and p in 
specific cell types showed remarkable interindividual concordance. This suggests a 
high degree of stability of cell type specific DNA methylation patterns.
At the genomic level, there are varying levels of DNA methylation in different 
classes of DNA. Genomic DNA can be fractionated according to its reassociation 
kinetics and there are a number of reports indicating that highly repetitive, rapidly 
annealing DNA is more highly methylated than moderately repetitive or unique 
sequence DNA (Drahovsky et al., 1979; Ehrlich et al., 1982).
The sites of methylation in animals, i.e. CpG dinucleotides, are themselves not 
arranged in a random manner throughout the genome. CpG is underrepresented in 
bulk vertebrate DNA and is present at only 10-20% of its expected frequency. The 
predicted frequency, however, does occur in specific regions of DNA of 0.5-3.0 kb 
and these clusters of CpG dinucleotides have been termed CpG islands or HTF 
regions (Bird, 1986). One important feature of CpG islands is that they are 
unmethylated in all tissues so far tested including the germline and are only found 
methylated on the inactive X-chromosome or in inactive genes in certain cells in 
culture.
1 .1 .1 .3  Maintenance and De Novo Methylation
The patterns of DNA methylation described in the previous section can be stably 
inherited and transmitted from one generation to the next by a process called 
maintenance methylation.
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Semi-conservative replication of a methylated DNA duplex produces a 
methylated strand paired with a non-methylated nascent strand (see figure 1.2). The 
enzyme DNA methyltransferase (DNA methylase) in some still yet unknown way 
recognises this so-called hemi-mcthylated site and transfers a methyl group to the 
cytosine on the daughter strand. This mechanism was first proposed by Holliday 
and Pugh, (1975) and Riggs, (1975) and was later confirmed by Wigler et al.,
(1981) who demonstrated that DNA introduced into cells retains its pattern of DNA 
methylation over 25 generations.
 mCG—
 GCm-
Fully methylated site
Replication
■mCG---------
— GC---------
■mCG---------
■-GCm------
■GCm------
■ C G --------------------
 GCm------
 mCG---------
Hemi-methvlated sites
DNA methylation
Fullv methylated sites
Figure 1.2 Maintenance Methylation
De novo methylation of previously unmethylated sites is widespread during 
gametogenesis and early embryogenesis and is thought to be important in the 
control of development (Monk, 1990; Cedar and Razin, 1990). Although the 
methylation pattern in somatic cells is relatively stable there is limited evidence to 
suggest that these cells also have the ability to carry out de novo methylations. Szyf 
et al.y (1989) for example, demonstrated that DNA fragments encoding the mouse 
steroid 21-hydroxylase gene are de novo methylated, in a sequence specific 
manner, when introduced into the mouse adrenocorticol tumour cell-line.
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1 .1 .2  The Enzymatic Modification of Cytosine Residues in 
DNA
1 .1 .2 .1  The Synthetic Reaction
DNA methylation is a post-replicative event The enzyme DNA
methyltransferase (DNA methylase EC 2.1.1.3.7) catalyses the transfer of a methyl
group from the methyl group donor, S-adenosyl methionine (SAM), to the 5
position on the cytosine ring. The products of the reaction are 5-methylcytosine and
S-adenosyl homocysteine (see figure 1.3.)
+
A-S-CH 2-CH2-CH -N H2 A -S-C H 2-C H 2-C H -N H 2
l 1
CH3 COOH COOH
DNA methylase
DNA
cytosine 5-ineihylcyiosine
Figure 1.3 The Enzymatic Methylation of Cytosine in DNA
Santi et al.,(1983,1984) proposed that the reaction probably involves the 
intermediate formation of an enzyme-DNA covalent link as this is the mechanism 
whereby other enzymes catalyse electrophilic substitutions at the 5 position of 
pyrimidine rings. This hypothesis has recently been confirmed by Chen et al.,
(1991) who demonstrated that the prokaryotic DNA methylase, MJfaeTH, forms a 
covalent link with a duplex oligonucleotide, containing the suicide substrate 5- 
fluoro-2 '-deoxycytidine, when incubated together in the presence of SAM. The
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DNA attachment site within the enzyme was found to be a cysteine residue that is 
contained within the Pro-Cys dipeptide motif that is found conserved in all known 
DNA methylases. This finding provides experimental verification for the hypothesis 
(Wu and Santi, 1987) that this Cys residue is the catalytic nucleophile.
DNA methylation takes place in the S-phase of the cell cycle. There is a short 
lag of one or two minutes between the incorporation of cytosine during replication 
and its first becoming methylated however, methylation is not completed for a 
period of several hours (Adams, 1971; Woodcock etal., 1982). Isolated nuclei 
from cells incubated with [3H-methyl]-SAM incorporate radioactive methyl groups 
into endogenous DNA at cytosine residues (Davis et al., 1985). As isolated nuclei 
arc not synthesising DNA this provides further evidence that methylation can 
continue even when DNA replication has ceased. This delay period is postulated to 
be important to allow certain reactions such as mismatch repair and chromosome 
segregation to occur.
1 .1 .2 .2  DNA M ethyltransferases
Mammalian DNA methyltransferases have been isolated from a number of 
sources including mouse ascites cells (Turnbull and Adams, 1976), HeLa cells 
(Roy and Weissbach, 1975), human placenta (Pfeifer etal., 1983) and mouse 
erythroleukemia cells (Bestor and Ingram, 1983).
DNA methylase is a large, single subunit enzyme found in the nucleus of the 
cell. Estimations of its molecular weight range from 50-200 kDa but this variation 
may partly reflect its sensitivity to proteolysis.
Eukaryotic DNA methylases have no cofactor requirements and are not 
stimulated by ATP or Mg2+. The pH optimum for mammalian enzymes is between 
pH 7.5 and pH 8.0 and the Km for S-adenosyl methionine is around 2 pM (Simon 
et al., 1978). The Km for DNA has been variously estimated between 0.5 pg per
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ml and 70 pg per ml depending on the substrate used. In vitro, the enzyme 
preferentially methylates hemi-methylated DNA although it is also capable to a 
lesser extent of methylating CpG dinucleotides de novo.
There is still relatively little known about the mechanism of action of DNA 
methylase. Drahovsky and Morris, (1971) postulated that the enzyme, once bound 
to native DNA, processes along the DNA in a ’’random walk" manner, methylating 
cytosines along the way. This mechanism of one-dimensional diffusion would 
greatly enhance the chances of methylase finding its substrate as opposed to an 
associadon-dissociation mechanism. When nadve DNA is used as a substrate to 
measure DNA methylase activity in vitro, the reaction is inhibited by high salt 
(Adams et al., 1979a). This suggests that the enzyme requires single-stranded 
regions with which to interact, a situation favoured by low salt and high 
temperature. Indeed, most mammalian enzymes prefer denatured to native DNA as 
a substrate in vitro. In contrast to these results however, single-stranded 
oligonucleotides have been demonstrated to be extremely poor acceptors of methyl 
groups (Carotti et al., 1986; Smith et al., 1991; Adams et al., 1992). The difference 
1 between denatured DNA and single-stranded oligonucleotides is probably that | denatured 
DNA has the ability to form transient duplex regions whereas the oligonucleotides 
do not contain significant self-complementary regions. These results suggest that 
although DNA methylase requires single-stranded regions with which to interact, 
the transfer of methyl groups to DNA occurs only in duplex regions.
As mentioned above, eukaryotic DNA methylase can carry out both 
maintenance and de novo methylations in vitro. In somatic cells, the primary 
methylation reaction occurring is that of maintenance whereas in non-differentiated 
cells de novo methylations are widespread, for example, during embryo 
development. There is no evidence for a separate enzyme in these non-differentiated 
cells hence both types of activity are speculated to be catalysed by the same 
methylase both in vivo and in vitro.
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Adams et al., (1983) demonstrated that the ability of DNA methylase, purified 
from Krebs II ascites cells, to add methyl groups to native unmethylated DNA i.e. 
de noxo activity, was stimulated by proteolysis. They later proposed the following 
model to explain the control of the two types of DNA methylase activity (Adams et 
al., 1986). In this model they envisage that the enzyme has two domains, one 
containing the active site and the other, a recognition domain which contains an 
allosteric site which inhibits the enzyme when it encounters an unmethylated 
symmetrical CpG site. Removal of this recognition domain by proteolysis would 
remove a constraint on the enzyme and allow it to methylate DNA de novo. 
Evidence to support this domain theory has come from Bestor et al., (1988) who 
have cloned and sequenced the cDNA encoding DNA methylase from mouse 
erythroleukaemia cells. The predicted amino acid sequence appears to be organised 
into two structural domains. The 573 amino acid C-terminal domain is homologous 
to bacterial type II DNA methylases and is thought to be the catalytic domain. The 
N-terminal domain is 1000 amino acids long and contains a putative Zn-binding 
motif and may be the recognition domain envisaged in the model by Adams et al., 
(1986).
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1 .1 .3  Functions of DNA Methylation
1 .1 .3 .1  DNA Methylation and Gene Expression
One of the major functions of DNA methylation in eukaryotes is postulated to 
be regulation of gene expression. In general terms, lack of methylation of a gene 
has been correlated with its expression. The first indications of this relationship 
came from studying the methylation patterns of tissue specific genes. Many studies 
demonstrated that the transcriptional control regions in tissues of expression were 
undermethylated relative to the same sequence in non-expressing tissues. The 
methylation patterns in these early studies were investigated using the isoschizomer 
restriction enzymes, Msp I and Hpa II in a technique developed by Waalwijk and 
Flavell, (1978). Both enzymes cleave the sequence CCGG however, Hpa II will 
not cut if the internal cytosine is methylated. Comparison of the size of the 
fragments obtained on digestion with these can therefore show the proportion of 
cytosines methylated in the CpG dinucleotide. The disadvantage of this approach 
however, is that only methyl groups in the recognition sequence CCGG are 
detected and this constitutes only a small fraction (4-6%) of the total number of 
cytosines in DNA.
One family of genes which has been extensively studied using this technique is 
the globin gene family. In chickens, the adult a  globin genes are undermethylated 
in haemoglobin producing reticulocytes but they are heavily methylated in other 
tissues. Conversely, the foetal genes are undermethylated in the foetal liver which 
contains the cells actively producing foetal haemoglobin (Weintraub et al., 1981; 
Haigh e ta l, 1982). Other genes which also show tissue specific hypomethylation 
correlating to gene expression include the mouse metallothionine gene (MT-1) 
(Compere and Palmiter, 1981) and the rabbit P globin genes (Shen and Maniads, 
1980).
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It should be noted however, that there are also a number of genes that show 
imperfect, patchy or no correlation at all between hypomethylation and gene 
expression. For example, the rat albumin and a  fetoprotein genes in 18 day old rat 
foetal liver are both heavily methylated when at this stage they are also being 
transcribed (Kunnath and Locker, 1983). In some cases only certain sites exhibit 
tissue-specific patterns of DNA methylation. In the chicken ovalbumin gene, for 
example, a number of Hpa II sites are always methylated or never methylated 
irrespective of activity whereas some sites show variable methylation patterns being 
undermethylated in the expressing tissue (Mandel and Chambon, 1979; Kuo et al., 
1979). This demonstrates that only critical sites need be hypomethylated to mediate 
gene expression in tissue-specific genes. Apparent anomalies may, therefore, be at 
least partly due to the limitations of using Hpa II as a means of detecting methylated 
sites. This limitation has recently been overcome by the development of a method 
called genomic sequencing which can detect m5C by chemical sequencing (Saluz 
and Jost, 1989) and this method has already been used to obtain detailed 
methylation profiles in a number of studies.
Although the types of experiments outlined above suggest that DNA 
methylation may be a mechanism for controlling gene expression, at least in some 
cases, they do not directly prove that DNA methylation of a gene is the cause of its 
suppression. More detailed evidence has come from the use of two different 
experimental approaches.
One approach is to use gene transfer. This involves methylating DNA in vitro 
and introducing it into cells. Yisreli et al., (1988) showed that endogenous p globin 
genes in human fibroblasts are methylated and not expressed however, 
unmethylated copies of the same gene transfected into the same cell type are 
transcribed.
A second approach uses the demethylating agent 5-azacytidine. This compound 
is a cytosine analog and once incorporated into DNA it appears to bind irreversibly 
to DNA methylase and hence inhibits DNA methylation. Treatment of cells with this
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drug has been shown to cause inactive genes to become active. For example, the 
inactive endogenous provirus gene in chicken AEV cells was turned on after the 
cells were exposed to 5-azacytidine and the corresponding gene sequences were 
found to be undermethylated (Groudine etal., 1981).
Although the correlation between DNA methylation and gene expression has 
been established for more than 10 years only now are the mechanisms by which the 
signal is transduced beginning to be understood. It was generally assumed that the 
modification of cytosines residues in some way altered the binding of proteins 
involved with transcription machinery. However, it was not clear if this was caused 
direcdy by influencing specific protein:DNA interactions or whether DNA 
methylation indirectly inhibits the access of the transcription machinery for 
example, by causing alterations in chromatin conformation. Recent studies indicate 
that both mechanisms probably occur and that the different mechanisms depend on 
the gene involved.
Initial evidence to suggest that chromatin structure could be related to the level 
of methylation come from a study by Razin and Cedar, (1977) who showed that 
DNA containing m5C was organised into chromatin that was relatively resistant to 
nucleases. Direct evidence that DNA methylation could cause DNA to adopt a 
nuclease insensitive structure came from a study by Keshct et al., (1986) who 
showed that the chromatin conformation of a transfected DNA sequence was a 
consequence of its methylation status.
Antequera et a l, (1989) have shown that methylated CpGs in intact nuclei are 
preferentially inaccessible to restriction endonucleases that normally cleave at these 
methylated sites in naked DNA. They postulate that this effect is due to the presence 
of a protein they have previously purified and characterised called methylated CpG 
binding protein (MeCP) which has been shown to bind preferentially to methylated 
cytosines in a non-specific manner (Meehan et a l, 1989). Tazi et al., (1990) 
examined the structure of a CpG island at the 5' end of housekeeping genes using a 
technique developed by Antequera et al, (1989). This method is based on the fact
12
that complete digestion of nuclei with CpG cutting restriction endonucleases gives 
short oligonucleotides derived mainly from CpG islands whereas bulk chromatin 
remains intact Analysing the protein content of the DNA derived from CpG islands 
they concluded that these islands differed from bulk chromatin in that they are 
nucleosome free and are bound by highly acetylated histone H3 and H4.
In addition to its effect on chromatin structure, DNA methylation has been 
shown to directly inhibit transcription by blocking the binding of positively acting 
transcription factors. For example, binding of the sequence specific transcription 
factors E2F and MLTF found in HeLa cells is inhibited by methylation of certain 
CpG residues (Kovesdi et al., 1987; Watt and Molloy, 1988). However, 
methylation of the binding site for Spl does not directly block the binding of the 
Spl protein (Harrington e ta i,  1988).
Proteins have also been isolated which require CpG methylation for binding, 
for example the protein MeCP discussed above. More recently Boyes and Bird
(1992) have shown that this protein can repress transcription when bound to a 
variety of different gene promoters but this repression is most effective when bound 
to promoters containing a high density of methylated CpG sites. They postulate that 
this protein is involved in the inacdvation of CpG island associated genes.
The above examples illustrate that the effect of CpG methylation is specific to 
each protein:DNA interaction and may be neutral, inhibitory or required for binding. 
However, despite these apparent contradictions, whenever methylation has an effect 
on protein:DNA interactions the net result is a repression of the gene.
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1 .1 .3 .2  DNA Methylation and X-Chromosome Inactivation
Normal diploid somatic cells in female mammals contain two X-chromosomes, 
twice as many as their male counterparts. However, to ensure that both have the 
same dosage of X-chromosome transcripts one of the female X-chromosomes is 
inactivated (or more than one in individuals with supernumerary X-chromo somes 
e.g. XXXY) to leave only a single active X.
X-chromosome inactivation occurs at a specific stage in embryogenesis. In the 
mouse this happens at 4-6 days gestation around the time of implantation. Both the 
maternal and paternal X-chromosomes have an equal probability of being 
inactivated but once this pattern is established the chromosomes retain their active or 
inactive state for the life of the individual. The only exception to this is found in the 
germ cells. Although the primordial germ cells undergo X-chromosome inactivation 
this inactive chromosome is then reactivated shortly before mieosis (reviewed by 
Gartler and Riggs, 1983; Lyon, 1989).
Initiation of inactivation is generally thought to begin at an X-chromosome 
inactivation centre and spread bidirectionally along the chromosome. Brown et al.,
(1991) have now narrowed the location of the human X-chromosome inactivation 
centre to a region within band Xql3. They speculate that it may bind a trans- 
activating factor which would inactivate this region on the active X-chromosome.
Riggs (1975) was first to propose that DNA methylation may play a role in the 
inactivation process. Since then, several X-chromosome genes have been shown to 
have a strong correlation between inactivity and hypermethylation of the 5 ' region. 
This includes the CpG rich islands at the 5 ' regions of housekeeping genes which 
are never methylated in autosomal genes or in the germ-line. Examples of genes 
showing these correlations are hypoxanthine phosphoribosyltransferase (HPRT), 
glucose-6-phosphate dehydrogenase (G6PD) and phosphoglyoerate kinase (PGK) 
(reviewed by Monk 1990). DNA methylation however, does not appear to be the 
initial step by which the gene inactivation occurs. Lock et al., (1987) have
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demonstrated that methylation of the HPRT gene on the inactive X-chromosome 
occurs after the inhibition event Thus, it has been proposed that DNA methylation 
may be an important factor in the maintenance of the active state once it has been 
established.
Further evidence to support the theory that DNA methylation is important for 
maintaining the inactive state has come from studies using 5-azacytidine. The 
reactivation of genes on the inactive X-chromosome by 5-azacytidine was first 
reported by Mohandas et al., (1981). They used the drug to reactivate the HPRT 
gene in mouse-human hybrid cells that only contained an inactive X-chromosome. 
More recently, Pfeifer et al., (1990) have used PCR aided genomic sequencing to 
determine the methylation status of the PGK gene in a similar human hybrid cell 
line after treatment with 5-azacytidine. On the inactive chromosome, 117 out of 121 
CpG sites were methylated near the promoter start site whereas the same sites on 
the active chromosome or on the chromosome of clones reactivated with 5- 
azacytidine were completely unmethylated.
In comparison to the work on somatic cells, relatively little is known about the 
DNA methylation events in oogenesis. Singer-Sam etal., (1992) have 
demonstrated that a critical Hpa II site in the promoter region of the PGK gene, 
critical in maintaining the X-inactivation in somatic cells, is unmethylated in female 
germ cells well before the inactive X-chromosome is reactivated. They speculate 
that this site is never methylated in these primordial germ cells. Hence, the germ- 
line inactivation-reactivation cycle may not involve methylation. This observation is 
consistant with the suggestion by Monk et al., (1987) that the germ-line cells are 
sequestered from the rest of the embryo early in development and hence avoid 
methylation.
15
1 .1 .3 .3  DNA Methylation and Cellular Differentiation
The process of development and cellular differentiation involves the complex 
control of gene activity. DNA methylation, because it is a means of regulating gene 
expression in a heritable manner, has been suggested to be an important epigenetic 
mechanism involved in the unfolding of the developmental program (reviewed by 
Cedar and Razin, 1990; Holliday, 1989).
In cultured cells, agents that can inhibit DNA methylation have been shown to 
induce differentiation. For example, Christman et al., (1977) showed that treatment 
of Friend erythroleukemia cells with ethionine results in their differentiation to 
haemoglobin producing cells. Ethionine has been shown to lead to the synthesis of 
undermethylated DNA and indeed, Christman et al., (1977) demonstrated that the 
DNA isolated from these cells is hypomethylated compared to uninduced cells. 
More recently this group have also shown similar effects using the drag 5- 
azacytidine (Christman, 1984).
Taylor and Jones, (1979) have also shown that 5-azacytidine can induce cellular 
differentiation. Cultured mouse embryo cells exposed to the drag differentiate into 
three distinct types of muscle cell. The expression of a single gene, called MyoD 7, 
has recently been shown to be sufficient to convert these cells to the differentiated 
phenotype (Davis et al., 1987). Jones et al., (1990) have shown that induction with 
5-azacytidine also results in the hypomethylation of this MyoD 1 gene. These 
experiments on cultured cells suggest, therefore, that DNA methylation may be 
important in establishing and maintaining the differentiation of cells during 
development
To investigate the role of methylation in embryonic development, attempts have 
been made to analyse m5C levels at various stages of cellular differentiation. The 
most extensive study has been undertaken by Monk et al., (1987) who used a 
highly sensitive technique based on restriction digestion with Hpa II and Msp I to 
perform comparative estimations of genome wide methylation in germ cells and in
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early mouse development. In accordance with previous studies, they showed that 
oocytes are under methylated compared to overall methylation levels in sperm DNA 
and DNA methylation in the 8-cell embryo was compatible with the presence of 
undermethylated maternal and methylated paternal DNA. During further 
preimplantation development, at around the blastocyte stage, the level of 
methylation then fell. This is followed, at around the time of implantation and X- 
chromosome inactivation, by a progressive increase in de novo methylation. This 
de novo methylation appears to occur independently in embryonic and 
extraembryonic lineages. Monk, (1990) also speculates that foetal germ cell DNA is 
delineated before this period of extensive de novo methylation and hence escapes 
this process.
It is generally accepted that the methylated ground state that is established is 
then maintained with demethylation being associated with the onset of expression of 
specific genes in different tissues at different times as differentiated cells become 
committed to their specialised functions. There is, however, very little experimental 
evidence as to the methylation fate of specific genes as a function development and 
as to whether the global alterations seen preceed or occur as a consequence of gene 
expression. Possible mechanisms for establishing these different patterns of 
methylation during development will be discussed later in section 1.1.5.
Another important role of DNA methylation in development that has emerged in 
recent years is the parental imprinting of genes.
Genomic imprinting is an epigentic mechanism that confers functional 
differences on certain autosomal genes depending on the sex of the parent from 
which they were inherited. In this respect, neither the maternal nor the paternal 
genome is totipotent and normal development only occurs in the presence of germ- 
line DNA from both parents (reviewed by Surani et al., 1990).
DNA methylation has been suggested to be an important epigenetic mechanism 
underlying imprinting and there is now evidence which shows that the methylation 
status of transgenes in transgenic mice can be dependent on whether they are
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inherited from the mother or the father. For example, Swain et al., (1987) created a 
transgenic mouse strain bearing elements of the Rous sarcoma virus long terminal 
repeat This gene was shown to be expressed in the heart only if inherited from the 
male parent but if inherited from the female parent it was not expressed at all. 
Interestingly, this pattern of expression correlated precisely with the imprinted 
methylation state. Paternal inheritance correlated with transgene undermethylation 
and tissue specific expression whereas maternal inheritance correlates with 
methylation and lack of expression.
One important property of any epigenetic imprinting mechanism is that it must 
be completely reversible to allow the genetic material to switch between paternal and 
maternal forms each generation. Chaillet etal., (1991) have followed the 
methylation status of maternal and paternal transgenes as they moved through 
various stages of development to investigate if DNA methylation correlates with 
these imprinting alterations. They found all methylation is erased in primordial germ 
cells then as the male and female germ cells mature, they then undergo de novo 
methylation to the appropriate parental form. After fertilisation, the maternal pattern 
is maintained whereas the methylation pattern in sperm undergoes further 
modification during embryogenesis.
1 .1 .3 .4  Additional Possible Functions o f DNA M ethylation
DNA methylation, as well as its role in modulating gene expression and the 
consequence of this on X-chromosome inactivation and cellular differentiation, has 
also been speculated to function in a variety of other roles, outlined below.
(i) Recombination
DNA methylation is speculated to have a function in the control of 
recombination. The highly repetitive sequences where recombination events occur
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are more highly methylated than other genomic sequences and therefore, DNA 
methylation may be acting as a protective mechanism against deleterious
recombination. Indeed, during mieosis when satellite DNA is undermethylated the
frequency of recombination is enhanced (Adams and Burdon, 1985).
As discussed in section 1.1.4.3, m5C is unstable and can readily deaminate to 
thymine which results in a G:C —> A:T mutation. In a recent paper, Kricker et al.,
(1992) propose that DNA methylation induced mutagenesis is a means to diversify 
duplicated sequences and hence protect against potentially damaging recombination 
mediated chromosomal rearrangements. Reducing the degree of similarity of 
sequences by only a few percent sharply reduces the frequency of recombination 
and thus they postulate that the small diversification of sequence resulting from 
methylation may be sufficient to control recombination. To support their 
hypothesis, Kricker et al., (1992) carried out sequense analysis and demonstrated 
that repeated sequences in mammals preferentially experience a high frequency of 
transition mutations at sites of cytosine methylation.
(iii Restriction/Modification
DNA methylation has also been postulated to be involved in a host defense 
mechanism similar to the restriction/modification system in prokaryotes (discussed 
in Doerfler, 1992). However, no sequence specific endonucleases have ever been 
isolated in mammals that are also inhibited by methylation. In addition, mammalian 
genomes are only partly methylated and therefore a large amount of the genome 
would be unprotected and subject to restriction.
(iii) Mismatch Repair
In prokaryotes there is only a short delay between replication and the 
methylation of nascent DNA. However, during this delay it has been demonstrated 
that the presence of m^A on only the parental strand directs a mismatch repair
19
system to the unmethylated nascent strand (Jones et al., 1987). In eukaryotes the 
lag period before the completion of methylation is longer but it is also postulated to 
play a role in guiding the strand selection of repair systems in a manner similar to 
that seen in prokaryotes. Evidence to support this theory has come from a study by 
Hare and Taylor, (1985). They transfected hemi-methylated SV40 DNA into cells 
and found that mismatch repair only occurred on the unmethylated strand.
fivl DNA Replication
DNA methylation has been demonstrated to play a role in the initiation of 
replication in certain prokaryotes such as E.Coli and plasmid PI. The origin of 
replication in the PI plasmid replication system contains a number of copies of the 
sequence GATC, the recognition site for E.Coli DNA adenine methylase and it has 
been demonstrated that replication of this plasmid requires the adenine methylation 
of this sequence (Bakker and Smith, 1989). Although there is limited evidence to 
suggest that cytosine methylation may also be involved in replication in prokaryotes 
(Billin, 1968) there is little evidence supporting the role of methylation in the 
control of replication in eukaryotes.
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1 .1 .4 DNA Methylation and Carcinogenesis
It is reasonably clear that, in certain circumstances. DNA methylation can 
influence gene expression. Therefore, it is conceivable that aberrant alterations in 
DNA methylation could lead to abberrant changes in gene expression which could 
lead to cancer.
Two different approaches have been used to address the question of whether 
DNA methylation is involved in carcinogenesis. Firstly, do tumour cells have 
altered levels of methylation compared to normal cells. Secondly, does treatment of 
cells with carcinogens lead to alterations in DNA methylation and hence, are 
demethylating agents, therefore, carcinogenic.
1 .1 .4 .1  Patterns of DNA Methylation in Tumours and Tumour Cell 
L ines.
The level of DNA methylation in various tumours was investigated by Gama- 
Sosa et al., (1983). Using HPLC, they examined the level of m5C in the bulk DNA 
of 103 human tumours which included samples representing a variety of stages of 
tumour development. They found that not only was the level of DNA methylation 
reduced in these tumours but also that the level of DNA methylation decreased 
going from primary malignant to metastatic tumours. Similar observations have 
since been published by a number of groups. Feinberg et a l, (1988) showed 
unequivocal hypomethylation of DNA from human colonic tumour cells and found 
an average reduction of 8-10% in the level of m5C in all colon adenomas and 
adenocarcinomas. However, they found similar levels of methylation in benign and 
malignant tumours indicating that hypomethylation occurs early in the development 
of these tumours.
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Similar studies have also been carried out on the levels of DNA methylation in 
cultured tumour cells. These results are less clear-cut than those obtained for 
tumours and have shown that although some tumour cell lines are hypomethylated 
(Amaud et al., 1985; Macnab et al., 1988) this is not always the case, with some 
cell lines showing no decrease or even showing increases in methylation (Kautianen 
and Jones, 1986; Flatau et al., 1983). The intepretation of these results is, 
however, complicated by the difficulty in obtaining the appropriate controls and the 
fact that there is evidence to suggest that DNA methylation patterns can change 
when cells are cultured.
The above studies analysed the DNA methylation levels in bulk DNA from 
tumour cells and cell lines. However, the effect of DNA methylation on gene 
expression may be mediated by only a small number of specific CpG sites in the 
genome. A number of groups have, therefore, chosen to compare the DNA 
methylation status of specific genes in normal and tumour cells. Feinberg and 
Vogelstein, (1983a and b) and Goelz etal., (1985) demonstrated that a number of 
genes were hypomethylated in all 23 neoplastic growths from the human colonic 
tumours they examined. The genes investigated included growth hormone, y- 
globulin, a-chorionic gonadotropin and y-crystallin The data obtained suggested 
that hypomethylation was a consistent characteristic of human colonic cancers, a 
finding later confirmed by Feinberg et al., (1988) who demonstrated the 
hypomethylation of bulk DNA from similar tumours.
The DNA methylation status of specific genes from cultured tumour cell lines 
has also been studied. Achten et al., (1991) investigated the methylation status of a 
number of genes includin several proto-oncogenes in normal human lymphocytes 
and a series human cell lines derived from lymphomas and leukaemias. Comparison 
of the DNA methylation patterns in a given DNA segment showed the tumour cell 
lines to have changes in these patterns in several instances. However, these changes 
were complex and included both increases and decreases in DNA methylation.
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De Bustros et al., (1988) have also discovered apparent contradictions to the 
observation that transformation and malignancy is associated with hypomethylation. 
They have examined the DNA methylation of a number of markers on chromosome 
11 in a number of human lung and colon carcinoma and leukaemic cells. They 
discovered that the 5’ region of the calcitonin gene to be hypermethylated, including 
sites within a CpG island, and the short arm of chromosome 11 in general to be a 
hot spot for hypermethylation in neoplastic cells. Interestingly, this chromosome 
region is thought to harbour several putative tumour supressor genes. Baylin et al., 
(1987) have found similar increases in methylation of the 5' region of the calcitonin 
gene in a number of human lymphoid and acute myeloid malignancies.
In conclusion, therefore, the correlation between DNA methylation and 
tumourigenesis may not be as simple as early studies suggested. The recent 
discovery of tumour supressor genes (reviewed by Marshall, 1991) has 
demonstrated that tumour progression is a complex process which may involve 
both the activation of and inactivation of important genes and hence any alteration in 
DNA methylation levels could still lead to abberrant changes in gene expression 
which could contribute to the transformation process.
1 .1 .4 .2  The Effect of Carcinogens on DNA Methylation
Further evidence to support the hypothesis that DNA methylation is important in 
carcinogenesis has come from findings that certain chemical carcinogens can 
interfere with DNA methylation both in vivo and in vitro.
Alkylating agents such as N-methyl-nitrosourea (MNU) and N-acetoxy-N-2- 
acetylaminofluorene (NAAAF) are electrophilic agents. These can react with 
nucleophilic sites in DNA to give alkylated bases, for example, 7-methyl guanine. 
Wilson and Jones, (1983) showed that DNA modified in this way was a poorer 
substrate for DNA methyltransferase than native, unmodified DNA.
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Treatment of cells with chemical carcinogens has also been shown to decrease 
DNA methylation levels in vivo. Ivarie and Morris, (1986) showed that the 
alkylating agent N-methyl-N-nitro-N-nitrosoguanidine (MNNG) could increase by 
some 50-100 fold the, reversion frequency of a mutant HeLa cell line harbouring a 
hypoxanthine phosphoribosyl transferase gene (HPRT) silenced by methylation. 
Lapeyre et al., (1981) also showed that hepatocarcinomas induced by three different 
carcinogens were undermethylated compared to normal liver samples. Some 
carcinogens have also been shown to have the opposite effect on DNA methylation 
i.e. they increase the level of methylation within modified DNA. For example, 
Farrance and Ivarie, (1985) showed that methylation of poly [d(C-G).d(C-G)] with 
ethyl methane sulphonate (EMS) stimulates the methyl accepting ability of the 
DNA.
If carcinogens exert their effect by altering the pattern of DNA methylation then 
it is reasonable to hypothesise that agents which induce these methylation changes 
should also be carcinogenic.
5-azacytidine has been widely used as a demethylating agent and in the past it 
has been used to treat leukemia. However, there is now growing evidence to show 
that it is a highly potent carcinogen and is more highly efficient at inducing a variety 
of tumour types than many other well known carcinogens. Inidal studies carried out 
by Benedict et al., (1977) demonstrated that 5-azacytidine induced the 
transformation of 10T1/2 cells in culture. A number of studies later confirmed these 
studies including Hsio etal., (1985) who also showed that transient exposure to 5- 
azacytidine increased the cells sensitivity to further transformation by the chemical 
carcinogen benzo[a]pyrene. Several studies have also demonstrated that alteration 
of methylation patterns using 5-azacytidine can induce changes in tumour 
diversification and can control progression to the metastatic phenotype. For 
example, Olsson et al., (1985) showed that clones of murine Lewis lung carcinoma 
cells selected for non-metastatic phenotype could be converted to a | metastatic 
phenotype by brief exposure to 5-azacytidine.
24
As well as its effect on DNA methylation, 5-azacytidine has been shown to have 
the ability to induce chromosomal aberrations (Benedict et al., (1977) and it, 
therefore, may not exert its carcinogenic effect directly through demethylation, 
however the concentrations shown to cause these chromosomal abberations are in 
excess of those shown to be maximally effective at causing cellular transformation.
1 .1 .4 .3 .  5-Methylcytosine as an Inherent Mutagen
In the previous two sections (1.1.4.1; 1.1.4.2) the possibility that 
carcinogenesis is correlated to alterations in gene expression which arise through 
alterations in DNA methylation was discussed. However, there is also now 
accumulating evidence to suggest that m5C is itself inherently mutagenic.
5-methylcytosine can readily deaminate to thymine and the resulting T:G 
mismatches cause C:G—*A:T transition mutations. Sved and Bind, (1990) have 
recendy calculated that methylation of cytosine increases its risk of undergoing such 
a transition by a factor of 12. Vertebrates have developed a repair system to repair 
T:G mismatches preferentially back to C:G (Brown and Jiricny, 1987). Weibaur 
and Jiricny, (1989) have recendy isolated the 200 kDa protein responsible for this 
repair system which appears to function by excising the thymidine monophosphate 
and filling in the resulting gap to generate G:C. This system however, does not 
appear to be 100% efficient as C—>T transitions account for a high proportion of all 
DNA polymorphisms with around 30-40% of all human germ line point mutations 
thought to be methylation induced (Cooper and Youssoufian, 1988). This high rate 
of transition mutations resulting from methylation of CpG dinucleotides is thought 
to be the reason that CpGs are under-represented in bulk DNA. CpG islands are 
thought to have escaped this fate as they are never methylated in the germ line.
A number of groups have investigated the role of m5C as a mutagen in specific 
human diseases. For example, Koeberl et al., (1990) have studied mutations in the
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factor DC gene in heamophilia patients and have shown that transitions at CpG 
dinucleotides were elevated 24-fold relative to transitions at other sites. Another 
gene which has been extensively studied is the p53 which is found to be altered in 
half of all human tumours. In colon cancer, there are two hot spots for mutation. 
These mutations all represent C—»T or G—>A transitions at CpG sites which are 
shown to be methylated in somatic cells (Rideout et al., 1990). Mutations in the p53 
gene appear to be different in different tumour types and may be the result of both 
m5C induced mutations and direct-acting environmental carcinogens (reviewed in 
Jones et al., 1992). Further analysis of the mutations observed in cancers may go 
some way to determing the cause of the mutations in specific cell types which in 
turn may prove useful for the prevention of cancer in future.
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1 .1 .5  Establishment and Alterations in DNA Methylation 
Patterns
As disscussed in the previous sections, there is now considerable evidence to 
suggest that DNA methylation may act as a "locking" mechanism for gene 
expression in somatic cells. In tissue-specific genes, there is a well established 
corrrelation between undermethylation of a gene and its expression. On the other 
hand, housekeeping genes have CpG islands at their 5 ' end which are unmethylated 
in all tissues and which appear to make them permanently available to be 
transcribed. These distinctive patterns of methylation are inherited from one 
generation to the next by the action of DNA methylase which recognises the 
methylation status of the the parental strand and methylates the corresponding site 
on the daughter strand in a process called maintenance methylation (see section 
1.1.1.3). Although this mechanism of maintaining methylation patterns is now 
widely accepted there is still relatively little known about how patterns of 
methylation can be changed.
1 .1 .5 .1  De Novo M ethylation
De novo methylation of DNA is most clearly seen during gametogenesis and 
early development During early stages of development there are periods of de novo 
methylation which result in the methylation of almost all tissue specific genes 
(discussed in section 1.1.3.3). However, despite this high level of de novo activity 
there is no evidence to suggest the presence of an additional DNA methylase and the 
reaction is thought to be catalysed by the same DNA methylase that is also capable 
of the maintenance reaction (Bestor et al., 1988). As discussed in section 1.1.2.2, 
the basis for the specificity of the DNA methylase reaction is still unknown but it is 
postulated that DNA methylase may have a recognition domain which inhibits its de
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novo methylation activity. There is limited evidence to support this theory however 
virtually nothing is known about the control of such a process.
Although there is widespread de novo methylation during development this 
process does not modify every sequence type and in particular CpG islands appear 
to remain unmodified (Kolsto et al., (1986). The 5 ' end of the Thy-1 gene contains 
a CpG island which has been shown to remain hypomethylated during the 
development of transgenic mice (Kolsto et al., 1986). Szyf et al., (1990) 
transfected embryonic stem cells (a totipotent cell line isolated from blastocytes with 
known de novo methylation activity) with either a control plasmid or a construct 
containing a 214 base pair region from the 5' Thy-1 promoter sequence. The Thy-1 
CpG island was shown to be protected from methylation whereas the control 
plasmid was extensively modified. Interestingly, the 214 base pair fragment was 
also able to protect flanking sequences from de novo methylation. Szyf et al., 
(1990) therefore speculated that this DNA fragment contains a sequence that binds a 
protein which in some way then inhibits the methylation of neighbouring island 
sequences. These results demonstrate that elements other than DNA methylase per 
se are likely to be involved in determining the specificity of the DNA methylase 
reaction.
Alterations in DNA methylation levels are also seen when cells are cultured. 
When first put into culture there is an initial rapid loss of m5C (Wilson et al.,
1983). However, the immortal cells which emerge appear to have undergone de 
novo methylation and are found to have methylated CpG islands (Jones et al.,
1990; Antequera et al., 1990). Again, the mechanism whereby de novo methylation 
is switched on in these cells, where it was previously repressed, is unknown.
In a recent paper, Szyf, (1992) proposed the following mechanism in an attempt 
to explain the mechanism of this non-specific spreading of de novo methylation. He 
speculates that de novo methylation of a gene is initiated at a centre of methylation 
(CM), similar to the proposed X-inactivation centre (discussed in section 1.1.3.2). 
The binding of protein factors to this centre enhances the affinity of DNA methylase
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which then methylates the sites adjacent to the CM. This de novo methylation is 
further spread by the binding of methylated DNA binding proteins to these newly 
methylated sites which causes the methylation of further adjacent sites.
1 .1 .5 .2  Demethylation
If, during early development, widespread de novo methylation occurs to 
establish what is termed a methylated ground state then the activation of tissue 
specific genes must correlate with programmed demethylation events.
Yisreli et al., (1986) used DNA mediated gene transfer to transfect in vitro 
methylated a-actin gene constructs into fibroblasts and L8 myoblasts, a cell line 
which is used as a model system for studying the activation and structure of muscle 
specific genes. Although DNA methylation significantly inhibited the expression of 
the a-actin gene in fibroblasts, both methylated and unmethylated constructs were 
expressed to the same extent in myoblasts. In these myoblasts, the methylated a- 
actin construct was found to have undergone site-specific demethylation whereas 
the methylation status of the gene introduced into fibroblasts remained unaltered. 
Similar results have been found in other transfection studies. For example, genes 
encoding the immunoglobulin K chains undergo demethylation specifically in p- 
lymphocytes and the rat insulin gene has been shown to under go cell-type specific 
demethylation in rat insulinoma cell line (reviewed by Frank et al., 1990). In all of 
the above studies, demethylation corresponded to the expression of the gene and the 
resulting methylation status resembled that of the endogenous gene in the same 
tissue. It would appear, therefore, that at least some differentiated cells retain the 
ability to recognise and demethylate a gene, presumably by the same mechanism 
that is used during development.
As well as these demethylation events correlating with the activation of tissue 
specific genes there is also evidence to suggest that a mechanism exists to
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demethylate CpG islands. Frank et al., 1991 introduced a methylated hamster 
adenine phosphoribosyltransferase gene (APRT) into mouse oocytes and analysed 
the methylation status of the gene in the resulting transgenic mice. The entire 5 ' 
CpG island of the APRT gene was found to be| demethylated whereas the 3 ' end of 
the gene remained methylated, the resulting pattern of methylation being essentially 
identical to that of the endogenous hamster gene. They also demonstrated that this 
demethylation event was restricted to embryonic cells as the APRT gene remained 
fully methylated when introduced into fibroblasts but was demethylated following 
transfection into F9 carcinoma cells. Although CpG islands are always 
unmethylated in all tissues and in the germ-line such activity may be required to 
reactivate the X-chromosome during oogenesis.
The mechanism of demethylation has long been assumed to occur passively. 
Razin and Riggs (1980) proposed that if, following replication of fully methylated 
DNA, the resulting hemi-methylated site in some way failed to be methylated then a 
second round of replication would result in a totally unmethylated symmetrical site 
in 50% of cells (see figure 1.4).
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Figure 1.4 Passive Demethylation
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Although this mechanism may well exist it is a slow process and there is now 
growing evidence to suggest that demethylation can also occur by an active process 
which happens in a much shorter timescale without the need for DNA replication. 
For example, Paroush et a l, (1990) followed up the studies of Yisreali et a l,
(1986) discussed above and showed that the activation and demethylation of the a- 
actin gene introduced into myoblasts occurred in two stages. Within 2 hours of 
transfection the construct was found to be hemi-methylated and the methyl group on 
the second strand was not removed until at least 48 hours later. The removal of both 
methyl groups occurred in the absence of DNA replication suggesting an active 
demethylation event. Their results also showed that transcription of the gene only 
occurred after it became fully demethylated.
A similar two stage demethylation event is seen at two sites within the oestrogen 
responsive element (ERE) of the vitellogenin gene in embryonic liver cells 
following activation with oestradiol (Saluz et a l, 1986). Demethylation of the upper 
strand correlates well with the induction of vitellogenin mRNA synthesis which 
occurs within one day of oestradiol treatment whereas demethylation of the lower 
strand lagged by about 24 hours. Again, the obseved demethylation occurs in the 
absence of DNA replication.
Active demethylation events have also been observed in mouse 
erythroleukaemia cells where DNA methylation falls transiently after stimulation of 
the cells with hexamethylene bisacetamide, a chemical capable of inducing 
differentiation in these cells. A demethylase type activity where the methyl group 
only is removed from m5C is improbable as this reaction is considered 
thermodynamically impossible. Razin e ta l, (1986) postulated that the active, 
genome-wide, demethylation occurs by a mechanism whereby m5C is specifically 
replaced by cytosine. They presented evidence to support a proposal that this 
replacement was caused by a transglycosylase reaction which replaces m5C with a 
cytosine residue without breaking the phosphodiesterase backbone of DNA. In 
contradiction to this, however, Adams et a l, (1990) have presented evidence to
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show that this demethylation is more likely due to a very short patch, excision 
repair-like mechanism.
Hughes et al., (1989) have purified a protein called NHP1 which binds to a site 
within the ERE of the chick vitellogenin gene. This protein shows a preference for 
methylated DNA and makes nicks in the DNA near its binding site. It is speculated 
that this ubiquitous protein plays a role in the active demethylation of DNA in this 
system and it may function by facilitating a similar short patch excision repair-like 
system which replaces m5C residues with cytosine.
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1 .2  Herpes Simplex Virus
1 .2 .1  Morphology of Herpes Simplex Virus
1 .2 .1 .1  C lassification
Herpes simplex virus is a member of the Herpesviridae family of eukaryotic 
double-stranded DNA viruses. This family can be divided into three subfamilies a, 
p, and y based on host range, tropism, length of reproductive cycle and the 
characteristics of latency (Roizman, 1982).
The two serotypes of herpes simplex virus, HSV-1 and HSV-2 belong to the a  
subfamily. Members of this family cause epithelial lesions and have the ability to 
become latent in nervous tissue, most often in ganglia. This group is also 
characterised by having a short reproductive cycle (<24 hours) and a broad host 
range. HSV-1 is the best studied example of the group and is generally associated 
with facial and oral lesion whereas HSV-2 infection is associated with genital 
lesions.
1 .2 .1 .2  Virion Structure
The herpes virion has four distinct moiphological elements.
(i) An electron-opaque core which contains the double-stranded DNA genome 
wrapped around a proteinaceous matrix in the shape of a torus (Furlong et al., 
1972; Nazerian, 1974).
(ii) An icosahedral nucleocapsid, consisting of 162 capsomeres, approximately 
100 nm in diameter, which encloses the DNA-containing core (Wildy et al., 1960).
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(iii) An electron-dense, amorphous material called the tegument which 
immediately surrounds the nucleocapsid (Roizman and Furlong, 1974).
(iv) An outer lipid bilayer envelope from which several viral glycoproteins 
protrude (Wildy, 1986).
1 .2 .1 .3  Genome Organisation
The HS V genome consists of a linear double-stranded DNA molecule. The 
genome of HSV-1 has been completely sequenced and consists of 152 260 base 
pairs with a G+C content of 68.3% (McGeoch et al., 1988). The HSV-2 genome 
has not been completely sequenced but its genome is estimated to be 50% 
homologous to HSV-1 (Kieff et al., 1972) with a G+C content of 69% (Goodheart 
et al., 1968). Hybridisation studies have shown the homologous regions to be 
colinear (Davison and Wilkie, 1983) and this has been more recently confirmed by 
the sequencing of a number of specific genes (discussed in McGeoch et al., 1991). 
The regions of least homology between the two genomes include the R l region 
region (see below) and McGeoch et al., (1991) propose that this may be because it 
is the most recently evolved major element of HS V and is still in a state of relatively 
rapid change.
The HSV genome consists of two linked components designated L and S. Each 
of these two components consists of a unique sequence (U l and Us) bracketed by 
inverted repeats as shown in figure 1.5. The long repeat R l and short repeat R$ are 
distinct. In addition, the molecule also contains a 400 base pair direct repeat 
sequence termed the a sequence which is present at the genomic termini and which 
is also present in the opposite orientation at the "joint’' between the L and S 
segments.
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Figure 1.5. Genomic Organisation of HSV 
For a description of the various sequence elements see text
The L and S segments can invert relative to each other and DNA extracted from 
wild-type virions consist of an equimolar mixture of four populations of sequence- 
orientation isomers. By convention, one isomer chosen arbitrarily is designated as 
the prototype (P) for the purposes of genomic maps (reviewed by Roizman, 1979).
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1 .2.2 Viral Protein Synthesis
Productive infection with HS V involves the expression of three sets of viral 
genes, immediate early (IE or a), early (E or (3) and late (Lory) in a coordinated, 
sequential manner (Honess and Roizman, 1974). The regulation of expression of 
these genes occurs primarily at the level of transcription which is carried out by the 
host cell RNA polymerase II (Costanzo et al., 1977).
Immediate early genes are transcribed immediately following infection and do 
not require de novo protein synthesis. Instead, initiation of viral gene expression 
requires the virion polypeptide Vmw 65 (Campbell et al., 1984) also known as 
VP16, ICP 25 or as TIE as well as the cellular transcription factor Oct-1 and at least 
one other cellular transcription factor (Gerster and Roeder, 1988; Kirstie et al., 
1989; Katan et al., 1990). The cis-acting regulatory sequences required to control 
expression of IE genes have been located in the 5 ' flanking region of these genes 
and the following motifs, important for transcriptional activation, have been 
identified.
(i) A "TATA" box sequence at approximately -25 base pairs 5 ' of the 
transcriptional start site.
(ii) Multiple Spl binding sites (Jones and Tijan, 1985).
(iii) GC rich sequences homologous to the core of the S V40 enhancer sequence 
(Preston and Tannahill, 1984).
(iv) Far-upstream sequences (usually beyond -110 base pairs) containing at 
least one copy of the the consensus sequence TAATGARAT (Gaffney et al., 1985) 
which show enhancer type properties.
Vmw 65 does not appear to independently bind to DNA. Rather, it forms a 
complex with the cellular transcription factor Oct-1 that, in turn, binds to the 
TAATGARAT motif (O'Hare and Goding, 1988; Preston et al., 1988; McKnight et
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al. 1987). This transcriptional complex also involves at least one other cellular 
factor (Xiao and Capone et al., 1990; Katan et al., 1990). However, the precise 
mechanisms by which the complex forms, binds to DNA and stimulates 
transcription are still unknown.
The gene sequence of the Vmw 65 homologue in HSV-2 has recently been 
determined (Greaves and O'Hare, 1991) and the deduced protein sequence shows a 
high degree of sequence conservation (86%) with HSV-1. In addition, the HSV-2 
protein also forms a transcription complex with Oct-1 and the TAATGARAT motif 
and displays powerful transactivating properties.
The HS V genome encodes 5 immediate early gene products, four of which are 
known to affect the expression of later viral genes. These gene products are named 
according to their apparent molecular weight (Vmw) as measured by SDS-PAGE or 
by infected cell polypeptide" (ICP) number and the properties and functions of 
these proteins are briefly summarised below.
Immediate Early Gene 1
This gene encodes the protein known as ICPO or Vmw 110. Shortly after 
synthesis, this protein is phosphorylated and localises to the nucleus, where it 
assumes a granular location throughout the duration of the infection (Pereira et al., 
1977; Knipe and Smith, 1986). Although it has been shown to bind to chromatin in 
infected cell nuclei there is no direct evidence that it binds directly to DNA (Hay and 
Hay 1980).
Vmw 110 can stimulate expression of all classes of HSV genes as well as other, 
non-HSV, eukaryotic genes in transient expression assays (O'Hare and Hayward, 
1985a; Everett, 1986; Sekulovich et al., 1988). Mutant viruses which have 
deletions in Vmw 110 are still able to grow, although at a low multiplicity of 
infection the mutants are slighdy impaired for lytic growth (Stow and Stow, 1986; 
Sacks and Shaffer 1987). Thus Vmw 110 is not essential for productive infection
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although it is required for fully effecient growth. Vmw 110 is also a requirement for 
the reactivation of HSV from the latent state (Leib et al., 1989).
In a recent study Cai and Schaffer, (1992) using mutants in Vmw 110, 
demonstrated that Vmw 110 upregulates E and L gene expression but not the 
expression of IE genes during productive infection. However, in the absence of 
Vmw 65, when cells were transfected with infectious DNA, Vmw 110 may play a 
role in activating IE genes during the early stage of reactivation from latency which 
proceedes in the absence of virion-associated proteins.
Immediate Earlv Gene 2
This gene encodes the protein known as Vmw 63 or ICP 27 and like the 
product of the IE 1 gene it is a phosphoprotein which is localised throughout the 
nucleus for the duration of the infection (Knipe and Smith 1986; Knipe et al.,
1987). Analysis of several different types of mutants have shown that Vmw 63 is 
essential for viral growth and it appears to be required to repress expression of 
certain IE and E genes as well as being an absolute requirement for the transcription 
of late genes.(Sacks et al., 1985; McCarthy et al.> 1989; Rice et al.9 1989).
The mechanism by which this protein carries out these various functions is still 
poorly understood but transfection assays have shown that it may mediate its action 
via interactions with and modifications of Vmw 175 and other viral or cellular 
proteins (Everett, 1986; Rice and Knipe, 1988; Sekulovich etaL, 1988; Su and 
Knipe, 1989; McMahan and Schaffer 1990). It has also been reported to be able to 
bind DNA (Hay and Hay, 1980) but it is unclear if this is related to its function.
Immediate Earlv Gene 3
The product of the IE 3 gene is the phosphoprotein Vmw 175 or ICP 4 and it is 
the best characterised of all the IE gene products. Vmw 175 translocates to the 
nucleus shortly after synthesis (Pereira et al., 1977). Initially it assumes a diffuse 
distribution within the nucleus but at later times it is localised in globular structures
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which correspond to the sites of HSV DNA replication (Knipe et al., 1987). The 
structure and composition of these replication complexes will be discussed in more 
detail later (section 3.7). This differential location may reflect different mechanisms 
by which Vmw 175 may influence gene expression at two different periods of the 
replicative cycle.
A number of studies using both temperature sensitive and deletion mutants have 
shown that Vmw 175 can down-regulate the expression of all 5 IE genes and up- 
regulate the expression of E and L genes (Preston, 1979; Dixon and Schaffer,
1980; DeLuca et al., 1985). These findings have been further supported by 
cotransfection studies where the Vmw 175 has been shown to transactivate 
transcription from E or L promoters but inactivates transcription from BE promoters 
(Everett, 1984; DeLuca and Schaffer, 1985; Gelman and Silverstein, 1985; O'Hare 
and Hayward, 1985a and b).
Smith and Schaffer, (1987a and b) have shown that the HSV-1 and HSV-2 
homologues of Vmw 175 are are functionally interchangeable despite a number of 
biochemical differences.
Vmw 175 has been purified and shows DNA binding activity. Faber and 
Wilcox, (1986) showed that the protein binds to the consensus sequence 
ATCGTNNNNYCGRC. However, although Muller, (1987) detected binding of 
Vmw 175 at this site in the 5 ' region of the IE 3 gene, other studies have shown 
Vmw 175 can also bind to other sequences within this promoter region (Kirstie and 
Roizman, 1886; Michael et al., 1988). The reason for these apparent anomalies is 
unclear but it is reasonable to suppose that the binding of the Vmw 175 to its own 
gene promoter is the mechanism whereby Vmw 175 autoregulates its expression.
The mechanism by which Vmw 175 causes transactivation of E and L genes is 
still not clearly understood and as yet there is no correlation between the sequences 
defined for Vmw 175 binding and transactivation.
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Immediate Earlv Genes 4 and 5
The gene products of IE 4 (Vmw 68 or ICP 22) and IE 5 (Vmw 12 or ICP 47) 
are not required for viral replication (Post and Roizman, 1981; Mavromara-Nazos et 
al., 1986) and the exact function of these proteins in viral growth is still unknown.
Earlv Genes
Transcription of early genes is dependent on the prior expression of IE proteins 
(Honess and Roizman, 1974,1975; Preston, 1979). E mRNAs are first detected 
about 3 hours post-infection (p.i) and reach maximum levels 5-7 hours p.i 
(Wagner, 1985). Early proteins include the proteins required for viral DNA 
replication as well as those responsible for altering the pool sizes of nucleoside 
triphosphates (e.g. ribonucleotide reductase and thymidine kinase)
The regulation of expression of E genes is not as well understood as the 
regulation of IE genes. Sequence comparison of the E promoters gD, tk and ICP 8 
have identified the following promoter elements (Su and Knipe, 1987)
(i) A "TATA" box at about -25 base pairs 5 ' to the mRNA start site.
(ii) A distal upstream promoter region containing A+T rich sequences and G+C 
rich inverted sequences. Two of these G+C regions fit the consensus binding 
sequence for SP1 and, indeed, the tk promoter has been shown to be able to bind 
this transcription factor (Jones and Tijan, 1985).
(iii) A "CCAAT" box at -80 base pairs in the tk promoter only.
None of the above sequence motifs are unique to HS V E promoters. Therefore, 
cellular transcription factors may be required to cooperate with viral proteins to 
activate transcription from these promoters but the precise mechanism of E gene 
expression is still unknown.
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The late genes (L or y) can be divided into two groups. The EL or yi genes 
which require 3-5 hours of viral protein synthesis and whose expression, although 
not dependent on DNA replication, is stimulated by it and the true late genes (L or 
Y2) whose expression has an absolute requirement for viral DNA synthesis 
(Holland et al., 1980; Wagner, 1985).
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1 .2 .3  HSV Replication
The HSV genome contains both cis and trans-acting elements which are 
necessary for its replication. The as-acting are two distinct but similar DNA 
sequences which function as replication origins. These are termed ori^, of which 
there is one copy in the U l portion of the viral genome (Weller et al., 1985) and 
ori$ which maps to the Rs region and hence is present at two copies per genome 
(one in TR$ and one in IR§) (Stow, 1982).
The trans-acting elements have been identified using an assay based on the 
transient replication of plasmids containing oh'l or ori$ and seven HSV genes have 
been identified and sequenced which are necessary for origin dependent HSV 
replication in this assay (McGeoch et a l, 1988; Wu et al., 1988). All seven have 
now been assigned functions and these are outlined briefly below.
Two of the genes, UL30 and UL29, encode the previously characterised 
proteins DNA polymerase (Purifoy et al., 1977) and the single-stranded DNA- 
binding protein ICP8  (Weller et al., 1983) respectively. The UL 42 gene has been 
identified as encoding the 65K DNA-binding protein ICP 34/35 (Parris et al., 1988) 
which is an accessory factor to DNA polymerase (Gallo et al., 1988). The three 
proteins encoded by the genes UL5, UL8  and UL52 have been shown to interact to 
form a functional helicase-primase complex (Crate et al., 1989) and the final 
essential gene UL9 has been identified as encoding the oris binding protein (Olivio 
etal., 1988)
As well as the seven proteins described above, viral replication in resting cells 
appear to require additional viral gene products. HSV encodes the enzyme 
ribonucleotide reductase, an enzyme responsible for the production of DNA 
precursors. This enzyme is composed of two subunits, the large subunit RRi 
designated ICP6  for HSV-1 and ICP10 for HSV-2 and the small subunit RR2  
designated UL40 for HSV-1. Viral mutants in the HSV-1 ICP6  gene are normal for 
replication in growing cells but DNA replication is reduced in resting cells
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(Goldstein and Weller, 1988) and similarly ICP10 expression is required for HSV- 
2 replication only in resting cells (Smith etal., 1992). The viral thymidine kinase 
gene is also not required for viral replication in growing cells but is essential for 
normal DNA replication in resting cells (Jamieson et al., 1974). These viral 
enzymes duplicate normal cellular genes, however, HSV has probably evolved 
these homologues of cellular enzymes in order to allow them to replicate in non­
dividing cells where these enzymes are not normally active.
Replication of HSV appears to occur in the nucleus in large globular structures 
termed replication complexes (reviewed by Knipe et al., 1990). 
Immunofluorescence studies have shown that one of the seven proteins essential for 
viral DNA replication, the major DNA-binding protein ICP8 , is associated with 
replicating viral DNA and is essential for the formation of these complexes (De 
Bruyn-Kops and Knipe, 1988). In addition to ICP8 , the viral DNA polymerase and 
the HSV alkaline nuclease, a protein necessary for the production of progeny virus, 
have also been shown to co-localise with viral DNA replication (Bush etal., 1991; 
Thomas et al., 1992) as have replicating cellular DNA and various host cell 
replication proteins (Wilcock and Lane, 1990).
The complete mechanism of HSV DNA replication is still not understood but 
electron microscopic studies and studies on the physical forms of DNA throughout 
the replicative cycle suggest that HSV DNA replicates by a rolling circle mechanism 
(reviewed by McGeoch, 1987).
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1 .2 .4  Effect of HSV Infection on Host Macromolecular 
Synthesis
HSV infection results in the inhibition of both host DNA and protein synthesis 
(reviewed in Fenwick, 1984).
Cellular DNA synthesis is inhibited at 2.5 hours by as much as 80% (Roizman, 
1969). The mechanism of this inhibition is still unknown and has not been mapped 
to any specific HSV protein or gene. A diagnostic feature of HSV infection is the 
displacement of cellular chromatin from the nuclear interior and its condensation at 
the nuclear membrane, an event which probably occurs between 0 - 1  hours p.i. 
(Dargan and Subak-Sharpe, 1983). It has been suggested that this margination of 
chromatin may remove the majority of it from nuclear sites of DNA replication and 
hence result in the inhibition of cellular DNA synthesis (Kaplan and Ben-Porat, 
1963; Knipe, 1990)
In comparison to the shut-off of cellular DNA synthesis, the shut-off of protein 
synthesis has been more extensively studied. This occurs in two stages, the primary 
phase does not require viral gene expression whereas a late shut-off function 
reduces the remaining level of host protein synthesis and requires the expression of 
viral genes (Fenwick and Clark, 1982). Both of these effects are mediated by the 
product of the virion host shutoff (vhs) gene of HSV which maps within the UL 41 
open reading frame (Kwong et al., 1988). The product of the vhs gene encodes a 
protein that is a structural component of the virion and early in infection it causes 
the inhibition of cellular protein synthesis by inducing the degradation of host 
mRNA (Strom and Frenkel, 1987; Kwong and Frenkel, 1989). The vhs protein 
also degrades viral mRNA from all three classes of viral genes (Strom and Frenkel, 
1987; Oroscar and Read, 1989) and hence, it appears to have a non-selective 
mRNA degradation function although the way it carries out this function is still 
unknown.
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1 .2 .5 HSV and Cellular Transformation
Both HSV-1 and HSV-2 are able to induce the morphological transformation of 
normal diploid mammalian cultured cells, a phenomenon first demonstrated by Duff 
and Rapp, (1971,1973) who observed transformation after exposing hamster 
embryo cells to the entire inactivated HSV genomes.
Three distinct regions of the HSV genome have since been identified which are 
sufficient to independently initiate transformation when transfected into cultured 
rodent cells (reviewed by Macnab, 1987). One of these, called MTRI 
(morphological transforming region I) is found in HSV-1 and maps to the 
restriction fragment
Bgl II i (0.32 to 0.42 map units) (Camacho and Spear, 1978; Reyes et al., 
1979). In HSV-2 the transforming regions have been localised to within the Bgl II 
n fragment (0.58 to 0.62 map units) (Reyes etal., 1979; Galloway and McDougall, 
1981) and to the Bgl n  c fragment (0.43 to 0.58 map units) (Jariwalla et al., 1983) 
and these are termed MTR II and MTR in  respectively (see figure 1.6).
Although these HSV sequences appear to be required to initiate the 
transformation process these are not necessarily retained within the cell and hence 
HSV is proposed to act by a ,,hit-and-Tun,, mechanism which does not require the 
continued expression of a virus encoded transforming protein (Skinner et al., 1976; 
Galloway and McDougall, 1983; Cameron et al., 1985). A number of different 
mechanisms have been proposed for the initiation of neoplastic transformation by 
HSV in a "hit-and-run" type manner and these include the following:
(i) DNA Structure o f Transforming Regions
Galloway et al., (1984) have identified a 737 base pair fragment within the 
Bgl D n fragment which has morphological transforming ability but which does not 
appear to specify a viral protein. Analysis of the DNA sequence of this small 
fragment revealed a region which could be proposed to form a stem-loop structure
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flanked by direct repeats similar to an insertion sequence-like element. Galloway et 
al., (1984) hypothesised that this structure may cause transformation by activating a 
cellular oncogene or it may function as an enhancer element or as a mutagen. 
Similarly, Jones et al.t (1986) proposed that a 481 base pair within the Bgl n  c 
fragment also contains an IS-like sequence. However, there is no direct proof as yet 
that these structures are important. In addition, neither of these structures are 
present in the corresponding regions of HSV-1 and may indeed be present at other 
regions of the genome which do not cause transformation (reviewed in Macnab,
1987).
(iil Ribonucleotide Reductase
A second possibility is that the viral enzyme ribonucleotide reductase is 
involved in the transformation process as it maps within the region containing both 
MTR II and MTR ID (see figure 1.6). The viral ribonucleotide reductase resembles 
the mammalian enzyme in that it consists of two non-identical subunits. The large 
subunit, RRi, Mr 140 000 (ICP6  in HSV-1 and ICP10 in HSV-2) is mostly 
encoded by Bgl II c but the carboxy terminus lies in the Bgl II n fragment. The 
small subunit, RR2* Mr 38 000, is entirely encoded by the Bgl II n fragment 
(McLauchlan and Clements, 1983; Bachetd et al., 1984; Frame et al., 1985) (see 
figure 1 .6 )
Although the entire RR2 subunit maps within the Bgl II n fragment, no HSV 
specified ribonucleotide reductase activity has been detected in cells transformed 
with the Bgl II n fragment (Cameron et al., 1985). Hayashi et al.t (1985) have 
detected the RRi subunit, using monoclonal antibodies, as far as passage 33 in cells 
transformed with the BamU I e fragment which encodes the entire RRj subunit. 
However a subfragment of BamU I e which encodes neither the amino nor carboxy 
terminus of RRi has also been shown to transform Rat-2 cells (Jariwalla et al., 
1986).
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Unlike the mammalian enzyme, it has recently been discovered that the HSV 
RRi subunit also possess serine/threonine specific kinase activity with similar 
properties to growth factor receptor kinases (Chung et al., 1989,1990)
Smith et al., (1992) transfected cells with expression vectors containing either 
the RRi or the RRi protein kinase domain and demonstrated that both are able to 
transform cells to a neplastic phenotype. Alterations of growth factor receptor 
kinase activity is believed to be involved in tumourigenicity (Yanden and Ullrich
1988) and Smith etal., (1992) speculate that the protein kinase domain may be 
functioning in a similar manner. The RRi protein kinase domain maps within the 
Bam H ie  and Bgl II c fragments discussed earlier and for these fragments this 
protein may prove to be an important transforming protein. However, this is clearly 
not the only mechanism of HSV DNA transformation as fragments which lie 
outside this protein kinase domain e.g. the Bgl II n fragment, can also 
independently cause transformation.
(iiil Altered expression o f Cellular Genes
Macnab et al., (1985) demonstrated that antisera, raised against HSV-2 rat 
embryo cells, immunoprecipitated a set of proteins from HSV transformed cells but 
not from control uninfected cells. These proteins were also precipitated with serum 
from tumour bearing animals or with a mouse monoclonal antibody, TG7A and 
peptide mapping confirmed these to be indistinguishable from cellular proteins. In 
addition, these proteins were also found in other transformed and immortalised 
cells. Macnab et al., (1985) therefore proposed that these proteins, which 
accumulate on HSV infection and which are expressed in transformed cells, may be 
important in the initiation of of transformation and that induction of the genes 
encoding these proteins by HSV may be a mechanism by which HSV initiates the 
transformation process.
A set of four polypeptides have been identified, a 90 kDa doublet, a 40 kDa 
and a 30 kDa species but only the 90 kDa doublet has been extensively studied. In a
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recent study, Hewitt et al., (1991) demonstrated that the upper and lower 90 kDa 
proteins were not induced by heat shock, glucose starvation, tunicamycin or 
calcium ionophore and hence are not related to the stress proteins, heat shock 
protein 90 (HSP 90) or the glucose regulated protein, GRP 94 as was previously 
speculated (Macnab et al.t 1985). In addition, infection of the HSV-2 transformed 
cell-line Bn5T with HSV-2 increases the amount of the upper 90 kDa polypeptide 
(U90) by 2.5 to 5 fold whereas the amount of the lower 90 kDa protein remains 
unchanged. From these results, Macnab et al., (1985) propose that the U90 
polypeptide is a novel transformation specific protein which can be induced by 
HSV-2 infection.
The means by which HSV-2 infection induces these cellular polypeptides is still 
unclear. Infection of rat embryo cells with HSV-2 causes the undermethylation of 
host cell DNA and cell strains derived from HSV transformed cells also show 
reduced levels of methylation in comparison to the parent cells. This 
hypomethylation may, therefore, be a possible mechanism whereby HSV-2 can 
activate the expression of these cellular genes (Macnab et al., 1988).
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1.2.6 DNA Methylation and Herpesviruses
In section 1.1.4.3 it was indicated that methylation of CpG dinucleotides is an 
inherently mutagenic process and that this phenomenon is probably resposible for 
CpG supression, and hence the relative excess of TpG and its complement CpA, in 
vertebrate genomes. The exception to this supression is found in CpG islands 
which have the expected frequency of CpG dinucleotides and this is proposed to 
occur because they are never methylated in the germ-line (Bird et a l, 1986).
Honess et al., (1989) investigated and compared the frequencies of CpG 
dinucleotides in all three herpesvirus subfamilies. The a  herpesviruses investigated 
(HSV and varicella-zoster virus) have frequencies close to those expected for their 
mononucleotide composition as did human cytomegalovirus, a p herpesvirus. In 
contrast, the members of the yhepesvirus subfamily (Epstein-Barr virus (EBV) and 
heipesvirus saimiri (HVS)) were both CpG supressed with an excess of TpG and 
CpA dinucleotides, indicative of sequences which have been subject to methylation.
Since virion DNA from productively infected cells is not detectably methylated, 
Honess et a l t concluded that any methylation mediated effects on dinucleotide 
composition must be due to methylation events occurring whilst the virus is in the 
latent state. The lack of CpG supression in HSV suggests that this virus is not 
methylated whilst latent and this is in accordance with the findings of Dressier et 
a l , (1987) who analysed the methylation status of HSV-1 DNA in the central 
nervous system of latently infected mice. However, in an in vitro model latency 
system Youssoufian et a l , (1982) found the HSV genome was extensively 
methylated but it may be that this apparent contradiction simply reflects the 
methylating capacity of the cells used in this experiment as in vivo HSV is normaly 
latent in non-dividing nervous tissue which has limited DNA methylase activity.
The y herpesviruses (EBV and HVS) investigated are both m ain tained as 
multicopy episomes within proliferating lymphoblastoid cells and hence it is 
feasible that these could become methylated by these cells active DNA methylation
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machinery and indeed, episomal EBV DNA is extensively methylated (Kinter and 
Sugden, 1981). Initial evidence for the involvement of DNA methylation in the 
EBV lytic cycle came from studying the effect of 5 azacytidine on latently infected 
EBV carrying cell lines. Treatment with this drug activated the lytic cycle in these 
latenly infected cell-lines (Ben-Sasson and Klein 1981) and |Szyf etal., (1985) 
demonstrated that genome wide hypomethylation precedes the expression of the 
virus. Different types of EBV carrying cell lines show different expression of a set 
of virus encoded latency associated genes and in more recent studies these cell-type 
specific expression patterns have also been correlated to the methylation status of 
the particular gene (Minarovits et al., 1991).
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1 .3  Aims of Project
DNA methylation is now widely accepted to be involved, at least at some level, 
in the control of gene expression and in general terms, lack of methylation of a gene 
has been correlated with its expression.
Infection of RE cells with HSV-2 inhibits the methylation of newly synthesised 
cellular DNA and various HSV transformed cell strains also show reduced levels of 
methylation in comparison with the parent RE cells (Macnab et a l, 1988). It has 
been postulated that this widespread hypomethylation may be a factor in the 
expression of a set of tumour-specific cellular proteins which accumulate on HSV 
infection. Although the functions of DNA methylation are beginning to be 
understood, little is known about how DNA methylation patterns are altered. The 
aim of this project, therefore, was to investigate the mechanism whereby HSV 
infection causes the hypomethylation of newly synthesised cellular DNA in RE 
cells.
The Bgl II n fragment of HSV-2 has been shown to independently induce 
transformation when transfected into RE cells although this DNA is not necessarily 
retained in transformed cells. An additional aim of the project was, therefore, to 
investigate if this DNA fragment causes this "hit-and-run" type of transformation by 
directly altering the level of cellular DNA methylation.
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Chapter 2 Materials and Methods
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2.1 Materials
2 .1 .1  Fine chemicals
Acrylamide, EDTA, glycerol, N-2-hydroxyethylpiperazine-N-2-ethane-sulphonic 
acid (HEPES), AW-methylene bis acrylamide, phenol, perchloric acid (PCA), 
SDS, and trichloroacetic acid (TCA), were supplied by FSA Laboratory Supplies 
(Fisons), Loughborough, England, U.K.
4-aminosalicylic acid, ammonium persulphate, bromophenol blue, 98% formic 
acid, 8 -hydroxy quinoline, mercaptoethanol, and NNN'N1-tetramethyl- 
ethylenediamine (TEMED) were supplied by BDH Chemicals, Poole, Dorset, 
England, U.K.
Ampicillin, bovine serum albumin, butyryl-CoA, calcium ionophore (A23187), 
chloramphenicol, coomassie brilliant blue G and R, ethidium bromide, monensin, 
ouabain, piperazine-AW-bis (2-ethane-sulfonic acid) (PIPES), 
phenylmethylsulphonylfluoride (PMSF), poly [ d(I-C).d(I-C) ], Tween 20 
(polyoxyethylene sorbitan monolaurate), salmon testis DNA and valinomycin were 
supplied by Sigma Chemical Co., Poole, Dorset, England, U.K.
m-cresol, dimethyl sulphoxide (DMSO), and Triton X-100 were supplied by 
Koch-Light Laboratories Ltd, Colnbrook, England, U.K.
Tetramethylpentadecane (TMPD) was supplied by Aldrich Chemical Co., 
Gillingham, Dorset, England, U.K.
Dithiothreitol (DTT) was supplied by Boehringer Mannheim, East Sussex, U.K.
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Xylenes was supplied by May and Baker, Manchester, England, U.K
Ecoscint A was supplied by National Diagnostics, New Jersey, USA.
Agarose (ultra pure, electrophoresis grade), was obtained from BRL,Life 
technologies Inc, USA.
All other chemicals were of the highest grade available. All solutions were prepared, 
where appropriate, with deionised distilled water (dH2 0 ).
2 .1 .2  Cell Culture Growth Media
BHK21 medium (Glasgow modification of Eagle's minimal essential 
medium), lOx concentrate, and Dulbecco’s modification of Eagle’s minimal 
essential medium (DMEM), lx concentrate, were supplied by Gibco BRL Ltd, 
Paisley, Scotland, U.K.
Newborn calf serum, foetal calf serum, sodium bicarbonate (7.5%), L-glutamine 
(200 mM), penicillin (10,000 U/ml)/streptomycin (10,000 mg/ml), non-essential 
amino acids (100X), and gentimycin (10 mg/ml) were also obtained from Gibco.
Mycostatin sterile powder (500,000 U made up in 10 ml distilled water) was 
obtained from E.R. Squibb & sons Ltd., Hounslow, Middlesex, England,.U.K.
Tryptose phosphate broth was obtained from Difco Laboratories, Detroit, U.S.A. .
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2 .1 .3 Bacterial Growth Media
Bactotryptone, yeast extract and bactoagar were obtained from Difco, Detroit, USA.
2 .1 .4  Chromatographic Media
Amberlite CG50 (chromatographic grade type II) was obtained from BDH 
Chemicals, Poole, Dorset, England, U.K. Aminex A6  resin was obtained from 
BIORAD Laboratories Ltd, Watford, England, U.K. P-l 1 phosphocellulose was 
obtained from Whatman Biosystems Ltd., Maidstone, Kent, U.K.
2 .1 .5  Enzymes
Ascites DNA methylase (purified according to Turnbull and Adams, 1976), was 
kindly provided by Dr R.L.P. Adams. SI nuclease and Proteinase K were obtained 
from Boehringer Mannheim East Sussex, U.K. Pronase was obtained from 
Calbiochem Novabiochem, Nottingham, England U.K.
2 .1 .6  Antibodies
Fluorescein-isothiocyanate conjugated (FTTC) goat anti-mouse IgG was obtained 
from Sigma Chemical Co., Poole, Dorset, U.K. FITC conjugated rabbit anti­
mouse IgG was obtained from ICN Row Biomedicals Ltd., High Wicombe, 
Bucks., England, U.K. Mouse monoclonal anti-5'-bromo-2'-deoxyuridine (IgG), 
was obtained from Amersham International pic, Amersham, England, U.K. as part 
of the cell proliferation kit (RPN 20) which also contained the nuclease solution,
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antibody diluent and the BrdU labelling reagent (1:10, 5’-bromo-2'- 
deoxyuridine:5'-fluoro-2'-deoxyuridine).
2 .1 .7 Radiochemicals
S-adenosyl-L-[methyl-3H]-methionine (500 mCi/mnx>l)
(15 Ci/mmol) 
(87 Ci/mnx>l)
[6 -3H]-uridine (23 Ci/mmol)
125i.protein A (30 mCi/mg)
chloramphenicol-D-threo-[dichloroacetyl-l-2-l4C] (55 mCi/mmol)
L-35S-methionine (800 mCi/mmol)
The above isotopes were obtained from Amersham International pic, Amersham, 
England, U.K.
2 .1 .8  Continuous Cell Lines
Baby Hamster Kidney 21, clone 13 cells (BHK21/C13), established by 
Macpherson and Stoker (1962) and maintained in the Institute of Virology, were 
routinely used to prepare and titrate stocks of virus.
Bn5T is a tumour cell line derived from a focus of RE cells transformed by the 
Bgl II n fragment of HSV-2 strain HG52. These were established by Cameron et 
al., (1985) and were used to study hypomethylation and transformation.
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2 .1 .9  Viruses
HSV-2 strain HG52 (Timbury, 1971) and the ts mutant of HSV-1 (G), ttK, 
(Marsden et al., 1976) were provided by Mrs M. Murphy, Institute of Virology, 
Glasgow University.
2 .1 .1 0  Cell Culture Solutions
BHK 21 medium (Glasgow modification of Eagle's minimal essential medium) was 
stored as a 10X concentrated solution. For use, 40 ml of the concentrate was added 
to 300 ml of sterile distilled water. This was supplemented with 40 ml of tryptose 
phosphate broth, 14 ml of sodium bicarbonate (7.5%), 4 ml of penicillin (10,000 
U/ml)/streptomycin (10,000 |ig/ml) and 4 ml of L-glutaminc (200 mM) to give a 
final concentration of IX BHK 21 medium.This medium was then further 
supplemented with 5% (v/v) or 10% (v/v) newborn calf serum and designated 
ETC5 or ETC10 respectively.
Dulbecco's modification of Eagle's minimal essential medium (DMEM) was stored 
as a IX concentrate. For use it was supplemented with 5 ml of L-glutamine (200 
mM), 5 ml of non-essential amino acids (100X), 5 ml of penicillin (10,000 
U/ml)/streptomycin (10,000 pg/ml), 0.3 ml mycostatin (50,000 U/ml), 0.5 ml of 
gentimycin (10 mg/ml) and 5% (v/v) foetal calf serum.
Versene was prepared as a stock solution in PBS A (0.2 g/1) containing 1% phenyl 
red. This was mixed 1:4 with trypsin immediately prior to use.
The complete compositions of GMEM and DMEM are given in table 2.1. The 
constituents of non-essential amino acids are given in table 2 .2 .
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Table 2.1 Eagle's Media Formulations (amino acid and vitamin 
com ponents).
GMEM DMEM
Amino acids (me/1)
I^arginine-HQ 42.0 84.0
L-cystine 24.0 48.0
L-glutamine 292.0 584.0
L-glycine 30.0
L-histidine HC1.H20 21.0 42.0
L-isoleucine 52.4 105.0
L-leucine 52.4 105.0
L-lysine-HCl 73.1 146.0
L-methionine 15.0 30.0
L-phenylalanine 33.0 66.0
L-serine 42.0
L-threonine 47.6 95.0
L-tryptophan 8.0 16.0
L-tyrosine 36.2 72.0
L-valine 46.8 94.0
Vitamins fmp/H
D-Ca pantothenate 1.0 4.0
choline chloride 1.0 4.0
folic acid 1.0 4.0
i-inositol 2.0 7.2
nicotinamide 1.0 4.0
pyridoxyl-HCl 1.0 4.0
riboflavin 0.1 0.4
thiamin-HCl 1.0 4.0
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Table 2.2 Eagle's Non-Essential Amino Acids
Eagle's non-essential amino acids were supplied as a lOOx concentrate which 
contained:
M
L- Alanine 0.89
L-Asparagine-H2 0  1.50
L-Aspartic acid 1.33
L-Glutamic acid 1.47
Glycine 0.75
L-Proline 1.15
L-Serine 1.05
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2.1 .11 Bacterial Growth Solutions
L-broth g/1
bactotryptone 1 0
NaCl 10
yeast extract 5
Adjusted to pH 7.2 with NaOH and made up to 1 litre with dH2 0 .
2 .1 .1 2  Solutions
During the course of this work a number of solutions were used repeatedly the 
compostion of which are given below.
Buffer M
Tris-HCl pH 7.8 50 mM
EDTA 1 mM
dithiothreitol 1 mM
NaN3 0.01%
glycerol 1 0 %
Buffer M+ has PMSF (60 |ig/ml) added just before use.
PBS
A: Na2HPC>4 10 mM
k h 2p o 4 1.84 mM
NaCl 0.17 M
KC1 3.35 mM
B: CaCl2 .6H20 6 .8  mM
C: MgCl2 .6H20 4.9 mM
A, B and C were autoclaved separately,when appropriate, and mixed in a ratio of 
8 :1:1 before use.
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Stopper Solution
SDS
EDTA
butanol
p-amino salicylate 
salmon testis DNA 
NaCl
1%
2mM
5%
3%
0.25 mg/ml 
0.125 M
SDS-mix
SDS 2%
EDTA 4 mM
butanol 1 0  %
Diphenvlamine reagent
diphenylamine 1.5 g
glacial acetic acid 1 0 0  ml
H2S(>4 Conc. 1.5 ml
Before use, 0.1 ml 1.7 % acetaldehyde was added per 20 ml 
T.E. buffer
Tris-HCl 10 mM
EDTA 1 mM
SDS Polvacrvlamide Gel Buffers
Resolving gel buffer:
Tris-HCl pH8 .8  
SDS
Stacking gel buffer:
Tris-HCl pH 6 .8  
SDS
of reagent
1.5 M 
I 0.4%
0.5 M 
0.4%
62
Running buffer:
Sample buffer:
Tris 25 mM
glycine
SDS 0.1%
SDS 6 %
glycerol 30%
mercaptoethanol 15%
bromophenol blue 0 .1 %
Tris-HCl pH 6 .8  0.2 M
Immunoblotting Buffers
Nitrocellulose transfer buffer:
Tris-HCl pH8.3 25 mM
glycine 0.192 M
methanol 2 0 %(v/v)
SDS 0.02%
Blotting buffer:
Tris-HCl pH7.2 20 mM
NaCl 0.15 M
Tween 20 0.1%(v/v)
NaN3 0.5 mg/ml
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2 .2  Methods
2 .2 .1  Cell Culture Methods
2 .2 .1 .1  Primary Cell Culture
Rat embryo (RE) cells were prepared from 18-day-old embryos of a highly 
inbred colony of Hooded Lister Rats. The pregnant rat to be used was killed by 
terminal general anaesthesia. The abdomen was opened and the uterus removed 
aseptically, using fresh forceps and scissors at every stage, into a large sterile Petri 
dish. After removing the embryos from their sacs into further sterile Petri dishes, 
the placentae were removed and the embryos eviscerated. Generally, each rat 
produced around 10-15 embryos. The embryos were then placed in sterile 
universals, washed twice with versene and minced using scissors. The minced 
embryos were transferred to a sterile 250 ml conical flask containing 100 ml of 
0.25% trypsin and were stirred gently at 37°C for 30 minutes on a magnetic stirrer. 
After allowing the tissue to settle briefly, the trypsinised cell suspension i.e non­
settled material, was removed and placed into two sterile plastic 50 ml centrifuge 
tubes containing 2 ml of foetal calf serum. A further 100 ml of 0.25% trypsin was 
added to the flask and the trypsinisation procedure repeated. To pellet the cells, the 
cell suspension was centrifuged at 1000 rpm for 5 minutes at 4°C. The cell pellets 
were then resuspended in a small amount of DMEM+5%(v/v) foetal calf serum and 
this was used to seed 4-6 plastic burrlers in total. After gassing with 5 %Q>2 in air 
the cells were uncubated for 1-2 days at 37°C to allow the cells to attach. Fresh 
medium was then added to these cells and the old medium was decanted into two 
fresh burrlers and incubated for a further 2 days at 37°C at which time the medium 
in these cells was also changed. All the cells were incubated at 37°C until 60% 
confluent, usually 1-2 days after changing the medium. At this stage the cells were
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then incubated at 31°C and were maintained for several weeks by replacing the 
medium twice weekly.
Prior to subculturing, the medium was replaced with fresh medium and the cells 
returned to 37°C for 2-6 hours. The cells were then subcultured as follows; the 
medium was first decanted and the monolayer washed twice with 2 0  ml of 
trypsin:versene. 10 ml of fresh trypsin:versene was then added to the cells. This 
was incubated at 37°C for 3-5 minutes during which time the cells became released 
into suspension. To inhibit the trypsin action, 10 ml of medium supplemented with 
serum was added to the cell suspension. The cells were then used to seed either, 
850cm2 plastic roller bottles at a density of 5xl07 cells in 150 ml DMEM+5%(v/v) 
foetal calf serum; 90 mm dishes at a density of 5X106  cells in 10 ml of medium or 
50 mm dishes at a density of 2X106 cells in 2 ml of medium. The cells were then 
incubated overnight at 37°C and used the following day. All RE cells used were, 
therefore, secondary cells.
2 .2 .1 .2  Growth of Continuous Cell Lines
BHK/C13 cells were cultured as monolayers in ETCio (Glasgow modification). 
Stocks of cells were maintained in the cytology unit in the Institute of Virology and 
were provided on request Plastic 850cm2 roller bottles were seeded at a density of 
2xl07 cells in 150 ml of medium and 50 mm plastic dishes were seeded at a density 
of 2X106  cells per dish in 4 ml of medium.
Bn5T cells were cultured in DMEM supplemented with 5%(v/v) foetal calf 
serum as monolayers in plastic 850cm2 roller bottles. At confluency, the cells were 
subcultured in the same way as RE cells (see section 2.2.1.1). Generally the cells 
were split 1:4 every 3-4 days. For experimental purposes the cells were split 1:2 
and incubated overnight at 37°C.
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2 .2 .1 .3 Virus Infection of RE Cells
RE cells were grown to approximately 80% confluence in the appropriate 
culture vessel. The medium was discarded and the appropriate amount of virus, 
sonicated briefly immediately prior to use, was addded to the cells in the minimum 
volume of medium (orTris-saline) necessary to cover the monolayer. To mock- 
infect cells, exactly the same procedure was followed as for infection except that no 
virus was added to the medium (or Tris-saline) at this point. To adsorb the virus, 
the cells were incubated for 1 hour at 37°C with HSV-2 or at 38.5°C with the 
mutant virus ts K. Following adsorption, the innoculate was removed, fresh 
medium was added to the cells and the incubation continued at the appropriate 
temperature. Infection was carried out, unless otherwise stated, at a multiplicity of 
infection of 20 PFUxell. To harvest, the monolayer was washed 2-3 times with 
PBS and the cells scraped into a minimum amount of the same buffer. The cells 
were pelleted by centrifugation in a microfuge at 2,000 rpm for 5 minutes at 4°C 
and were stored, if necessary, at -20°C.
2 .2 .1 .4  Production of HSV-2
HSV-2 stocks were prepared by infecting 20, just subconfluent, 850 cm2  
plastic roller bottles of BHK C l3 cells with 1 PFU of virus per 300 cells in a total 
of 20 ml of ETCio. The infected cells were incubated at 31°C for 4-7 days until the 
cells were begining to dislodge. The cells were then harvested by shaking to 
remove all the cells into the medium. This cell suspension was decanted into two 
sterile glass 250 ml MSE bottles and spun at 2,000 rpm for 10 minutes. The 
supernatants were discarded except for 2 x 5 ml which were retained to resuspend 
the infected cell pellets. These suspensions were transferred to sterile 25 ml glass 
universals and sonicated for 5 minutes at 4°C. The cells were pelleted by
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centrifugation at 2 ,0 0 0  rpm for 1 0  minutes and the supernatants combined and 
stored at -70°C. The cell pellets were then resuspended in 5ml of fresh medium, 
sonicated and centrifuged as above. The second supernatants were also stored at 
70°C. This procedure produced 20 ml of virus of between lxlOS-SxlO8 PFU:ml 
(for titration see the next section, 2 .2 .1 .6 ).
The sterility of the virus was checked by streaking the virus onto blood agar 
plates and incubating at 37°C and 31°C for 7 days.
2 .2 .1 .5  Titration of HSV-2
Serial 10-fold dilutions of virus were made in ETC5 . 200 pi of each dilution (in 
the range lxlO-4 to lxlO'9) was added to duplicate 50 mm dishes of almost 
confluent monolayers of BHK 2 1/C 13 cells. The virus was then adsorbed for 1 
hour at 37°C. Following the adsorption, 5 ml of overlay medium (1:1, ETC5:3% 
(w/v) methylcellulose) was added to the cells and the incubation continued at 37°C 
for a further 2 days. The overlay medium was discarded and the monolayers stained 
with Giemsa stain for 30 minutes at room temperature. Excess Giemsa stain was 
removed by carefully washing the plates in water. The plates were then dried and 
the plaques counted using a plate microscope. Titres were expressed as the number 
of plaque forming units per ml (PFU:ml). The titre obtained for HSV-2 was in the 
range 1x10s to 8x10s PFU:ml.
2 .2 .2  Estimation of Protein Concentration
Protein concentration was estimated by the method of Bradford, (1976) using 1 
mg/ml bovine serum albumin (BSA) as the standard protein solution.
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2 .2 .3 Estimation of DNA Concentration
2 .2 .3 .1  Optical Density Measurement
The absorption at 260 nm of the appropriate dilution of the sample was 
measured using a quartz 1 ml cuvette in a Cecil linear readout spectrophotometer. 
The concentration was estimated assuming that an A260 of 1 is equivalent to 50 
pg/ml of doubled stranded DNA or 40 pg/ml of denatured DNA.
2 .2 .3 .2  Burton DNA Assay
The DNA concentration in cell extracts was measured according to the method 
of Burton, (1956). 0.9 ml of 0.5 N PCA was added to 0.1 ml of the sample or 
standard to be assayed and this was incubated at 70°C for 30 minutes. The samples 
were then cooled and 2  ml of diphenylamine reagent (see section 2 .2 .1 2 ) was 
added. The samples were left overnight in the dark to allow the colour to develop 
and the E^ OO was then determined.
2 .2 .4  Fractionation of RE Cells
RE cells were mock-infected or infected with HSV-2 for the appropriate length 
of time and washed and pelleted as described in section 2.2.1.3. All following steps 
were carried out at 0-4°C.
The cells were swollen by washing 1-2 times in buffer M+ (1-2 ml per 5x106 
cells), the cells pelleted each time by centrifugation at 2,000 rpm for 5 minutes. The 
swollen cell pellet was resuspended in buffer M+ containing TritonX-100 again in 
1-2 ml per 5 x1 0 6  cells. The cells were then lysed by either incubating on ice for 15
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minutes; passing through a large bore needle or by homogenisation (3-4 strokes). 
The cell lysis was checked microscopically. If required, an aliquot of sample was 
saved at this point and was termed cell lysate.
To prepare nuclei, the remaining sample was centrifuged at 3,000 rpm for 5 
minutes. The supernatant was discarded and the nuclei resuspended in a minimum 
volume of buffer M+. Again, if required, an aliquot of sample was saved at this 
point.
To prepare nuclear extract and residue, the nuclei were pelleted at 3,000 rpm for 
5 minutes as above and were resuspended in a minimum volume of buffer M+. 
Added to this was an equal volume of buffer M+ containing 0.4 M NaCl to give a 
final concentration of 0.2 M NaCl. The cells were incubated on ice for 15 minutes 
and were centrifuged at 2,000 rpm for 5 minutes. The supernatant was removed to 
a clean tube and was termed 0.2 M NaCl nuclear extract. The pellet was 
resuspended in a minimum volume of buffer M+ and was termed nuclear residue.
When DNA methylase activity was being assayed the samples were generally 
used immediately. For immunoblotting, the samples were mixed with 0.5 volumes 
of SDS-polyacrylamide gel sample buffer, boiled for 5 minutes and stored at -20°C 
until required.
2 .2 .5  DNA Methylase Assay
DNA methylase activity was assayed in a reaction mixture containing 5 pi 
poly[d(I-C).d(I-C)] (0.1 mg/ml) and 3 pi S-adenosyl-L-(methyl-3H) methionine 
(87 Ci/mmol, 1 pCi/pl). The sample to be assayed was made up to 15 pi with 
buffer M+ and hence the final volume was restricted to 23 pi.
After incubation at 37°C for 1 hour the reaction was stopped by the addition of 
500 pi of stopper solution. DNA was then purified for scintillation counting as 
follows:
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To obtain complete recovery of the DNA, 50 pg of pronase was added and the 
incubation continued for a further 15 minutes at 37°C. Protein was removed by 
extraction with 300 pi of phenol mix (88% phenol, 12% m-cresol, 0.1% 8- 
hydroxyquinoline). After centrifugation in a microfuge for 10 minutes, the upper 
aqueous layer was removed to a fresh tube and the DNA precipitated by mixing 
with 2 volumes of ethanol. The DNA was pelleted by centrifugation in a microfuge 
for 5 minutes, redissolved in 50 pi of 0.3 M NaOH and incubated for 1 hour at 
37°C to degrade RNA. The solution was spotted onto filter paper squares 
(Whatman 3MM, 2.5 cm2). The DNA was precipitated and acid soluble removed 
by washing 5 times with 5% TCA at 4°C. The DNA was then further washed with 
ethanol and ether and dried under a stream of air. The filters were transferred to 
scintillation vials and the DNA solubilised by heating at 60’C for 30 minutes in 300 
pi of 0.5 M perchloric acid (PCA). Ecoscint scintillator was added and the 
radioactivity counted using a liquid scintillation counter.
2 .2 .6  Base Composition Analysis of DNA
2 .2 .6 .1  Purification of DNA
RE cells were incubated for the appropriate length of time with [6-^H]-uridine 
which results in the incorporation of tritium into cytosine, methyl cytosine and 
thymine. The cell monolayer was then washed 5 times with PBS to remove excess 
label and the cells scraped into a small volume of the same buffer. For purification 
of the DNA from 850 cm2 plastic roller bottles for Cot analysis see section 2.2.11. 
For purification of DNA from 50 mm or 90 mm dishes the cells were firstly pelleted 
by centrifugation in a microfuge for 5 minutes. The supernatant was discarded and 
the cell pellet resuspended in 100-500 pi of SDS or stopper mix to lyse the cells. If
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at this stage, the solution was extremely viscous 0.1 mg/ml Pronase was added and 
the cells incubated for 30 minutes at 37°C.
Protein was removed by adding 0.7 volumes of phenol mix and vortexing 
thoroughly. After centrifugation in a microfuge for 5 minutes, the upper aqueous 
layer was removed to a fresh tube and 2 volumes of ethanol were added to 
precipitate the DNA. The DNA was pelleted by centrifugation in a microfuge for 5 
minutes, redissolved in 0.3 M NaOH and incubated at 37°C for 1 hour to degrade 
RNA. At this stage, the samples were transferred to thick walled Pyrex tubes. The 
DNA was precipated by the addition of 3 ml of 5% TCA and pelleted at 3,000 rpm 
for 15 minutes at 4°C. The pellet was washed a further twice with TCA and once 
with ethanol, each time pelleting by centrifugation at 4°C as before. The pellet was 
then left to dry before being pyrolysed.
2 .2 .6 .2  Pyrolysis and Fractionation of the Bases
The base composition of DNA was assayed by a modification of Adams et al, 
(1979b).
Radiolabelled DNA samples were dissolved in 50 |il of 98% formic acid and 
sealed in thick walled Pyrex tubes. The DNA was pyrolysed by heating at 175°C 
for 90 minutes. The tubes were cooled before opening and the formic acid was 
evaporated. The pyrolysed material was then dissolved in 50 |xl of 20 mM 
ammonium carbonate buffer (adjusted to pH 10.2 with ammonia) and applied under 
pressure to an Aminex A6 column (27 cm x 12 cm) equilibrated at 50°C. The 
column was eluted with the same buffer at 50°C at a flow rate of 1 ml/minute. 1 ml 
samples were collected. To these were added 5 ml of Ecoscint scintillator and the 
radioactivity counted using a liquid scintillation counter. The elution of the bases 
was followed by measuring the absorbance at 260 nm and figure 2.1 shows a 
typical elution profile and the corresponding cpm.
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Figure 2.1 HPLC Base Analysis
DNA, labelled with [6-3H]-uridine, was purified as in section 2.2.6.1. The 
DNA was then pyrolysed and the bases fractionated on an Aminex A6 column as 
described in section 2.2.6.2. The solid line shows the absorption profile at 260 nm. 
The broken line shows the elution of tritium incorporated into thymine, cytosine, 
methyl cytosine.
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2 .2 .7  Analysis of SAM and SAH Levels
Intracellular pool sizes of SAM and SAH were measured by a modification of 
Amaud et a i, (1985).
2 .2 .7 .1 .  Preparation of Cell Samples
Intracellular pools of SAM and SAH in RE cells were radioactively labelled by 
the addition of 35S-L-methionine (800 mCi/mmol) to the external medium to a final 
concentration of 20 pCi/ml. After the appropriate incubation period at 37°C the cells 
were washed 3 times with PBS containing 600 mg/litre of methionine and were 
scraped in to 1 ml of this buffer. The cells were pelleted in a microfuge for 5 
minutes at 4°C and the DNA and protein precipitated by the addition of 500 |il of 
7.5% TCA. The precipitate was pelleted by centrifugation in a microfuge for 10 
minutes at 4°C and the supernatant removed to a fresh tube and stored at -20°C 
until use. Before use, the supernatant was thawed and extracted 3 times with an 
equal volume of ether saturated with water in order to remove TCA.
The precipitate was washed twice with 7.5% TCA and was resuspended in 500 
pi of 0.3 M NaOH by boiling for 10 minutes. When required, this was used for 
protein determination.
2.2.7.2 P - ll  Phosphocellulose Column Chromatography
The appropriate volume of cell sample, and controls where applicable, were 
loaded onto a 10 ml column of P-l 1 phosphocellulose equilibrated with 10 mM 
HC1 at 4°C. The sample was then eluted with a stepwise gradient of HC1 (10 mM, 
100 mM, 500 mM) at a rate of 70 ml/hour. 10 ml samples were collected, 5 ml of 
each were removed to scintillation vials containing 5 ml of Ecoscint scintillator and
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the radioactivity measured using a liquid scintillation counter. The remainder of 
each of the samples was used to determine the absorbance at 260 nm.
2 .2 .8  SAM'ase Assay
The rate of breakdown of S-adenosyl-L-methionine was measured by a 
modification of the method of Gefter et al., (1966).
RE cells were mock-infected or infected for 4 hours with HSV-2 and harvested 
as described in section 2.2.1.3.
The cells were swollen in 1ml buffer M+ and pelleted by centrifugation at 3,000 
rpm for 5 minutes at 4°C. To lyse the cells, the cell pellet was resuspended in 300 
pi buffer M+ containing 1% Triton X-100 and left on ice for 15 minutes. 250 pi of 
this cell lysate was then incubated with 10 pCi S-adenosyl-L-fmethyl-^H] 
methionine (15 Ci/mol) at 37°C for 30 minutes. The reaction was stopped by quick 
freezing the samples. Prior to use, the samples were thawed and the cell debris 
removed by centrifugation in a microfuge for 2 minutes. 1 ml of Amberlite CG50 
(100 mg/ml in 0.02 M phosphate buffer pH 7.0) was added to the supernatant in a 
fresh tube and vortexed thoroughly. The Amberlite was then sedimented by 
centrifugation in a microfuge for 1 minute and the supernatant removed to a 
scintillation vial. Ecoscint scintillator was added and the radioactivity counted using 
a liquid scintillation counter.
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2.2 .9  Immunoblotting
2 .2 .9 .1  SDS Polyacrylamide Gel Electrophoresis
SDS polyacrylamide gel electrophoresis was performed according to the method 
of Laemmli, (1970). An 8.75% separating gel was prepared using the following 
components:
10 ml resolving gel buffer
11.7 ml acrylamide stock
(30% w/v acrylamide:0.8% w/v NN '’-methylene bis acrylamide)
18 ml dH20
200|il 10% ammonium persulphate
50 pi TEMED
TEMED was added last and the gel poured immediately. 0.1% SDS was layered 
over the gel to exclude oxygen. A 3% stacking gel was then prepared using the 
following components:
2.5 ml stacking gel buffer
2 ml acrylamide stock (as above)
5.5 ml dH20
200 pi 10% ammonium persulphate
75pl TEMED (added immediately prior to use)
When the resolving gel was set, the SDS was removed, the stacking gel poured 
on top and the comb inserted. 0.5 volumes of the sample buffer was added to the 
samples and these were then denatured by boiling for 5 minutes. Electrophoresis 
was carried out in running buffer for 3-4 hours at 40 mA. When appropriate, the 
protein bands were visualised by staining with coomassie blue (0.1% coomassie 
brilliant blue R in 50% (v/v) methanol: 10% (v/v) acetic acid) for 1 hour at 40*C and
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destaining in 50% (v/v) methanol: 10% (v/v) acetic acid for the appropriate length of 
time.
2 .2 .9 .2  Western Blotting
Western blots were performed in a Biorad transblot apparatus. Proteins were 
transferred onto Hybond C+ at 400mA for 4-5 hours or at 50mA overnight in 
nitrocellulose transfer buffer according to manufacturers instructions. To ensure 
transfer had occurred the membrane was stained breifly with Ponceau S stain (0.2 
% (w/v) Ponceau S, 3% (w/v) trichloroacetic acid, 3% (w/v) sulfosalicylic acid) 
and destained with dH20. The blot was then transferred to blotting buffer and either 
stored overnight at 4‘C or incubated for 1 hour at room temperature.
2 .2 .9 .3  Detection of Proteins
Following incubation in blotting buffer, as described above in section 2.2.9.2, 
the membranes were incubated for 90 minutes at room temperature with blotting 
buffer, minus Tween, supplemented with 5% (v/v) heat inactivated goat serum 
(inactivated by heating to 65*C for 10 minutes), 3% Marvel (non-fat milk powder) 
and the appropriate volume of primary antiserum. 10 ml of buffer was sufficient to 
just cover one membrane. The membrane was then washed for 5 minutes at room 
temperature in blotting buffer, minus Tween, supplemented with 3% Marvel and a 
further 4 times in blotting buffer. To decorate the primary antibodies, the membrane 
was incubated for 1-2 hours with 1-2 pCi of 125I-protein A (30 mCi/mg) in 10 ml 
of blotting buffer. Enough 125I-protein A was added to give a minimum of lxlO6 
cpm/10 ml of buffer. Finally, the membrane was washed 5 times in blotting buffer
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at room temperature, (for a minimum of 5 minutes per wash), dried, and 
autoradiographed as below (2.2.9.4).
2 .2 .9 .4  Autoradiography
Dried Hybond C+ membrane were exposed to a sheet of Fuji RX medical X-ray 
film with an intensifying screen at -70*C for 1-10 days.
2 .2 .1 0  Immunofluorescence Microscopy
Sterile glass coverslips were placed in 50 mm plastic culture dishes (7-8 
coverslips per dish) and were seeded with RE cells at a density of lxlO6 cells/dish. 
The cells were incubated overnight at 37*C and were infected or mock-infected for 
4 hours at 10 PFU: cell with the appropriate virus (as described in section 2.2.1.3). 
For labelling with bromodeoxyuridine (BrdU), the labelling reagent (10:1 5-bromo- 
2'-deoxyuridine:5-fluoro-2,-deoxyuridine) was diluted 1:1000 with cell growth 
medium and this was added to the cells 1 hour post infection. Following the 
infection, the cells were washed 3x with PBS and were then fixed by immersing the 
coverslips in a large volume of 3:1 methanokacetone at -20*C for 10 minutes. The 
coverslips were then dried and stored at -20*C until required.
To rehydrate the cells, the coverslips were immersed in PBS for 5 minutes. 
They were then incubated for 10 minutes in PBS+2% foetal calf serum (FCS) to 
block non-specific binding sites. The primary antibody was diluted to the 
appropriate concentration with PBS+2% FCS with the exception of the monoclonal 
anti-BrdU antibody which was diluted in buffer containing a nuclease in order to 
denature the DNA and allow access to the BrdU epitopes. The coverslips were 
incubated in a humidified box with 100 pi of the primary antibody solution for 1
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hour at 37*C (or at room temperature using the anti-BrdU antibody). The coverslips 
were then washed 3 times in PBS and twice in PBS+2% FCS over 5-10 minutes. 
100 pi of the appropriate FITC conjugated 2nd antibody, again diluted in PBS+2% 
FCS, was added and the coverslips incubated in a humidified box for a further 1 
hour at 37*C. The cells were then washed 3 times with PBS and mounted in 
glycerol.
Microscopy was performed with a Leitz Wetzler fluoresence microscope with a 
40x or lOOx NPL Fluotar objective lens.
2 .2 .1 1  Co/ Analysis
2.2.11.1 Preparation of DNA
To radioactively label DNA from RE and Bn5T cells, subconfluent 850 cm3 
plastic roller bottles of cells were labelled for 2 days with 200 pCi of [6-3H]- 
uridine (23 mCi/mmol), in 50 ml of growth medium. Following the incubation, the 
cell monolayer was washed 3 times with PBS and the cells scraped into 
approximately 40 ml of the same buffer. The cells were pelleted by centrifugation at
1,000 rpm for 5 minutes at 4*C. DNA was then prepared, free of protein, by 
extraction with phenol/chloroform and precipitation with ethanol. To prepare 
phenol/chloroform, solid phenol was firstly melted and saturated with T.E. buffer. 
It was then mixed with an equal volume of chloroform:isoamyl alcohol (24:1).
The cell pellets were resuspended in 10 ml of PBS and added dropwise to an 
equal volume of SDS-mix with constant stirring. Proteinase K was added to a final 
concentration of 50 pg/ml and the solution incubated at 37*C for 1 hour. An equal 
volume of phenol/chloroform was then added and mixed vigorously for 1 minute. 
After centrifugation at 3,000 rpm for 20 minutes at 4*C in a Beckman benchtop 
centrifuge, the aqueous layer was removed to a clean tube. This extraction was
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repeated twice more with phenol/chloroform and once with chloroform. The DNA 
was then precipitated by the addition of 1/10 th volume of 3 M Na acetate pH 6 and
2.5 volumes of ethanol. This was vortexed and left overnight at -20*C. The DNA 
was pelleted by centrifugation at 10,000 ipm for 10 minutes. To remove the RNA, 
the pellet was resuspended in 400 pi NaOH and incubated for 1 hour at 37*C. 
Following the incubation, the DNA was precipitated with 5 % TCA and pelleted at
3,000 rpm for 15 minutes at 4'C. The pellet was washed a further twice with 5 % 
TCA and once with ethanol and dried. The pellet was resuspended in a small 
volume of T.E. buffer and left overnight at 4’C to dissolve. The DNA concentration 
was then measured spectrophotometrically.
2 .2 .1 1 .2  Fractionation of DNA into Frequency Classes
The theoretical basis of the reassociation kinetics was from Britten et. al., 
(1974).
In order to obtain controlled rates of reassociation, the DNA was firstly 
fragmented into shorter lengths (< lkb). The DNA was sheared by passing through 
a small j gauge needle and the size of fragments checked by agarose gel 
electrophoresis.
To denature the DNA, NaOH, at a final concentration of 0.175 M, was added to 
40 pg of DNA. The samples were then heated to 60°C for 5 minutes.
The following Cot values were chosen to represent the three main frequency 
classes of DNA:
1. Highly repetitive DNA Cor < 0.01
2. Moderately repetitive Cor 0.01-70
3. Unique CoT > 70
Cor is defined as the initial concentration (Q)) in moles nucleotide per litre, 
multiplied by the time (t) in seconds it takes for the DNA to reanneal. Reassociation
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is also dependent on salt concentration and where a correction is applied for this the 
appropriate term is equivalent Cor (ECor). However, at 0.175 M Na+, the 
equivalent value is 1 and hence ECor is simply Cor. Since the concentration of DNA 
in the reassociation mixture is known, the time of reassociation was determined to 
give the above frequency classes. To start the reassociation, HC1 was added to a 
final concentenration of 0.175 M to neutralise the NaOH (the two solutions were 
previously titrated against each other). In addition, 4 pi of lOx PIPES buffer 
(piperazine-N/V'-bis [2-ethane-sulphonic acid]) were added and the volume made 
up to 40 pi with dH20. This was then incubated for the appropriate time at 60° C. 
To stop the reassociation, the samples were placed on ice. 20 pi of Si nuclease 
reaction buffer (330 mM Na acetate, 0.15 M NaCl, 0.3 mM ZnS0 4 ) were added 
and the volume made up to 200 pi with dH20. To digest the single-stranded DNA, 
10 units of SI nuclease were added and the samples incubated at 37*C for 30 
minutes. At this stage, 200 pg of calf thymus DNA were added as a carrier. The 
DNA was then precipitated with 5 % TCA and pelleted at 3,000 rpm for 15 
minutes. The pellet was washed a further twice with 5 % TCA and once with 
ethanol. The supernatant from each of the steps was retained and counted by liquid 
scintillation spectrophotometry to determine the percentage of single-stranded DNA 
in each of the samples. The DNA pellets were then air dried, pyrolysed with formic 
acid and the bases separated by HPLC as described in section 2.2.6.
80
2 .2.12 Large Scale Isolation of Plasmid DNA
The alkaline lysis method of Birmboin and Daly, (1979), was used to prepare 
milligram amounts of pure pLW4 and Bgl II n plasmid DNA for use in transfection 
assays.
E. coli bacterial stocks (stored in a 50 % (v/v) glycerol/L-Broth solution), of 
HB101 cells transformedwith pLW4 and DH5 cells transformed with the Bgl II n 
plasmid were kindly provided by Dr M. Bryans, formerely of our laboratory, and 
Dr J.C.M.Macnab, respectively. These were plated onto LB plates containing 
ampicillin.
10 ml of L-Broth containing ampicillin (100 (ig/ml) was inoculated with a single 
colony of bacteria transformed with the appropriate plasmid and incubated 
overnight at 37#C. 5 ml of this culture were then used to inoculate 500 ml of L- 
Broth. The bacteria were grown at 3TC  with vigorous shaking until they reached 
an optical density of 0.8 at 630nm. At this point, chloramphenicol was added to a 
final concentration of 165 pg/ml and the culture was then further incubated at 37 *C 
overnight. Chloramphenicol allows the plasmid copy number per cell to increase by 
preventing the bacteria multiplying while still allowing plasmid replication to occur.
To pellet the bacteria, the culture was centrifuged at 5,000 rpm for 10 minutes at 
4*C in a Beckman J2-21 centrifuge. The supernatant was discarded and the pellet 
resuspended in a total volume of 3 ml of alkaline lysis buffer I (50 mM glucose,
10 mM EDTA, 25 mM Tris-HCl pH 8) at 4*C. The bacterial suspension was then 
transferred to a Ti60 centrifuge tube and 150 pi of lysosyme (40 mg/ml in alkaline 
lysis buffer I) added. The suspension was mixed and incubated on ice for 30 
minutes before adding 6 ml of alkaline lysis buffer II (0.2 M NaOH, 1 % SDS) and 
continuing the incubation for a further 5 minutes. 3.75 ml of alkaline lysis buffer III 
(3 M Na acetate, pH 4) was added and incubation on ice continued for a further 60 
minutes. The samples were then centrifuged in a Ti60 rotor in a Beckman 
ultracentrifuge at 30,000 rpm for 30 minutes at 0*C. The supernatant, containing
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the plasmid was retained and decanted into a sterile 30 ml Corex tube. To this was 
added 0.6 volumes of isopropanol and the DNA was left to precipitate by 
incubating at room temperature for 10 minutes. To pellet the DNA, the solution was 
centrifuged at 8,000 rpm for 15 minutes at room temperature in a Sorvall SS-34 
rotor. The pellet was then dissolved in 10 ml of T.E. buffer (10 mM Tris-HCl, pH 
8.0,1 mM EDTA) and was subjected to CsCl/EtBr centrifugation as follows;
CsCl (9.6 g) and EtBr (0.6 ml of a 10 mg/ml stock) were added and the 
solution clarified by centrifugation at 1,500 ipm for 30 minutes in a Beckman 
benchtop centrifuge. After removing the supernatant to a clean tube, the density of 
the solution was checked using a refractometer and adjusted to a density of 1.59 
g/ml by the addition of solid CsCl as necessary. The solution was then transferred 
to VTi50 heat-sealable 5 ml tubes and centrifuged at 200,000 g at 20*C for 16 hours 
in a Beckman LH-8 ultracentrifuge. Long wave U. V. light was used to visualise the 
plasmid DNA which migrates ahead of the host chromosomal DNA in the caesium 
gradient After removing the tops of the tubes, plasmid DNA was removed by side 
puncture of the tube using a 21 guage needle and a 5 ml syringe to withdraw the 
band. To remove the EtBr the band was extracted four times with an equal volume 
of isoamylalcohol. The lower aqueous was then transferred to a 15 ml Corex tube 
containg 4 volumes of T.E. buffer and to this was added a further two times the 
total volume of ethanol. The DNA was left to precipitate overnight at -20* C. To 
pellet the DNA the sample was placed on dry ice for 15 minutes and then 
centrifuged at 10,000 rpm in a Sorvall HB4 centrifuge for 30 minutes at 0*C. The 
supernatant was discarded and the pellet resuspended in 200 |il T.E buffer and 
transferred to an Eppendorf tube. The DNA was then further precipitated by the 
addition of 0.1 volumes of 3M Na acetate pH 6 and 2.5 volumes of ethanol at 
-20*C. This was left on dry ice for 10 minutes and spun for 15 minutes at 4*C in a 
microfuge. The supernatant was discarded and the pellet washed with 500 ill of 
ethanol. After a brief spin, the pellet was drained and redissolved in a minimum
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volume of T.E. buffer. The DNA concentration was determined 
spectrophotometrically and the purity examined by agarose gel electrophoresis.
2 .2 .1 3  Agarose Gel Electrophoresis
Electrophoresis on 1% (w/v) agarose gels was used to assess the purity of 
plasmid DNA and the size of genomic DNA. The agarose was dissolved in TBE 
buffer (89 mM Tris-HCl, 89 mM boric acid, 25 mM EDTA, pH 8.3) by boiling for 
5 minutes. The agarose was left to cool to approximately 50*C and EtBr was then 
added to a final concentration of 0.5 (ig/ml before pouring. One tenth volume of 
bromophenol-blue (BPB) containing sample buffer (15 % Ficoll, 100 mM EDTA, 
0.1 %BPB) was added to the samples before applying to the gel. Electrophoresis 
was then carried out at room temperature at 40 mA for 1-2 hours on a BRL Horizon 
58 mini gel kit in TBE buffer containing 0.5 pg/ml EtBr. The DNA was visualised 
using a UV transilluminator.
2 .2 .1 4  Transfection of Cells with Plasmid DNA
All the following procedures were carried out aseptically.
10 fig of the control plasmid, pLW4, and 10 pg of the appropriate test plasmid 
were mixed with 125 pi of 2 M CaCl2  and 20 Jig of salmon testis DNA. This was 
made up to 1 ml with sterile dH2 0  and mixed thoroughly by inversion or pipetting. 
The mixture was then added dropwise, with constant mixing to ensure the 
formation of a fine precipitate, to a tube containing 1 ml of 2x HBS buffer (50 mM 
Hepes, 280 mM NaCl, 1,5 mM Na2HP0 4 f pH 7.12). The mixture was then 
incubated at room temperature for 30 minutes to allow the formation of the 
Ca3(PC>4 ):DNA precipitate. 1 ml of this precipitate was added directly to duplicate,
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subconfluent 50 mm dishes of RE cells. The cells were incubated at 37*C for 45 
minutes at which time 4 ml of growth medium were added and the incubation 
continued at 37’C. 4 hours after the addition of the precipitate, 2 ml of a boost 
solution, ( 20% glucose and 10% DMSO in lxHBS buffer), were added for 4-5
I _
minutes. This was removed and the cells washed twice with growth medium. 4 ml 
of fresh growth medium were then added and the incubaton continued at 37*C for a 
further 20 hours. To allow the determination of % m5C levels, 100 pi [6-^H]- 
uridine (23 Ci/mmol) was added at this point to the medium. In addition, where 
appropriate, 100 mM ZnSC>4 was also added to the medium at this point and the 
incubation was continued for a further 24 hours. The cells were then harvested asii
follows:
iI
The medium was discarded and the cell monolayer washed 3 times with PBS. 1 
ml of TEN buffer (0.04 M Tris-HCl, pH 7.8,0.01 M EDTA, 0.12 M NaCl) was 
then added and the cells incubated for 5 minutes at room temperature before being 
scraped off the dish with a rubber policeman. The cells were pelleted by 
centrifugation at 1,000 rpm for 5 minutes in a microfuge at 4’C and resuspended by 
pipetting in 90 pi of 0.25 M Tris-HCl, pH 7.8 on ice. The cells were then lysed by 
three cycles of freeze/thawing consisting of 5 minutes incubation on dry ice (-70*C) 
followed by 5 minutes at 37*C. The cell debris was pelleted by centrifugation at
5,000 rpm for 4 minutes in a microfuge. The supernatant was removed to a fresh 
tube and aliquots were used for protein estimation and for assaying CAT activity. 
The cell debris pellet was resuspended by pipetting in 100 pi of SDS-mix (2%
SDS, 4 mM EDTA, 10% butanol). The tritium labelled DNA was then extracted 
from the cell debris and analysed as in section 2.2.6.1.
84
2 .2 .1 5 Chloramphenicol Acyl Transferase Assay
Chloramphenicol acyl transferase activity was assayed by the method of Seed 
and Sheen, (1988).
60 pi of cell extract were added to an Eppendorf tube containing 100 mM Tris-HQ, 
pH 7.8,0.2 pCi [14C]-chloramphenicol (55 mCi/mmol) and 250 pM butryl CoA 
(freshly prepared) in a total volume of 100 p i . After incubation at 37*C for 1 hour 
the reaction was terminated by the addition of 2 volumes of a 2:1 mixture of TMPD 
(tetramethyl pentadecane):xylenes and mixed vigorously by vortexing. After 
centrifugation for 1 minute in a microfuge, 90% of the upper organic phase was 
removed to a scintillation vial and the radioactivity counted using a liquid 
scintillation counter.
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Chapter The Mechanism of HSV-2 Infection Induced 
Hypomethylation of Newly Synthesised 
DNA in RE cells.
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3.1 Introduction
Macnab et al., (1988) demonstrated that infection of RE cells with HSV-2 
results in the hypomethylation of host cell DNA synthesised during infection. In 
order to verify these results, RE cells were infected for 4 hours with HSV-2 at 20 
PFU/cell as described in section 2.2.1.3. The cells were labelled between 1 and 4 
hours post infection with [6-3H] uridine (50 |lCi per 50 mm dish) in order to 
incorporate tritium into cytosine, methylcytosine and thymine. DNA was then 
isolated, pyrolysed and the bases fractionated by HPLC as described in section 
2 .2 .6 .
The results are presented in table 3.1 and show that HSV-2 infection causes a 
significant reduction in the methylation of DNA synthesised during the infection. 
Macnab et al., (1988) could not detect any appreciable amounts of viral DNA at 4 
hours post-infection and hence the results reflect the level of methylation in newly 
synthesised cellular DNA. Both the levels of methylation and the C7T ratios 
correlate well with those reported by Macnab et a!., (1988).
C/T ratio=(C+m5C/T) %m5C=[ (m5Cx 100)/(C+m5C)]
Mock-Infected 0.49 ± 0.02 (4) 3.38 ± 0.14 (4)
Infected 4.38 ± 1.18 (4) 0.46 ±0.12 (4)
Table 3.1 The Effect of HSV-2 Infection on %m5C
The results show the mean values from 3-4 separate experiments ± standard 
deviation.
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This inhibition of DNA methylation that occurs following infection of RE cells 
with HSV-2 could, theoretically, occur in a number of ways. For example, HSV-2 
infection might
(i) Directly inhibit DNA methylase activity in vivo.
This could be achieved by altering the structure of the enzyme, for example by
i
proteolysis or by modification of certain amino acids by phosphorylation or 
glycosylation. Alternatively, infection may induce inhibitory cofactors which bind
I to DNA methylase and inhibit its action in this way.
i
(ii) Alter the metabolism of the cell.
[ This may result in rate limiting concentrations of the methyl group donor, S-
i
adenosyl methionine or high concentrations of the feedback inhibitor, S-adenosyl 
homocysteine.
(iii) Alter the cellular environment.
Changes in the pH or ionic concentration of the cell might indirectly inhibit 
DNA methylase activity in vivo.
(iv) Alter the accessibility of DNA methylase to DNA.
DNA binding proteins may be induced which physically block the access of 
DNA methylase to its substrates sites on DNA either by binding to the specific
l
substrate sites or by altering DNA conformation. Alternatively, there may be a 
movement of DNA methylase or replicating DNA within the cell, distancing the 
enzyme from its substrate.
The aim of the experiments described in this chapter is to address the above 
hypotheses and investigate the mechanism of HSV-2 induced hypomethylation of 
newly synthesised DNA in RE cells.
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3 .2  The Intracellular Distribution of DNA Methylase Activity
DNA methylase in mammalian cells, with the exception of bovine thymus (Sano 
et al., 1983), is found associated with the nucleus. 70-80% of the enzyme, 
however, is only loosely associated with the nucleus and can be removed by 
extraction with low salt treatment (Turnbull and Adams, 1976). The remaining 
activity remains firmly associated with 2 M NaCl resistant nuclear matrix-like 
structures (Burdon et al., 1985). There is evidence to suggest that this "bound" 
form of the enzyme is responsible for maintenance methylation in vivo (Davis et al., 
1985, Burdon et al., 1985). Additional evidence for the importance of the "bound" 
enzyme in methylating newly synthesised DNA comes from findings that DNA 
methylase activity is associated with a high molecular weight "replitase" complex 
which contains a number of enzymes required for DNA replication (Noguchi et al., 
1983). More recent reports confirm the existence of such complexes which are 
found associated with the nuclear framework (reviewed by Huberman, 1987).
Macnab et al., (1988) reported that the activity of DNA methylase in 0.2 M 
NaCl nuclear extracts was unaltered following infection of RE cells with HSV-2 
despite the dramatic inhibition of methylation of newly synthesised DNA. It is 
possible, however, that infection may cause a dissociation of methylase from the 
matrix and a redistribution of methylase within the cell which would result in the 
loss of the ability to methylate newly synthesised DNA in vivo.
The aim of the following set of experiments was to investigate if HSV-2 
infection alters the distribution of DNA methylase activity in the cell and nucleus of 
RE cells.
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3 .2 .1 The DNA Methylase Microassay
The original standard assay for DNA methylase was developed by Turnbull and 
Adams, (1976) to assay partially purified enzyme fractions. However, in order to 
analyse DNA methylase activity in small numbers of tissue cultured cells it was 
necessary to devise a more sensitive microassay. Both assays involve measuring 
the incorporation of radioactivity from S-adenosyl-L-(methyl-3H)-methionine into 
DNA. Methylated proteins and RNA are excluded by phenol extraction and alkali 
digestion, respectively.
In the microassay, to ensure the complete recovery of DNA, an incubation with 
protease is included after the initial incubation to facilitate the isolation of DNA that 
may be tightly associated with protein. In this section, the parameters investigated 
were the concentration of the DNA substrate and the concentration of S-adenosyl-L- 
(methyl 3H)-methionine. Other parameters which have been previously investigated 
by Dr Adams in the development of the microassay are (i) the nature of the DNA 
substrate and (ii) the linnearity of the reaction (Adams et al., 1991).
3 .2 .1 .1  Poly [d(I-C).d(I-C)] Concentration Curve
The best substrate for DNA methylase in vitro is hemi-methylated DNA and this 
is thought to be the normal substrate in vivo (Turnbull and Adams, 1976; Bestor 
and Ingram, 1983; Pfiefer et al., 1983). Mammalian enzymes also prefer denatured 
DNA to native indicating that the enzyme probably requires single-stranded regions 
with which to interact (Drahovsky and Morris, 1971; Adams et al., 1979a). Hemi- 
methylated DNA can be prepared in a number of ways e.g. from primed single 
stranded M13 replicated in the presence of methyl dCTP (Adams, 1990). These 
methods, however, are time consuming and it is difficult to obtain reproducible 
samples of such DNA. In the standard assay, denatured M. luieus DNA is used as
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i
the substrate in the presence of 100 mM NaCl, which stimulates the reaction. 
Although this DNA is unmethylated, it has a high proportion of C+G (72 mole 
percent) and hence a high CpG content. Poly [d(G-C).d(G-C)] is, theoretically, an 
even better unmethylated substrate than M. luteus DNA. This, however, produces a 
very stable structure which is less likely to ,'hreatheH to form the single-stranded 
regions necessary for DNA methylase to bind to and this reduces its capacity to be 
methylated. A more suitable substrate, and the one chosen for use in the 
microassay, is poly [d(I-C).d(I-C)]. Replacing guanosine with inosine improves 
the ability to accept methyl groups (Pfiefer and Drahovsky, 1986) presumably 
because this reduces the stability of the molecule and allows DNA methylase to 
interact
I To optimise the concentration of poly [d(I-C).d(I-C)] in the assay, 5 pg of a
crude fraction of DNA methylase, prepared from Krebs II ascites by Dr 
R.L.P.Adams, were incubated at 37*C for 1 hour with 1.5 pM S-adenosyl-L- 
(methyl-3H)-methionine (87 Ci/mmol) and varying amounts of poly [d(I-C).d(I-C)] 
in a total volume of 23 pi in buffer M+. The incorporation of 3H into DNA was 
then assayed as described in section 2.2.5.
Figure 3.1. shows that a concentration of 40 pg/ml (0.5 pg in 23 pi) was 
saturating in the microassay and this was the concentration used in subsequent 
assays.
91
65
4
3
a. 2
1
0
1.0 1.50.0 0.5
pg po!y[d(I-C).d(I-C)]
Figure 3.1 DNA Methylase Microassay:
Poly [d(I-C).d(I-C)] Concentration Curve
5 |ig of a crude fraction of DNA methylase and 1.5 pM S-adenosyl-L- 
(methyl-3H) methionine (87 Ci/mmol) were used to methylate 0,0.5,1.0,1.5, |ig 
of poly[d(I-C).d(I-C)] in a DNA methylase microassay (see section 2.2.5). Jhe 
level of methylation is expressed as cpm of 3H incorporated into DNA.
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3 .2 .1 .2  S-Adenosyl-L-(m ethyI-3H)-inethionme Concentration 
Curve
To optimise the concentration of S-adenosyl-L-(methyl-^H>-methionine in the 
microassay, 5 jig of a crude fraction of DNA methylase was incubated with 0.5 pg 
poly [d(I-C).d(I-C)] and varying amounts of S-adenosyl-L-(methyl-3H)-methionine 
in a total volume of 23 pi in buffer M+ at 37*C for 1 hour. The incorporation of 3H 
into DNA was then assayed as described in section 2.2.5.
Figure 3.2. shows that a concentration of 1.5 pM was saturating in the assay. 
This is a similar concentration to that used in the standard assay and this was then 
used in subsequent assays. To obtain the maximum amount of counts incorporated 
into DNA, a new high specific activity form of S-adenosyl-L-(methyl-3H)- 
methionine (TRK 581, 87 Ci/mM), recently made available from Amersham 
International was used in the assaay. To obtain a concentration of 1.5 pM requires 
the use of 3 pCi/23 pi and it was partly to economise on this expensive reagent that 
the assay volume was limited to 23 pi.
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Figure 3.2 DNA Methylase Microassay:
SAM Concentration Curve
5 |ig of a crude fraction of DNA methylase and 0,0.5,1.0, or 1.5 pM S- 
adenosyl-L-(methyl-3H) methionine (87 Ci/mmol) were used to methylate 0.5 jig 
poly[d(I-C).d(I-C)] in a DNA methylase microassay (see section 2.2.5). The level 
of methylation is expressed as cpm of 3H incorporated into DNA.
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3 .2 .2  The Effect of HSV-2 Infection on the Intracellular
Distribution of DNA Methylase Activity
Subconfluent 50 mm dishes of RE cells were infected or mock-infected for 4 
hours with HSV-2 as described in section 2.2.1.3. Following infection, the cells 
were fractionated into cell lysate, nuclei, 0.2 M nuclear extract and a fraction termed 
nuclear residue (as described in section 2.2.4.).
Figure 3.3. shows that the distribution of methylase activity is not significantly 
altered following infection with HSV-2.
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1-40 |ig of protein from the appropriate cell fraction of RE cells, mock-infected 
or infected for 4 hours with HSV-2 were assayed for DNA methylase activity (see 
section 2.2.4, 2.2.5). This activity is expressed as specific activity (units/mg 
protein) and the results are mean values of 8-20 estimations from 2 separate 
preparations ± standard deviation.
(1 unit = 1 pmole methyl groups incorporated into DNA/hour)
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3 .3 . The Effect of HSV-2 Infection on the Metabolism of S- 
Adenosylmethionine and S-Adenosylhomocysteine
In section 3.2. DNA methylase activity was assayed in vitro in the prescence of 
excess DNA and SAM and the results showed no difference in the enzymic activity 
following infection with HSV-2. In vivo, however, HSV-2 infection may alter the 
metabolism of SAM, causing it to be a limiting factor in the reaction and leading to 
an inhibition of DNA methylation. Alternatively, HSV-2 infection could alter the 
metabolism of one of the products of the DNA methylase reaction, S-adenosyl 
homocysteine (SAH), a potent inhibitor of methyltransferase catalysed reactions 
(Uleland, 1982). SAH can be degraded by the enzyme, SAH hydrolase (EC 
3.3.13) to L-homocysteine and adenosine, see figure 3.4.
SAH Hydrolase
A -S-C H 2-C H 2-C H -N H 2 + H2O -------- > A-OH + H -S-C H 2-C H 2-C H -N H 2
I I
COOH COOH
(SAH) (adenosine) (homocysteine)
Figure 3.4 SAH Hydrolysis (A represents the adenosylj group)
Although the reaction equilibrium lies in the direction of condensation, adenine 
land homocysteine are continuously utilized in metabolic pathways within the cell and 
thus in vivo the enzymatic reaction is towards the hydrolysis of SAH. If the balance 
of adenine or homocysteine is disrupted in the cell, however, SAH levels can rise 
and lead to an inhibition of methylation of DNA and other compounds such as 
proteins, lipids or polysaccharides. For example, Kredich and Martin, (1977) 
showed that the treatment of cultured S49 mouse lymphoma cells with a specific
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inhibitor of adenosine deaminase resulted in high levels of adenosine and 
consequently high levels of SAH which lead to an inhibition of DNA methylation.
It is possible, therefore, that HSV-2 infection could lead to metabolic alterations in 
the cell which could result in the accumulation of SAH and cause an inhibition in 
DNA methylation.
To study these two hypotheses the rate of SAM breakdown and the ratio of 
SAM/SAH was measured in RE cells mock-infected and infected with HSV-2.
3 .3 .1 .  The Rate of S-Adenosylmethionine Breakdown
T3 bacteriophage encodes an enzyme SAM hydrolase (SAM'ase) which 
catalyses the breakdown of SAM to 5 '-deoxy-5 -(methyl thio)-adenosine (MTA) and 
homoserine see figure 3.5. This enzyme is the product of the first T3 gene 
transcribed and it allows the phage to overcome the restriction system of its host E. 
coli B or E. coli K 12 (Spoerel et al., 1979). The expression of this protein also 
results in an inhibition of the methylation of newly synthesised E. coli DNA (Gefter 
et al., 1966).
SAM Hydrolase
+
A -S-C H 2-C H 2-C H -N H 2 + H2O *  A -S  + CH 2(O H )-C H 2-C H -N H 2
CH3 COOH CH3
(MTA)
COOH
(SAM) (homoserine)
Figure 3.5 SAM Hydrolysis (A represents the adenosyll group)
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The aim of the following experiment was to investigate if infection with HSV-2 
induces a similar SAM'ase type activity in RE cells. A modification of the assay 
developed by Gefter et al., (1966) was used to monitor SAM breakdown. In this 
assay the formation of 5'-deoxy-[5 methyl-3H-thio]-adenosine from S-adenosyl-L- 
[methyl-3H]-methionine was determined. The former does not bind to an Amberlite 
CG50 column (equilibrated with 0.02 M potassium phosphate pH 7.0) whereas 
SAM does bind under these conditions. Control samples containing 10 pCi S- 
adenosyl-L-[methyl-3H] methionine (15 Ci/mmol) in 250 pi buffer M+ were 
applied to a 1 ml column of Amberlite CG50 equilibrated with 0.02 M potassium 
phosphate buffer. The sample was then eluted in a total of 5 ml of 0.02 M 
potassium phosphate buffer and the radioactivity counted in a scintillation counter. 
4-5% of the total counts applied were eluted from the column indicating very little 
degradation of the stock solution. Similar values, however, could be obtained by 
simply mixing the above with 1 ml of a 1 mg/ml Amberlite suspension (in 0.02 M 
potassium phosphate pH 7.0), sedimenting the Amberlite by centrifugation and 
counting the radioactivity present in the supernatant in a liquid scintillation corner. A 
concentration curve of Amberlite versus cpm unbound was carried out (results not 
shown) to ensure a saturating concentration of Amberlite.
Subconfluent 50 mm dishes of RE cells were mock-infected or infected for 4 
hours with HSV-2 as described in section 2.2.1.3. Cell lysates were prepared as 
described in section 2.2.8 and 250 pi of this lysate was incubated at 37*C for 30 
minutes with 10 pG  S-adenosyl-L-[methyl3H]-methionine (15 G/mmol). The 
formation of tritiated MTA was then assayed as in secdon 2.2.8.
The results in table 3.2.show that HSV-2 infection does not significantly alter 
the rate of breakdown of SAM.
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Specific Activity 
(pmoles SAM cleaved/30 minute/mg protein)
Mock-infected 83.0 ± 17.4 (5)
Infected 83.6 ± 22.4 (5)
Table 3.2 SAM breakdown in mock-infected and infected RE cells 
The results are expressed as a mean value of 5 observations ± standard 
deviation.
3 .3 .2  Measurement of the Intracellular Ratio SAM/SAH
Intracellular pool sizes of SAM and SAH in RE cells were measured according 
to Amaud et al., (1985) (for details of this procedure see section 2.2.7.). Briefly, 
35S-L-methionine (800 mCi/mmol) was added to the extracellular medium of the 
cells at a final concentration of 20 pQ/ml for the appropriate time. The cells were 
then harvested and treated with 7.5% TCA and the acid-soluble material analysed 
by ion-exchange chromatography on a P-l 1 phosphocellulose column.
3 .3 .2 .1  Separation of Standards
Initial experiments were carried out to determine the optimal [HC1] gradient 
required to effectively separate SAM, SAH and methionine.
A mixture of 500 pi of unlabelled cell extract (prepared as in section 2.2.7.2.), 
100 pi SAH (10 mM in 5 mM HC1), 0.5 pG  S-adenosyl-L-(roethyl 3H)- 
methionine and 15 pG  5^S-L-mcthionine (800 mG/mmol) was applied to a 10 ml 
P -ll phosphoceiluiosc column equilibrated with 10 mM HG.The column was
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eluted with a stepwise HC1 gradient at a rate of 70 ml/hour. 10 ml samples were 
collected, a fraction of each was used to measure the absorbance at 260 nm and a 
second aliquot of each was used to measure the radioactivity by liquid scintillation 
counting. Figure 3.6. shows the separation of the three standards.
Separation of a mixture of cell extract (unlabelled), SAM and methionine (as 
above) gave no detectable absorbance at 260 nm (results not shown) hence, the 
absorbance values in figure 3.6B correspond only to the cold SAH added. The 
gradient used is a slight modification of that used by Eloranta etal., (1976) in the 
original separation procedure. They used a stepwise gradient of 1,10,50 and 500 
mM HQ but in our hands SAH failed to elute in the 50 mM HQ fraction as 
expected. Instead, both SAH and SAM eluted in the 500 mM HQ  fraction. The 
modified gradient (10,100 and 500 mM HQ), however, is clearly able to separate 
the three standards.
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Figure 3.6 Separation of Standards on a P - ll  
Phosphocellulose Column
500 pi of unlabelled cell extract, 100 pi SAH (10 mM in 5 mM HC1),
0.5 pCi S-adenosyl-L-(methyl ^H) methionine and 15 pCi of 35S-L-methionine 
(800 mCi/mmol) were separated on a P-l 1 phosphocellulose column with a 
stepwise [HCL] gradient as described in section 3.2.2.1. The results are shown 
on three separate graphs.
(A) cpm derived from 35S-methionine.
(B) Absorbance at 260 nm derived from SAH.
(C) cpm derived from S-adenosyl-L-(methyl 3H) methionine.
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3 .3 .2 .2  Timecourse of Extracellular Methionine Equilibration
with Intracellular SAM
Pool sizes of SAM and SAH were measured by first equilibrating cells with 
3 5S-L-mcthionine and then isolating and separating the SAM and SAH as described 
in section 2.2.7. In order to obtain reliable results on the pool sizes of SAM and 
SAH it was necessary to ensure equilibration of the extracellular 35S-L-methionine 
with the internal SAM pool.
At time zero, 80 pCi aliquots of 35S-L-methionine (800 mCi/mmol) were added 
to the medium of duplicate plates of RE cells to give a final concentration of 20 
|iCi/ml. This does not affect the methionine concentration in the medium which 
remains at 30 mg/1. Cells were harvested at 15 minutes, 30 minutes, 1 hour, 2 
hours and 4 hours after the addition of the 35S-L-methionine. In addition, at 4 
hours, the medium from one set of plates was replaced with unlabelled medium and 
the cells harvested after a further 2 hours incubation at 37*C. All of the samples 
were then separated on a P-l 1 phosphocellulose column as in section 2.2.7. to 
determine the amount of 3^ S labelled SAM present in the cell (SAM elutes in the 
500 mM HC1 fraction).
Figure 3.7. shows the result of the time course. Equilibration of extracellular 
methionine with intracellular SAM has occurred by around 2 hours and hence this 
was the labelling time used in future experiments. This is in agreement with the 
results obtained German et al., (1983). They reported that the time required for 
equilibration of extracellular methionine with intracellular SAM did not exceed 90 
minutes in exponentially growing WI-L2 lymphoblasts. The graph also shows that 
nearly all of the labelled SAM is metabolised within 2 hours of the removal of 35S- 
L-methionine from the extracellular medium demonstrating the rapid turnover of 
SAM within the cell.
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Figure 3.7 Timecourse of Equilibration of Extracellular 
Methionine with Intracellular SAM
Subconfluent RE cells were incubated for 0 .5 ,1 ,2 ,4  or 6  hours with normal 
medium supplemented with 35S-L-methionine (800 mCi/mmol) at a final 
concentration of 20 pCi/ml. At 4 hours, the labelled medium was removed and 
replaced with normal medium. The samples were then fractionated on a P-l 1 
phosphocellulose column (as in section 22.12.) to determine the amount of 35S 
labelled SAM present in the cells and this is expressed as cpm.
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3 .3 .2 .3  Comparison of the Ratio of SAM/SAH in HSV-2 
Infected and Mock-Infected RE cells
90 mm plates of subconfluent RE cells were infected at 20| PFU/cellas 
described in section 2.2.1.3. 2 hours post-infection, 80 |iQ  of 35S-L-methionine 
(800 mCi/mmol) was added to the extracellular medium at a final concentration of 
20 jiCi/ml. 4 hours post-infection, acid-soluble material was prepared as in section
2.2.7.1. and analysed on a P -ll phosphocellulose column as described in 3.2.2.1. 
100 |il of SAH (10 mM in 5 mM HC1) was added along with the extract as an 
internal standard.
Figure 3.8. shows a typical separation profile of a 35S-L-methionine labelled 
cell extract The peak of absorbance at 260nm reflects the elution profile of the 
added SAH.
Table 3.3. shows the amounts of SAM and SAH and the ratios of SAM/SAH in 
HSV-2 mock-infected and infected RE cells. These results demonstrate that 
infection of RE cells with HSV-2 does not alter the ratio SAM/SAH.
SAM
(pmoles/mg protein)
SAH
(pmoles/mg protein)
SAM/SAH
Mock-infected 216.3 30.6 7.1
185.8 2 0 .8 8.9
Infected 213.5 23.7 9.0
155.9 15.5 1 0 .1
Table 3.3 SAM/SAH ratio in mock-infected and infected RE cells
The results shown are duplicate observations.
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Figure 3.8 Separation Profile of SAM and SAH on a P - ll  
Phosphocellulose Column
RE cells were labelled for 2 hours with 35S-L-methionine at a concentration of 
20 pCi/ml. 500 pi of the acid soluble material was separated on a P-l 1 
phosphocellulose column as with a stepwise [HC1] gradient as described in section 
2 .2 1 .2 .
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3 .4  Endogenous DNA as a Methyl Group Acceptor
In section 3.2. DNA methylase activity was assayed in vitro by its ability to add 
methyl groups to an excess of exogenous poly[d(I-C).d(I-C)]. This activity was 
found to be unaltered following infection with HSV-2 despite the hypomethylation 
which is seen to occur in the cell. In vivo, however, HSV-2 may cause an alteration 
in the suitability of endogenous DNA to act as a substrate for DNA methylase. 
HSV-2 is known to encode a number proteins with the ability to bind to DNA 
(Bayliss et al., 1975; Purifoy and Powell, 1976) and these may inhibit the DNA 
methylation, for example, by directly blocking the access of DNA methylase to its 
substrate sites or by indirectly inhibiting the access of DNA methylase by altering 
DNA chromatin structure.
The aim of the following experiment was, therefore, to assay the ability of 
endogenous DNA in the nuclei of HSV-2 mock-infected or infected RE cells to 
accept methyl groups from S-adenosyl methionine.
Nuclei were prepared from RE cells mock-infected or infected with HSV-2 for 
4 hours as described in sections 2.2.1.3 and 2.2.4. The appropriate volume of 
nuclei containing 2-20 pg of DNA was incubated with 3 pCi S-adenosyl-L-(methyl 
3H )-methionine (87 pCi/mmol) in a total volume of 23 pi in buffer M+. The 
incorporation of methyl groups into DNA was then assayed as in section 2.2.5.
Figure 3.9 shows that DNA in infected cell nuclei has a greater ability to accept 
methyl groups than that in mock-infected nuclei. Both mock-infected and infected 
nuclear preparations had a similar protein:DNA ratio as well as the same specific 
activity of DNA methylase as measured using exogenous poly [d(I-C).d(I-C)] as a 
substrate (results not shown).
108
800
<
z.
Q
©
jjz
eo
2
©
0 .U
©©C
S
CO
600
Q. 400
200
200 10
•  Infected 
■ Mock-Infected
(ig DNA
Figure 3.9 Endogenous DNA as a Methyl Group Acceptor
Nuclei were prepared from RE cells infected of mock-infected with HSV-2 for 
4 hours (see sections 2.2.1.3 and 2.2.4). The appropriate volume of nuclei was 
then incubated with 3 |iCi of S-adenosyl-L-(methyl 3H)-methionine (87 |iCi/mmol) 
for 1 hour and then assayed for the incorporation of 3H methyl groups into DNA 
(section 2.2.5).
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3 .5  Characterisation of the Molecular Weight of DNA 
M ethylase Following Infection with HSV-2
The molecular weight of eukaryotic DNA methylase, which has now been 
purified from a number of plants and animals, has been variously estimated 
between 50-200 kDa (Adams, 1990). This variation in size may be the result of 
proteolysis as the enzyme is sensitive to proteolytic degradation both in vivo and in 
vitro (Adams et a i, 1986,1989).
Although DNA methylase in cultured rat cells has not previously been 
characterised, the mouse DNA methylase has been extensively investigated. It 
consists of a single subunit of 185-190 kDa (Turnbull and Adams, 1976) and this 
observation has been confirmed by the cloning and sequencing of the cDNA 
encoding DNA methylase from cultured murine erythroleukaemia cells (Bestor et 
al., 1988). When the enzyme is subjected to trypsin it is degraded through a series 
of intermediates to yield a 100 kDa form. Degradation to this form of the enzyme 
results in an increase in de novo enzyme activity and this activity only decreases as 
the 100 kDa form is degraded (Adams et al., 1986,1989). In somatic cells in vivo, 
there is little evidence for de novo methylation suggesting DNA methylase requires 
to recognise a methyl cytosine on one strand of hemimethylated DNA before 
catalysing the transfer of a methyl group to the opposite strand. It has been 
postulated by Adams et al., (1986) that proteolysis removes the domain which 
recognises hemimethylated sites and hence removes a constraint and allows de novo 
methylation to occur.
In the following experiments, polyclonal antisera raised against purified DNA 
methylase and against peptides synthesised from the predicted amino acid sequence 
of murine DNA methylase were used to probe western blots of cell extracts from 
HSV-2 mock-infected and infected RE cells. Hence, the effect of HSV-2 infection 
on the size of DNA methylase was investigated.
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3 .5 .1 Polyclonal Antiserum
Antiserum 173 is a polyclonal antiserum raised in a rabbit against DNA 
methylase purified from mouse Krebs II ascites cells. This antiserum has a titre of 
greater than 1 in 12,000 as measured in an ELISA assay and can inhibit 
transmethylation when added to a methylase assay (Adams et al., 1986).
Bestor et al., (1988) have cloned and sequenced the cDNA encoding mouse 
DNA methylase. The inferred protein sequence has 1573 amino acids and appears 
to be organised into two structural domains. The 1000 amino acid N-terminal 
domain contains a putative zinc DNA-binding motif and the C-terminal domain of 
570 amino acids shares strong sequence specificities with bacterial type II DNA 
methyltransferases. The C-terminal domain is, therefore, thought to contain the 
catalytic site and the N-terminal domain may be important in the regulation of 
activity.
Antisera 34,35 and 36 are polyclonal antisera raised against synthetic peptides 
corresponding to the predicted amino acid sequence. Figure 3.10 shows the 
position of these peptides in the predicted amino acid sequence
of DNA methylase. Antiserum 34 is raised against a peptide at the N-terminus, the 
region thought to be most sensitive to proteolytic degradation. Antiserum 35 is 
raised against a synthetic peptide corresponding to a region in the N-terminal 
domain adjacent to the Cys-rich region which has the characteristics of a metal- 
binding region, the region thought to be important in regulating the enzyme activity. 
Antiserum 36 is raised against a synthetic peptide corresponding to a region in the 
C-terminal domain between the Pro-Cys motif, thought to be located at the catalytic 
centre, and a 31 amino acid sequence which is highly homologous to bacterial type 
II methylases. In all of the above the synthetic peptides were prepared by Biomac in 
the department of Biochemistry. These were coupled to KLH and were injected 
subcutaneously into rabbits.
All 4 antisera were prepared by Dr R.L.P.Adams.
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3 .5 .2  Immunoblots of HSV-2 Infected and Mock-Infected RE 
Cells
Subconfluent RE cells were mock-infected or infected with HSV-2 for 4 hours 
(as in section 2.2.1.3.). 50 |i.g of 0.2 M NaCl nuclear extract and nuclear residue 
fractions, prepared as in section 2.2.4., were electrophoresed on an 8.75% SDS- 
polyaery 1 amide gel (as described in section 2.2.9.1.). This was transferred onto a 
nylon membrane (Hybond C+) by western blotting as in section 2.2.9.2. The blots 
were then probed with the appropriate antibody and were illuminated using protein 
A labelled with 125I as described in section 2.2.9.3.
Mouse DNA methylase is a single subunit enzyme of 185-190 kDa but because 
of its sensitivity to proteolysis it is often observed by SDS-polyacrylamide gel 
electrophoresis or immunoblotting as a group of 3 or 4 high molecular weight 
bands of 150-190 kDa. Bestor and Ingram, (1985) reported the purification of three 
closely related forms of DNA methylase from murine erythroleukaemia cells of 
190,175 and 150 kDa and these are speculated to be generated by proteolysis. 
When Adams et al., (1989) carried out a time course of trypsinisation of purified 
DNA methylase they observed 16 different sized bands during the course of the 
experiment.
Figure 3.11.shows, with all 4 antisera, the highest molecular weight DNA 
methylase present in the nuclear residue fraction. This is in accordance with a 
number of findings that suggests that it is the nuclear matrix bound form of the 
enzyme that is responsible in vivo for the maintenance methylation reaction.
Antiserum 173 (figure 3.1 la), detects a high molecular weight band in the 
nuclear residue fraction of 190 kDa and bands of approximately 185 kDa and 160 
kDa in the nuclear extract There are also a number of faint lower molecular weight 
bands but there are no major differences between the samples from mock-infecteced 
and infected cells.
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Antiserum 34 and 35 (figure 3.11 b&c), detect some high molecular weight 
material but strongly react with a group of proteins of 50-70 kDa. These antisera are 
raised against peptides in the N-terminal domain, the region thought to be sensitive 
to proteolysis, and hence they may correspond to highly antigenic cleavage 
products of DNA methylase. Again, there are no major differences in the pattern of 
bands obtained in mock-infected or infected cells.
Antiserum 36 (figure 3.1 Id ), detects the characteristic high molecular weight 
bands in the nuclear residue fraction along with a number of lower molecular 
weight species. There is one major difference, however, in the pattern of bands in 
the mock-infected and infected cells. A 40 kDa band appears to be present in both 
the nuclear extract and residue fractions but only from HSV-2 infected cells. The 40 
kDa band present in the 0.2 M nuclear extract was not seen, however, in 
subsequent experiments when an additional wash with buffer M+ was added before 
the 0.02 M NaCl extraction although it was still present in the nuclear residue 
fraction. This indicates that the 40 kDa band seen in the 0.2 M NaCl nuclear extract 
is probably a protein that can be readily leached from the nuclei. The appearance of 
the 40 kDa band in the nuclear residue fraction does not appear to correspond to any 
major degradation of the other bands. It may be that only very limited proteolysis is 
occurring but which produces a highly antigenic protein. Alternatively, it may be a 
viral protein which cross reacts with the antipeptide antiserum 36 and this possibilty 
is discussed further in the following section.
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Figure 3.11 The Size of DNA Methylase in HSV-2 Infected 
and Mock-Infected RE Cells
RE cells were infected or mock-infected with HSV-2 for 4 hours. 50 p.g of 
0.2 M nuclear extract or 50 fig of nuclear matrix were electrophoresed on an 
8.75% SDS-polyacrylamide gel and western blotted. The blots were then 
reacted with either (a) a 1:500 dilution of antibody 173 , (b) a 1:25 dilution of 
antibody 34, (c) a 1:100 dilution of antibody 35 or (d) a 1:25 dilution of 
antibody 36. All 4 blots were then reacted with l25I-labelled protein A and 
visualised by autoradiography (see section 2.2.9).
Lane 1 :5 0  pg nuclear matrix (infected).
Lane 2 : 50jig nuclear matrix (mock-infected).
Lane 3 : 50 |ig 0.2 M NaCl nuclear extract (mock-infected).
Lane 4 : 50|ig 0.2 M NaCl nuclear extract (infected).
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3 .5 .3  Timecourse of 40 kDa Protein Accumulation
Subconfluent RE cells were infected for 1 ,2 ,3  or 4 hours or mock-infected for 
4 hours with HSV-2 as described in section 2.2.1.3. 50 pg samples of nuclear 
residue prepared as in section 2.2.4.were electrophoresed on an 8.75% SDS- 
polyaery 1 amide gel and western blotted onto hybond C+ membrane (see sections
2.2.9.1.and 2.2.9.3.). The membrane was then probed with a 1:25 dilution of Ab 
36 and illuminated with 125I labelled protein A as in section 2.2.9.4.
Figure 3.12 shows that the 40 kDa protein is visible as early as 1 hour post­
infection and it accumulates with time up to the last time point of 4 hours post­
infection. Again, this does not appear to coincide with the dissappearance of any of 
the other bands. If the band is of viral origin, the pattern is most characteristic of an 
immediate early protein, the first set of viral proteins which are maximally 
expressed at 3-5 h post-infection. This subset of viral proteins, however, are well 
characterised (see section 1.2.2) and none are of the appropriate size. The possible 
origin of the 40 kDa polypeptide is discussed further in section 3.8.
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Figure 3.12 Timecourse of 40 kDa Protein Accumulation
RE cells were infected with HSV-2 for 1, 2, 3, or 4 hours or mock-infected 
for 4 hours. 50 |ig samles of nuclear matrix were electrophoresed on an 8.75% 
SDS-polyacrylamide gel and western blotted. The blot was reated with a 1:25 
dilution of antibody 36 followed by l25I-protein A and visualised by 
autoradiography.
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3 .6  Alterations in the Intracellular Ionic Environment as a Possible 
Mechanism for the Inhibition of DNA Methylation
HS V induced DNA polymerase has a number of biochemical properties 
different from its cellular counteiparL The HS V induced enzyme has a requirement 
for high salt concentrations (150 mM) for maximal activity and these high salt 
concentrations correspondingly inhibit the cellular enzyme by 90-100% (Keir et al., 
1966; Weissbach et al., 1973). In addition, the optimal Mg2+ concentrations are not 
the same. The viral enzyme shows maximal activity at 3 mM whereas the cellular 
enzyme requires a concentration of 8  mM for maximal activity. Mao et al., (1975) 
further demonstrated that 0.2 mM MnC^completely inhibited the HSV DNA 
polymerase but only inhibited the cellular enzyme by 35%.
The HSV induced ribonucleotide reductase also shows different biochemical 
properties to its cellular counterpart. Langelier and Butdn, (1981) demonstrated that 
at a concentration of 50 mM NH4 SO4 only 5% of the cellular activity remained 
whereas the HSV induced enzyme still retained 60% of its activity at this 
concentration.
These findings suggest that the intracellular ionic conditions may be altered on 
infection of cells with HSV-2. In the following two sections attempts were made to 
mimic these possible alterations in the intracellular environment to investigate if this 
was a possible mechanism whereby DNA methylase could be reversibly inhibited in 
vivo.
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3 .6 .1  The Effect of Increasing External [NaCl] on DNA
Methylation
When native DNA is used as a substrate to measure DNA methylase activity in 
vitro the reaction is strongly inhibited by salt Adams et al., (1979a), reported that 
50 mM N ad  brings about a 70% inhibition in activity. The probable reason for this 
being that the enzyme requires single-stranded regions with which to interact and 
these are available when the enzyme breathes, a situation favoured by low salt and 
high temperature. If denatured DNA is used in the assay, however, salt is 
stimulatory up to 100 mM NaCl.
To manipulate the internal NaCl concentration, the appropriate amount of NaCl 
was added to the external medium of subconfluent RE cells growing in 50 mm 
dishes to give a final concentration of 0-100 mM NaCl above the 120 mM already 
present in the cell medium. 100 JlCi [6 -3H]-uridine (23 Ci/mmol) was added along 
with the NaCl to a final concentration of 50 pCi/ml and the cells were labelled for 6  
hours at 37*C. Following the incubation, DNA was prepared, pyrolysed and the 
bases separated on an Aminex A6  column as described in section 2.2.6. As the 
DNA is labelled using [6 -3H]-uridine, the bases thymine, cytosine and 
methylcytosine are all labelled with trithm^see figure 2.1). The percent m5C is then 
calculated as below.
%m5C = [(m5C x 100)/(C + m^C)]
The cpm in thymine, cytosine and methylcytosine were summed to give a 
measure of the extent of DNA synthesis.
Figure 3.13 shows the effect of increasing the external concentration of NaCl ' 
on DNA synthesis and %m5C. When the external NaCl concentration is raised to 
220 mM, DNA synthesis is inhibited by 75% (figure 3.13a). This is in accordance
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with Saborio et al., (1974) who reported that these conditions lead to a dissociation 
of polysomes with concomitant inhibition of protein synthesis and cell growth.
The %m5C however, does not show the same inhibition (figure 3.13b) hence 
the limited DNA made under these conditions of high salt is fully methylated. DNA 
methylase in vivo therefore does not appear to be as sensitive to alterations in the 
NaCl concentration as it is in vitro. As was discussed above, high salt in vitro 
probably probably inhibits the breathing of DNA but in vivo, DNA helicases and 
single-stranded DNA-binding proteins generate and stabilise the single-stranded 
regions thought necessary for DNA methylase to interact with DNA.
The above results suggest, therefore, that any possible increase in salt 
concentration following HSV-2 infection is not responsible for the inhibition of 
methylation of newly synthesised cellular DNA in infected cells.
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| Figure 3.13 The Effect of NaCl Concentration on DNA
Methylation and DNA SynthesisI
RE cells were incubated in the presence of 0, 25,50, and 100 mM excess NaCl 
and 100 pCi [6 -3H] uridine for 6  hours. %m5C was determined according to 
section 2.2.6. DNA synthesis is expressed as cpm in thymine plus cytosine plus 
methylcytosine (see section 3.6.1).
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3 .6 .2 The Effect of Various Ionophores and Ouabain on
DNA Methylation
Ionophores are small, hydrophobic molecules that dissolve in lipid bilayers and 
increase ion permeability of the bilayer either by acting as mobile carriers or as 
channel formers. Certain ionophores show high discrimination between different 
ions and thus are useful tools to specifically alter the ionic milieu of a cell. In this 
experiment, cells were treated with a number of ionophores and the effect on DNA 
methylation levels were investigated. The ionophores used were as follows:
(i) Valinomycin This transports K+ down its electrochemical gradient
In addition, ouabain, a potent inhibitor of the Na+/K+ ATFase was used. This 
is not an ionophore but inhibition of the Na+/K+ ATPase prevents the uptake of K+ 
and the active extrusion of Na+ and thus upsets the cells ionic balance.
Subconfluent RE cells were incubated with the appropriate concentration of 
ionophore in a total volume of 2 ml for 2 hours at 37'C. 100 (iCi [6 -^H] uridine (23 
Ci/mmol) was then added and the cells were incubated for a further 6  hours. 
Following the incubation, DNA was prepared, pyrolysed and the bases separated 
on an Aminex A6  column (section 2.2.6).
(iii) Monensin
(ii) A23187
and hence depletes intracellular K+ levels.
This catalyses the electroneutral exchange of divalent 
cations such as Ca2+ and Mg2+ with two H+ and is 
widely used to increase the concentration of 
free Ca2+ in the cytosol.
This catalyses the electroneutral exchange of Na+ and 
H+. This results in increased intracellular levels of
Na+.
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Figure 3.14 shows that none of the treatments significantly altered the level of 
%m5C hence DNA methylase activity in vivo does not appear to be affected by 
alterations in the concentration of Na+, K+ or Ca2+ in the cell.
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Figure 3.14 The Effect of Ionophores and Oubain on DNA 
M ethylation Levels
RE cells were incubated in the presence of 1 mM|ouabain, 0.25 mM 
valinomycin, 100 pM monensin and 7 pM A23187 (Ca 2+ ionophore) for 2 hours. 
The cells were then labelled with 100 pCi [6 -3H] uridine for a further 6  hours. 
%m5C was determined as in section 2.2.6 and is expressed as % of the control 
value i.e. RE cells not treated with ionophore.
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3 .7  Immunofluorescence Microscopy
DNA replication occurs at numerous discrete sites in eukaryodc cell nuclei, each 
site containing a cluster of replication forks (Nakamura et al., 1986; Mills etal., 
1989; Nakayasu and Berezney, 1989), closely associated with the nucleoskeleton 
(Jackson and Cook, 1986; Van der Velden and Wanka, 1987). There is evidence to 
suggest that the enzymes involved in DNA replication are clustered into functional 
complexes, termed replicases, also associated with the nuclear matrix (reviewed by 
Huberman, 1987). Further evidence for the localisation of replication proteins at 
these sites has come from the use of antibodies against some of these replication 
proteins such as DNA polymerase a  and proliferating cell nuclear antigen (PCNA) 
(an accessory factor to DNA polymerase d). Immunofluorescence microscopy 
studies have shown that these proteins colocalise with the sites of DNA replication 
which are visualised using antbodies against bromo-deoxyuridine (BrdU) 
incorporated into newly synthesised DNA (Nakamura et al., 1984; Celis and Celis, 
1985; Bravo and Macdonald-Bravo, 1987; Hutchison and Kill, 1989). Eukaryotic 
DNA replication, therefore, appears to be a highly structured and complex process.
The DNA methylase responsible for maintenance methylation in vivo, is 
thought to be that which remains firmly associated with the 2 M NaCl resistant, 
nuclear-matrix structures (Burdon et al., 1985). There is still debate, however, as to 
its localisation within this salt-resistant nuclear fraction and its association with the 
replication apparatus. Noguchi et al., (1983) reported that DNA methylase co­
purified with a high molecular weight complex of proteins released from nuclei by 
sonication. This complex is composed of proteins involved in DNA replication, 
contains both template and newly synthesised (nascent) DNA and is capable of 
catalysing the incorporation of 14C-rCDP into DNA suggesting it is a functional 
complex in vivo. Ciafa etal., (1988), however, have demonstrated that the so- 
called "matrix-bound" form of DNA methylase is not attached to the matrix itself, as 
previosly suggested by several groups (Burdon etal., 1985; Drahovsky etal.,
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1985; Tubo and Berezney, 1987) but is localised in the DNA loops of such nuclear 
preparations. Digestion of the nuclear matrix fraction with DNAse 1 to leave only 
the "DNA attachment" sites showed no DNA methylase activity remained in this 
fraction. Such DNA attachment sites have been suggested to be the sites of 
replication complexes (Gross andlGarrard, 1987) and therefore the above findings 
suggest that DNA methylase may not be as intimately asssociated with these 
complexes as was previously suggested.
The replication of HSV also occurs in ordered structures termed replication 
compartments containing all the elements necessary for viral DNA replication 
(reviewed by Knipe, 1990). De Bruyn-Kops and Knipe, (1988) demonstrated 
using anti-BrdU immunofluoresence, that cellular replication complexes relocate to 
the sites of viral DNA replication. Wilcock and Lane, (1991) further demonstrated 
using antibodies against several cellular proteins that various proteins involved in 
cellular DNA replication e.g DNA polymerase a  and single stranded DNA binding 
protein, also relocate to these viral replication sites whereas the non-replication 
proteins tested did not.
Although the exact location of DNA methylase in replicating cells is not known 
it is essential that it has access to the newly synthesised DNA. It was discussed 
above that HSV infection alters the localisation of both replicating cellular DNA 
and certain cellular proteins. The inhibition of cellular methylation following HSV-2 
infection may, therefore, be due to a disruption in the association of cellular 
replication and DNA methylase which would distance the enzyme from its 
substrate.
To investigate this hypothesis, immunofluorescence microscopy was used to 
compare the localisation of DNA methylase and the sites of replication in cells 
mock-infected or infected with HSV-2.
127
3 .7 .1  The Effect of HSV-2 Infection on the Intracellular
Distribution of DNA Methylase
RE cells were grown directly onto glass coverslips at a density of lx l0 6  cells 
per 50 mm dish. Subconfluent cells were then infected or mock-infected for 4 hours 
as in section 2.2.1.3. Following infection the cells were fixed with 3:1 
methanol:acetone and stored at -70*C until required.
To locate the DNA methylase, the cells were incubated with 100 |il of a 1:10 
dilution of either Antibody 34,35 or 36. These are all polyclonal antisera raised 
against synthetic peptides corresponding to the predicted amino-acid sequence of 
murine DNA methylase (see section 3.5.1). In addition, as a control, cells were 
incubated with 100 |il of a 1:10 dilution of PR-6 , a monoclonal antibody raised 
against GRP-94 (a glucose regulated protein), kindly donated by Dr J.C.M. 
Macnab, followed by an incubation with a 1:20 dilution of rabbit anti-rat IgG. The 
cells were all then incubated with 100 |il of a 1:80 dilution of FITC-conjugated goat 
anti-rabbit IgG. For details of the immunofluorescence staining and microscopy 
procedures see section 2 .2 .1 0 .
Figure 3.15 shows that the staining pattern with all 3 anti-methylase antibodies 
differs in mock-infected and infected cells. Antibodies 34 and 35 show a faint 
nuclear staining in mock-infected cells (figures 3.15a, c) which appears to be 
evenly distributed. With antibody 36 in figure 3.15e however, it is difficult to 
distinguish the staining from that of the background staining. Various methods 
were tried to reduce this background which included;
(i) Increasing the concentration of the blocking agent, foetal calf serum, 
from 2% to 5%.
(ii) Including 0.2% Tween 20 in all buffers.
(iii) Titrating both the first and second antibodies.
(iv) Increasing the length of washes.
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These approaches, however, did not abolish the background staining (results 
not shown) but as time was limited no further parameters were investigated. It is 
clear, however, that the pattern of staining is altered on infection. With all 3 anti- 
methylase antibodies the infected cells show distinctive perinuclear staining (figures 
3.15b, d, f).
The control cells (figures 3.15g, h) show the same granular cytoplasmic 
staining in both infected and mock-infected cells.
The increase in intensity of immunofluorescence staining seen with the an ti­
me thylase antibodies followingl infection may be the result of a more concentrated 
localisation of DNA methylase or it may be a result of increased immunogenicity as 
the results in section 3.2.2 indicate that there is no increase in nuclear DNA 
methylase levels following infection with HSV-2.
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Figure 3.15 The Intracellular Distribution of DNA Methylase
RE cells were mock-infected (a, c, e, g) or infected (b, d, f, h) with HSV-2 
for 4 hours and were fixed with 3:1 methanol:acetone (see section 2.2.10). The 
cells were then incubatedi with antibody 34 (a, b), antibody 35 (c, d), antibody 
36 (e, f) or PR- 6  (g, h) followed by an incubation with the appropriate FITC- 
conjugate antibody (see section 3.7.1). Immunofluoresence micrographs were 
taken using a Leitz Wetzler fluorescence microscope equiped with a 40X NPL 
fluotar objective lens.
131
3 . 7 . 2  Localisation of the Sites of DNA Replication 
Following Infection with HSV-2
De Bruyn-Kops and Knipe, (1988) demonstrated that replication of both 
cellular and viral DNA in HSV infected cells takes place in the same replication 
compartments throughout the nucleus. In section 3.7.1 it was shown that DNA 
methylase concentrates around the nuclear periphery following infection with HS V- 
2. This suggests that in infected cells DNA methylase may not be present in these 
replication compartments and hence not have acess to its substrate DNA. It was 
therefore decided to localise the sites of DNA replication in HSV-2 infected cells 
and compare these to the localisation of DNA methylase.
Two different antibodies were used to localise these sites using 
immunofluoresence microscopy; an antibody against the major DNA binding 
protein of HSV-2 and an antibody against BrdU incorporated into newly 
synthesised DNA. Infected cell protein 8  (ICP 8 ), the major DNA binding protein, 
of HSV-1 is one of the seven viral proteins essential for viral DNA synthesis (see 
section 1.2.3). Prior to the induction of viral synthesis ICP8  is found at numerous 
discrete sites in the nucleus, associated with the nuclear framework, termed 
prereplicative sites. Following the onset of viral DNA synthesis ICP8 accumulates 
in large globular compartments associated with viral DNA. De Bruyn-Kops and 
Knipe, (1988) demonstrated that the cellular DNA replication sites relocate 
following infection and colocalise with ICP8  in these prereplicative and replicative 
compartments. Wilcock and Lane, (1991) also demonstrated, using 
immunofluorescence microscopy, that various cellular proteins involved in cellular 
DNA replication also relocate to viral replication sites. In the absence of ICP8 , i.e 
using mutant strains of virus, relocation of cellular replication does not occur hence 
ICP8  is thought to be responsible for the organisation of the viral DNA replication 
machinery and for the relocalisation of both replicating cellular DNA and cellular 
replication proteins. ICP11/12 is the HSV-2 homolog to ICP8  in HSV-1 (Yeo et
al., 1981). Mutations in the gene encoding ICP11/12 also prevent HSV viral DNA 
replication suggesting a similar, important function for the HSV-2 major DNA 
binding protein. Hence, antibodies against ICP11/12, were used as one marker for 
viral replication sites.
To detect ICP11/12, HSV-2 mock-infected and infected cells (prepared as in 
section 2.2.10) were incubated in a humid chamber for 1 hour at 37*C with a 1:50 
dilution of LP4 (a mouse monoclonal anti ICP11/12 kindly provided by Dr J.C.M. 
Macnab). This was then followed by a 1 hour incubation with a 1:250 dilution of 
FITC-conjugated goat anti-mouse IgG. DNA methylase was detected using 
antibody 34 as in section 3.7.1.
Figure 3.16b shows the distribution of ICP11/12 and hence sites of replication 
in cells infected for 4 hours with HSV-2. The staining covers most of the nucleus, 
with the possible exception of the nucleoli. This is in contrast to figure 3.16d where 
DNA methylase is localised around the nuclear periphery as was also shown in 
section 3.7.1. There appears again, however, to be a slight problem with 
background staining as seen in figure 3.16a which shows a faint reaction of 
uninfected cells with LP4.
BidU immunofluorescence microscopy was also used as second alternative way 
to identify sites of DNA replication. Cells were labelled with the BrdU labelling 
reagent (1:10,5'-bromo-2'-deoxyuridine:5'-fluoro-2'-deoxyuridine) from 1-3 
hours post-infection. The BrdU epitopes were then detected using anti-BrdU 
monoclonal antibody followed by an FlTC-conjugared second antibody as 
described in section 2.2.10. DNA methylase was detected in BidU-labelled cells 
using antibody 36 (as well as 34 and 35, results not shown) as described in section 
3.7.1.
Figure 3.17 shows that the sites of DNA replication again appear to be 
distributed throughout the nucleus (figure 17a, b)). DNA methylase is also seen to 
relocate to the nuclear periphery.(figure 3.17c, d) following infection.
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In order to investigate the spatial relationship of ICP11/12, DNA replication 
and DNA methylase in closer detail it would be necessary to perform double 
labelling experiments along with confocal microscopy but time did not allow for 
this to be carried out. However, what is clear from this experiment is that DNA 
methylase is not associated with the bulk of the HSV major DNA binding protein or 
sites of DNA replication and therefore is excluded from most, if not all of the DNA 
replication compartments.
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Figure 3 .16  The Cellu lar Localisation of  DN A M ethylase and
I C P 1 1 /1 2
RE cells were mock-infected (a, c) or infected (b, d) for 4 hours with HSV-2 
and were fixed with 3:1 methanol:acetone (see section 2.2.10). The cells were then 
reacted for 1 hour with a 1:50 dilution of LP4 (a, b) or a 1:10 dilution of antibody 
34 (c, d) followed by a 1 hour incubation with a 1:250 dilution of H  1C conjugated 
anti-mouse (a, b) or a 1:80 dilution of FTTC-conjugated anti-rabbit IgG(c, d) (see 
section 2.2.10).
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F igu re  3 .17  T h e  C ellu lar  L ocalisation  o f  D N A  M ethylase and
R ep lica t in g  D N A
RE cells were mock-infected (a, c) or infected (b, d) with HSV-2 for 4 hours in 
the presence of BrdU (see section 2.2.10). The cells were then incubated for 1 hour 
with a 1:100 dilution of anti BrdU antibody (a, b) or a 1:10 dilution of antibody 36 
(c, d) followed by a 1 hour incubation with 1:250 dilution of FITC conjugated anti­
mouse (a, b) or a 1:80 dilution of FITC conjugated anti-rabbit (c d) antibodies.(see 
section 2.2.10).
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3 . 7 . 3  The Effect of a Mutation in Vmw 175 on the
Relocalisation of DNA Methylase
Vmw 175 (ICP4) is the product of one of the five IE genes expressed by HSV 
and is essential for viral early and late gene transcription (see section 1 .2 .2 ). 7 sk is 
a temperature sensitive mutant which at the non-permissive temperature of 38.5’C 
makes a defective Vmw 175 along with the other IE early proteins and one early 
polypeptide Vmw 136 (Preston, 1979).
Macnab et al., (1988) demonstrated that infection with this mutant at the non- 
permissive temperature only resulted in a 20-25% inhibition in the level of 
methylation as opposed to the 90-95% inhibition seen using wild-type virus. This 
may demonstrate that Vmw 175 is not the only factor involved in the inhibition of 
DNA methylation following infection with HSV. Alternatively, the mutant virus 
infection may have been "leaky" resulting in the expression of small amounts of the 
protein. Whichever the case however, the presence of a functional Vmw 175 
appears to play an important role in the observed inhibition of DNA methylation.
The aim of this experiment was, therefore, to investigate if a functional Vmw 
175 was also required to cause an alteration in the nuclear localisation of DNA 
methylase as seen following HSV infection in sections 3.7.1 and 3.7.2.
RE cells were grown directly onto glass coverslips and were infected with 
HSV-2 or tsK at the non-permissive temperature (38.5‘C) for 4 hours after which 
time the cells were then fixed with 3:1 methanol:acetone (see section 2.10). To 
locate DNA methylase the cells were reacted with one of the two anti-methylase 
antisera 35 or 36 followed by an incubation with FITC-conjugated goat anti-rabbit 
IgG.
In an attempt to reduce the background, the primary antibody concentration 
used in this experiment was reduced to a 1:100 dilution. At this dilution, the 
characteristic perinuclear staining seen in infected cells in the previous experiments 
is clearly visible in the cells infected with wild-type vims with both antibodies 35
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and 36 (figures 3.18e, f). This is not seen however, in the cells infected with tsK 
(figures 3.18c, d) and the faint staining throughout the cell is presumably 
background (which has been seen to be a slight problem in the previous two 
secdons).This background staining also makes it difficult to distinguish the location 
of DNA methylase in mock-infected cells.
This experiment therefore shows that Vmw 175 expression is necessary for the 
redistribution of DNA methylase to the nuclear periphery following infection with 
HSV-2.
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Figure 3.18 The Effect of a Mutation in the HSV Protein, 
Vmw 175 on the Localisation of DNA 
Methylase
RE cells vere infected with HSV-2 (e, f), tsK (c, d) or mock-infected (a, b) 
for 6  hours at38.5*C and were fixed with 3:1 methanol:acetone (see section 
2.2.10). The cells were then reacted with a 1:100 dilution of antibody 36 (a, c, 
e) or antibodj 35 (b, d, f) for 1 hour followed by a 1 hour incubation with a 
^  1:80 dilutionjbf FITC conjugated goat anti-rabbit IgG.
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3 .8  Discussion
The aim of the experiments presented in this chapter was to investigate the 
possible mechanisms by which HSV-2 infection could inhibit the methylation of 
newly synthesised cellular DNA in RE cells.
The Intracellular Distribution of DNA Methvlase Activity
From the data obtained in section 3.2 it is unlikely that the reduction in 
methylation levels, following infection with HSV-2, occurs as a result of a loss of 
DNA methylase activity. Both the overall level of activity, as measured in cell 
lysate, and the activity of the "bound" form of the enzyme thought to be responsible 
for maintenance methylation in vivo (as measured in the nuclear residue fraction) 
were found to be unaltered following infection.
A number of groups have similarly reported that the reductions in methylation 
levels seen in transformed cells do not necessarily correspond with reductions in 
DNA methylase activity and indeed some groups have shown increases in DNA 
methylase activity in transformed cells (Lapeyre et al., 1981; Amaud etal., 1985; 
Kautiainen and Jones, 1986). Szyf et al., (1985,1991) have demonstrated that the 
expression of DNA methylase is cell cycle-dependent and they speculate that 
imbalances in the cell cycle that occur in transformed cells may lead to these 
increases in DNA methylase activity. Hence, a reduction in DNA methylase activity 
is not a prerequisite for the inhibition of DNA methylation in vivo.
The Effect of HSV-2 Infection on SAM and SAH Metabolism.
The second hypothesis addressed in this chapter was that HSV-2 coaid cause an 
imbalance in the metabolites SAM and SAH which could indirectly lead to an 
inhibition of DNA methylation in vivo (as discussed in section 3.3). Measurement 
of the rate of SAM breakdown shows no differences between mock-infected and 
infected cells ruling out the possibility that infection with HSV-2 induces a
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SAM'ase type enzyme. The amount of SAM degraded in this assay corresponds to 
a turnover of approximately 40% of the total amount of SAM (as measured in 
section 3.2.2.3) in 30 minutes. This is in accordance with the results obtained in 
section 3.2.2.2 where >90% of 35S-labelled SAM is metabolised within 2 hours of 
removing the source of the label i.e. 35S-methionine. This also correlates with the 
results of Guilidori et al., (1984) who demonstrated that the half-life of SAM in 
vivo was approximately 30 minutes. SAH is a potent inhibitor of the DNA 
methylase reaction and alterations in its metabolism and therefore in the ratio of 
SAM:SAH have been shown to be sufficient to cause a decrease in the m5C content 
of DNA in rats (Wilson et al., 1984). Adams and Bunion, (1985) have shown that 
when SAM and SAH are present at equimolar concentrations in vitro, DNA 
methylase activity is inhibited by some 84%. In vivo, the ratio of SAM:S AH has 
been variously estimated between 3 and 25 (Wilson et ai> 1984; De Sanchez et al., 
1991) which is in accordance with the results obtained in this study however, no 
significant difference was seen in the SAM:SAH ratio in HSV-2 infected and mock- 
infected RE cells. Amaud et al., (1985) similarly found that the hypomethylation of 
rat kidney cells transformed by avian sarcoma virus (compared to normal control 
cells) was not related to alterations in SAM:S AH ratios which they calculated as 
being 10.94 and 12.32 respectively. The values obtained, in this study, for the 
amount of SAM and SAH relates to intracellular concentrations of approximately 30 
pM and 3pM respectively and these values also correlate well with the reported Km 
and Ki values for DNA methylase (Adams and Burdon, 1985). HSV infection 
therefore, does not appear to cause the hypomethylation of newly synthesised DNA 
by altering the metabolism of SAM or SAH.
Endogenous DNA as Methyl Group Acceptor
In experiment 3.4, DNA from HSV-2 infected cells accepts methyl groups more 
readily than DNA from mock-infected RE cells. As discussed in section 1.1.2.2 the 
preferred substrate of DNA methylase is hemi-methylated DNA. Following
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infection of RE cells with HSV-2, only the newly synthesised strand of DNA fails 
to be methylated. The parent strand is not demethylated as the level of methylation 
in DNA synthesised prior to infection is not altered (Macnab et al., 1988) and 
therefore the cellular DNA in infected cells must be largely hemi-methylated. This 
hemi-methylated DNA is theoretically an ideal substrate for DNA methylase and this 
correlates with the finding that DNA from infected cells accepts methyl groups more 
readily than DNA from mock-infected cells. The aim of the experiment was to 
investigate if DNA methylation was inhibited by DNA binding proteins blocking the 
access of DNA methylase to its substrate sites. However, although endogenous 
DNA from infected cells accepts methyl groups more readily than that from mock- 
infected cells this may be the net result of a balance between increased hemi- 
methylated sites and inhibitory proteins. From the results alone, therefore, it cannot 
be concluded that are no such inhibitory proteins bound to DNA in infected cell 
nuclei.
Characterisation of the Molecular Weight of DNA Methylase following 
Infection with HSV-2
The results obtained section 3.5 show that there is no significant degradation of 
the high molecular weight species of DNA methylase following infection with 
HSV-2. However, one of the antipeptide antibodies used (Ab 36) detects an HSV-2 
induced 40 kDa polypeptide in the nuclear residue fraction which can be detected as 
early as one hour post-infection. This polypeptide is highly antigenic and it may be 
generated from only limited proteolysis of DNA methylase. Alternatively, the 
polypeptide cross-reacts with the anti-methylase antibody may not be part of DNA 
methylase. If the band is of viral origin the pattern of accumulation is most 
characteristic of an immediate early protein. However, none of the set of 5 IE 
proteins are of the appropriate size and hence, the 40 kDa polypeptide could only 
correspond to a breakdown product of one of these proteins. Computer analysis
was used to compare the amino acid sequence of the
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peptide 36 with the amino acid sequences in the EMBL databank. Some] identity 
was found with the IE protein Vmw 175 (4 out of 10 amino acids are identical, see 
Fig. 3.19) although it is uncertain as to the degree of cross-reactivity that this 
identity would confer.
1 CKDMSPLVAA 10 Peptide 36
I I II
695 QSLRPLLAA 703 Vmw 175
Figure 3.19 Identity Between Peptide 36 and Vmw 175
(The numbers represent the amino acid position)
In addition, there is no evidence to suggest that the Vmwl75 protein is 
degraded in this way and no accumulation of a 175 kDa protein is seen in the 
timecourse assay in section 3.5.
A second alternative is that the 40 kDa polypeptide may be a cleavage product of 
DNA methylase. Antibody 36 was raised against a synthetic peptide corresponding 
to a region with the C-terminal of the predicted amino acid sequence of murine 
DNA methylase (see section 3.5). Since these experiments were performed, cDNA 
clones encoding the human DNA methylase have been isolated and sequenced and a 
sequence identical to peptide 36 is found within the homologous region of the 
predicted amino acid sequence of the human enzyme suggesting that this region 
may be functionally important (Yen et al., 1992). Both of these mammalian DNA 
methylases also show strong sequence similarities to all of the approximately 30 
known bacterial cytosine 5-methyltransferases. These comparisons also suggest 
that the carboxy terminal one-third of the enzyme is the catalytic domain (see section 
3.5). However, peptide 36 does not lie within the predicted active site which is 
thought to be centered around the most carboxy-terminal Pro:Cys motif (Chen et 
al., 1991). Cleavage of 400 amino acids from the caiboxy terminus to give a 
polypeptide of approximately 40 kDa would not, theoretically, remove the active
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site although it may reduce activity. The findings in section 3.2 show that DNA 
methylase activity measured in vitro is not inhibited at 4 hours post-infection at a 
time when the 40 kDa protein is present on immunoblots. It cannot be ruled out that 
this extreme carboxy-terminal region of DNA methylase is important in allowing the 
methylation of DNA in vivo but is not required for activity in vitro. However, the 
results in section 3.5 suggests that the bulk of the enzyme is unaltered following 
infection and therefore limited proteolysis of the enzyme may not result in any 
significant alteration in the overall DNA methylase activity.
Alterations in the Ionic Environment as a Possible Mechanism for the Inhibition 
of DNA Methylation
Manipulation of the internal ionic environment by increasing the external [NaCl] 
in experiment 3.6 had a dramatic effect on the synthesis of DNA however, the 
%m5C in the limited amount of DNA synthesised was unaltered under these 
conditions of hypertonicity.
Robbins et al., (1970) demonstrated that the inhibition of macromolecular 
synthesis following exposure of HeLa cells to hypertonic medium was readily 
reversible suggesting that the cells are not permanently damaged by this treatment 
Saborio et al., (1974) reported that hypertonicity inhibits protein synthesis by 
causing a dissociation of polysomes but the mechanism of inhibition of DNA 
synthesis is still unclear. Inhibition of DNA replication and/or an increase in the 
ionic concentrations caused by the increased osmolarity however had no effect on 
the level of DNA methylation. These results correlate to the results of Woodcock et 
al., (1982) who similarly showed, using specific inhibitors, that inhibition of DNA 
replication has no effect on DNA methylase activity in vivo. In addition, more 
specific manipulations of the ionic environment using ionophores to alter the 
concentrations of specific ions also had no effect on the level of DNA methylation.
The results from these two experiments show that DNA methylase activity in 
vivo is relatively stable in a variety of ionic environments. Therefore, any
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alterations in the ionic milieu of the cell following infection with HSV is unlikely to 
be the cause of viral induced inhibition of cellular DNA methylation.
Immunofluoresence microscopy
In section 3.7, HSV-2 infected cells showed strong perinuclear staining when 
reacted with all three anti-peptide, anti-methylase, antisera. This is in contrast to the 
staining pattern seen in mock-infected cells which showed only weak nuclear 
staining, in some cases indistinguishable from the background staining, when 
reacted with the same antiserum.
Previous immunofluoresence studies on the intracellular localisation of DNA 
methylase have shown that it is only visible during S-phase but at this time it 
appears to be evenly distribute throughout the nucleus (Vogel et al., 1988). There 
have been no studies to date, however, investigating the colocalisation of DNA 
methylase and replication compartments and hence the spacial relationship between 
DNA replication and methylation is still unclear.
What is clear from the studies presented in section 3.7 is the dramatic alteration 
of DNA methylase localisation following infection with HSV-2 which appears to 
remove the DNA methylase from the proximity of the majority of sites of DNA 
replication (as demonstrated in section 3.7.2). From these results it is speculated 
that the inhibition of methylation of cellular DNA following infection with HSV-2 
occurs as a consequence of this distancing of the enzyme from its substrate i.e. 
newly synthesised hemi-methylated DNA. This hypothesis also correlates with the 
other findings described in this project in that such a mechanism would not require 
any direct or indirect aletrations in DNA methylase activity in vivo.
The remaining question to be addressed is how DNA methylase is relocated following 
infection with HSV. Only one candidate HSV function, the IE protein Vmw 175, was 
investigated as time was limited. From the results obtained in section 3.7.3 it appears 
that the expression of Vmw 175 is a requirement for the ielocalisation of DNA 
methylase. This correlates with the findings of Macnab et al., (1988) who
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demonstrated, using an HSV mutant, that a functional Vmw 175 is required to cause 
maximal inhibition of DNA methylation. However, Vmw 175 is a trans-acting factor 
(see section 1 .2 .2 ) and from these experiments alone it is impossible to determine if 
relocalisation is mediated by this protein or by proteins expressed as a consequence of 
Vmw 175 expression.
Chapter 4 DNA Hypomethylation and HSV 
Transformation.
148
4 .1  The Effect of HSV Transforming Regions on DNA
Methylation
Macnab et al., (1988) demonstated that cell-lines derived from foci 
morphologically transformed by the Bgl II n fragment of HSV-2 were 
hypomethylated in comparison to the parent RE cells. Although the genes encoding 
the entire small subunit (RR2) and part of the large subunit (RRi) map within this 
fragment there is no requirement for retention of the fragment or for the continued 
expression of ribonucleotide reductase in the maintenance of the transformed state 
(Cameron e ta l., 1985) (see section 1.2.5).
The aim of the experiment in this section was to investigate if the Bgl n  n 
transforming region or regions of HSV-2 encoding ribonucleotide reductase could 
possibly initiate transformation by influencing the level of DNA methylation. To 
address this question, four different plasmids containing the HSV-2 sequences of 
interest were transfected into RE cells using the calcium phosphate DNA co­
precipitation method (see section 2.2.14).
The Bgl II n plasmid contains the Bgl II n fragment of HSV-2 cloned into the 
the vector pAT 153 at the Bam H I site and was constructed by A.J. Davison of the 
Institute of Virology (see figure 4.1).
Plasmids containing sequences encoding either, or both, of the two subunits of 
ribonucleotide reductase were constructed by P. Clarke, S. Simpson, I. Nikas and 
J.B. Clements also in the Institute of Virology. The plasmid pOCi contains the 
gene encoding the ribonucleotide reductase large subunit, RRi and pOC2 contains 
the gene encoding the small subunit, RR2 , both of which are under the control of 
the metallothionine promoter (MT-1). The plasmid POC3 contains the genes 
encoding both of the ribonucleotide reductase subunits, the small subunit gene 
being under control of its own promoter whilst the large subunit gene is under 
control of the metallothionine promoter (see figure 4.1). All three pOC plasmids 
have been demonstrated to be transcribed in transfection assays and this
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pOC2
mrRR2
pO Cl
MT
RRI
pOC3
RR2
MT
RRI
pLW4
A
CAT
Egl 11 n
Bgl II n
Figure 4.1 Plasmids used in Transfection Assays
Plasmids not shown to scale. The abbreviations used are as follows: 
RR: Ribonucleotide Reductase 
MT: Metallothionine Promoter 
A: Activator Sequence 
P: HSV IE Promoter
T: Terminator Sequence (for details see section 4.1)
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transcription is optimally induced with 100 mM Zinc Sulphate (Clarice, 1990). 
However, only cells transfected with POC3 or co-transfected with pOCi and pOC2 
were shown to demonstrate viral ribonucleotide reductase activity as both of the 
functional subunits are required for activity.
To monitor the success of the transfection, the plasmid pLW4 was co­
transfected with each of the plasmids described above. The plasmid pLW4 was 
constructed by Lindsay Whitton (Gaffney et al., 1985) at the Institute of Virology, 
Glasgow and it contains the bacterial chloramphenicol acyl transferase (CAT) gene 
under the control of an HSV-2 IE promoter. In addition, it contains an activator 
sequence which has been demonstrated to increase the transcription of the CAT 
gene 2-3 fold in transcription assays (Gaffney et al., 1985). Mammalian cells do 
not contain the gene encoding CAT and hence any CAT activity found in transfected 
cells gives a measure of the success of transfection.
Chloramphenicol acyl transferase transfers acyl groups to the hydroxyl groups 
on Ci and C3 of chloramphenicol and this activity is normally measured by 
quantifying the level of 14C-chloramphenicol acylated using thin-layer 
chromatography. However, a new, simpler and morel sensitive method introduced 
by Seed and Sheen, (1988) was used in this project. This assay uses butyryl-CoA 
as oppossed to acetyl-CoA as the acyl donor and the greater hydrophobicity of 
butyrylated chloramphenicol allows an effective discrimination between free and 
butyrylated chloramphenicol by a simple phase-extraction assay (see section 
2.2.15).
RE cells were transfected with a suspension containing 5 |ig of the test plasmid 
and/or 5 jig of the control plasmid pLW4 (as described in section 2.2.14) made up 
to a total of 20 fig with calf thymus DNA. 48 hours after transfection, the cells were 
harvested and the level of CAT activity (see section 2.2.15) and m5C (see section 
2.2.6.1) determined. Table 4.1 shows the results obtained. None of the plasmids 
used has a significant effect on the %m5C when transfected into RE cells as
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compared to the control values. The CAT activity in cells co-transfected with the 
pOC plasmids and pLW4 is lower than that in cells transfected with pLW4 alone.
However in each of the transfection assays, CAT activity was detected 
signifying that DNA was being taken up by the cells.
Plasm id CAT Activity 
(% of control)
% msC
pLW 4-Control 100 3.77 ± 0.69 (5)
C arrier Only 0.50 ± 0.17 (6) 3.68 ± 0.43 (5)
B g lll  n Plasmid 114, 102 3.39, 3.28
pO C i:Zn Induced 59.7, 66.7 3.91
pO C i:U ninduced 13, 18 4.28, 4.18
pO C 2 :Zn Induced 65, 66 3.79
pO C 2 :Uninduced 20, 19 3.63, 3.81
pO C 3 :Zn Induced 38.5, 56 3.97
pO C 3 :Uninduced 23, 33 3.82, 4.19
Table 4.1 The Effect of HSV-2 Transform ing Regions on 
DNA M ethylation.
The transfection assays using the pOC plasmids were carried out as two 
separate experiments. The first without added ZnSC>4 and the second with ZnS0 4  
added 24 hours after transfection.
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4 .2  The Intragenomic Distribution of m5C in Bn5T Cells
Hsiao et al., (1985), demonstrated that treatment of mouse embryo fibroblasts 
with the demethylating agent, 5-azacytidine can lead to cell transformation and other 
groups have shown similar results in the same (Jones and Taylor, 1980) or in 
different (Darmon et al., 1984; Reitz et al., 1984) cell systems. In these cases, 
widespread demethylation is suggested to lead to the chance activation of cellular 
genes involved in cell transformation although this may, in fact, be only one factor 
in a multistage process (see section 1.1.4).
DNA methylation levels in Bn5T cells are less than half that of the parent RE 
cells. The aim of this experiment was to investigate if this hypomeythlation is 
widespread throughout the genome and hence could feasibly influence gene 
expression. It is possible, however, that reduced methylation levels in toto could 
result from a drastic reduction in, for example, the amount of methylation of 
satellite DNA with the same or even increased methylation in the other DNA 
fractions which encode proteins.
To study the intragenomic distribution of m5C, subconfluent burrlers of RE and 
Bn5T cells were labelled for 2 days with 6-3H uridine (200 |iCi, 23 Ci/mmol) in a 
total of 50 ml of media. The tritium labelled DNA, prepared as in section 2.2.11.1, 
was then fractionated into different frequency classes (see section 2.2.11.2).
Briefly, the DNA was denatured in 0.175 M NaOH at 60*C for 10 minutes. 
Renaturation was initiated with the addition of 0.175 M HC1 and PIPES buffer and 
the reaction mixture incubated at 60*C for the appropriate length of time to achieve 
the desired Cor value. Cor values were chosen to represent the following three 
classes of eukaryotic DNA.
(i) Highly repetitive DNA: CoT < 0.01
(ii) Moderately repetitive DNA: Cot 0.01-70
(iii) Unique DNA : Cot > 70
Co* value is defined as the initial concentration (Co) expressed as moles 
nucleotide per litre multiplied by the time (t) in seconds it takes for the DNA to 
reanneal.
Following the appropriate reannealing time, single-stranded DNA was digested 
with S1 nuclease. The duplex DNA was precipitated with 5% TCA and washed 
twice with 5% TCA and once with absolute alcohol. To determine the %m5C in 
each of the frequency classes the DNA was pyrolysed with formic acid for 1.5 
hours at 175'C and the bases separated on an Aminex A6 column as described in 
section 2.2.6.2.
Figure 4.2 shows that in both RE and Bn5T DNA samples, the satellite DNA 
fraction (Cot < 0.01) has the highest proportion of its cytosines methylated. This is 
in accordance with a number of previous studies which have shown rapidly 
annealing DNA to be the most highly methylated DNA fraction in various tissues 
and cells (Drahovsky et al., 1979, Ehrlich et al., 1982).
In the unique, single copy fraction, the methylation levels in both Bn5T and RE 
are very similar to the total DNA levels. There is a slight difference in the relative 
methylation levels in the mildly repetitive fraction but the pattern overall suggests 
that there is a lower level of methylation in all classes of DNA in Bn5T cells 
compared to RE cells with HSV-2.
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□  R.E Cells 
0  Bn5T Cells
Repetitive Intermediate Ueique Total
DNA Class
F igure 4.2 DNA M ethylation Levels in Various Cot fractions  
of RE and Bn5T Cells
Burrlers of RE and Bn5T cells were labelled with 6-3H uridine (200 pCi, 23 
Ci/mmol) for 2 days. The tritium labelled DNA was then purified and fractionated 
into the different frequency classes as described in section 4.2.(see section 2.2.11 
for details). The %m5C in each of these fractions was then determined according to 
section 2.2.6.
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4.3 Discussion
The aim of the experiments in section 4.1 of this chapter was to assess the 
ability of known transforming regions of HSV-2 to directly influence DNA 
methylation levels when transfected into RE cells. In addition to the Bgl n  n 
plasmid which contains the region of HSV-2 responsible for generating the Bn5T 
cell-line, three further plasmids containing overlapping sequences were also used 
(see Fig. 4.1 and Fig. 1.6).
The evidence accumulated to date from studies on the mechanism of HSV 
transformation suggests that, although the regions of the HSV genome that 
independently cause transformation centre around the genes encoding 
ribonucleotide reductase there is no requirement for the expression of a complete, 
functional enzyme either in the establishment or in the maintenance of the 
transformed state (discussed in section 1.2.5). Hence, although we carried out the 
transfection studies with the pOC plasmids ± ZnSC>4 it was not essential that these 
subunits were expressed.
The transfection procedure itself appears to have been successful as all 
transfected cells showed levels of CAT activity significantly higher than control 
values. However, the CAT activity in cells co-transfected with pOC plasmids and 
pLW4 was reduced compared to those transfected only with pLW4. The reason for 
this is unclear, it may be that there is competition for transcription factors in the co­
transfected cells and that using smaller amounts of DNA may have eliminated this 
problem.
What is clear from these experiments is that none of the sequences transfected 
into RE cells had any effect on the level of DNA methylation as measured 48 hours 
after transfection. These results suggests that the HSV-2 transforming region 
investigated does not exert its oncogenic effect by causing a widespread reduction 
in DNA methylation. However, it cannot be ruled out that DNA methylation levels 
are altered in a small proportion of cells as this experiment would not detect such
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changes. It would appear, therefore, that the reduction in methylation is a secondary 
event in the transformation of primary RE cells by the Bgl II n fragment although 
these reduced methylation levels may be an important factor in maintaining the 
transformed state in these cell-lines.
Bovine sperm DNA has reduced levels of methylation in comparison to other 
bovine cells however, this reduction in toto is due almost entirely to the loss of 
methyl groups from satellite DNA only, which has been shown to have near zero 
levels of methylation (Adams et al., 1983). It is unclear as to whether this satellite 
DNA is undermethylated because it is in some way protected from the de novo 
methylation that occurs in embryogenesis or if it occurs by a specific demethylation 
event such as selective DNA replication in the absence of methylation. The results 
in section 4.2, however, show that the reduced levels of methylation in Bn5T cells 
is due to a reduction in the methlation level of all classes of DNA. This suggests 
that the mechanism of demethylation is non-specific and not targeted to any 
particular subclass of DNA
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Chapter 5 Discussion
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5 .1  Introduction
Infection of RE cells with HSV results in a reduction in the methylation levels 
of newly synthesised cellular DNA. The results obtained in chapter 3 demonstrate 
that, despite this inhibition of DNA methylation, RE cells infected with HSV-2 
appear to retain all the factors necessary for DNA methylation to take place. Thus, 
(a) SAM and SAH levels are not significantly different from those measured in 
mock-infected cells and the levels correspond with the reported Km and Ki values 
for DNA methylase (see section 3.3), (b) DNA methylase is present in cell nuclei as 
shown by activity in an in vitro methylase assay and (c) cellular DNA in these cells 
retains the ability to accept methyl groups.
However, upon infection, DNA methylase concentrates around the nuclear 
periphery. This is in contrast to the sites of DNA replication which are distributed 
throughout the nucleus and this differential distribution leads us to speculate that the 
inhibition of DNA methylation following infection occurs as a result of DNA 
methylase being distanced from its substrate, newly synthesised DNA.
5 .2  Margination of Cellular Chromatin upon Infection with HSV
The first visible effect of HSV infection involves changes in the cell nucleus. 
These effects include the swelling and displacement of the nucleolus, chromosomal 
breakage, displacement of chromatin and a condensation of this displaced chromatin 
at the nuclear membrane. All of these cytopathic effects are widely documented and 
have been used as a diagnostic feature of HSV infection (Crouse et al., 1950; 
Shwartz and Roizman, 1969; Dargan and Subak-Sharpe, 1983).
Margination of cellular chromatin is visible in HSV infected cells at 3-4 hours 
post-infection. The mechanism and the HSV functions involved in this chromatin 
margination, however, are still unclear. Dargan and Subak-Sharpe (1983), using a
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variety of temperature sensitive mutants, suggest that the margination of chromatin 
is initiated very early in the HSV replication cycle at around 0-1 hour post-infection. 
Knipe, (1989) postulates that chromatin marginates as a result of the expansion of 
globular replication compartments in HSV infected cells and there is evidence to 
suggest that cellular chromatin and viral DNA replication compartments show 
complementary distributions (Randall and Dinwoodie, 1986). However, this 
hypothesis appears to condradict that of Dargan and Subak-Sharpe (1983). 
Formation of globular replication compartments require the expression of the viral 
protein ICP8 (discussed in section 1.2.3) and the mutant studies of Dargan and 
Subak-Sharpe suggest that expression of this protein is not required for chromatin 
margination to take place.
Following infection with HSV cellular DNA synthesis is rapidly inhibited by as 
much as 80% at 2.5 hours post-infection (Roizman, 1969). It is possible that this 
inhibition of cellular DNA replication occurs a result of chromatin margination 
which removes the majority of DNA from the nuclear sites of replication. The 
cellular DNA which continues to be synthesised in infected cells, which we have 
demonstrated to be hypomethylated, may correspond to DNA that has been "left 
behind" after margination or alternatively this DNA may have been actively retained 
within the interior of the nuclei. Wilcock and Lane, (1991) demonstrated that 
various cellular proteins involved in cellular DNA replication colocalise with the 
sites of viral DNA replication in cells infected with HSV. Again, it is not clear if 
these proteins play a role in HSV replication and hence are actively recruited into 
viral DNA replication complexes or are redistributed passively as a result of their 
association with replicating DNA.
The DNA methylase responsible for maintenance methylation is thought to be 
bound to DNA loops in a form that resists extraction with 2 M NaG. Hence, DNA 
methylase may simply be marginating to the nuclear periphery in association with 
cellular chromatin.
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In section 3.8 the immunofluorescence studies using the mutant tsK suggest 
that a functional Vmw 175 is required to allow the relocation of DNA methylase. 
This correlates with the results of Macnab eta l., (1988) who demonstrated that 
there is only a slight reduction of methylation levels following infection with tsK 
and suggests that the relocation of DNA methylase and the inhibition of DNA 
methylation are related. Dargan and Subak-Sharpe, (1983) however, demonstrated 
that cells infected with the tsK mutant show the characteristic margination of 
chromatin seen following infection with wild-type virus. This study differs from 
ours and that of Macnab et al.t (1988) in that the infection was left to proceed for a 
longer time period of 24 hours. It is possible that there is a delay in chromatin 
margination in cells infected with tsK or, alternatively, HSV functions other than, 
or in addition to, chromatin margination are required to displace DNA methylase to 
the nuclear periphery. For example, this displacement of DNA methylase to the 
nuclear periphery may require the formation of replication compartments which 
require the viral DNA-binding protein ICP8 for assembly.
5 .3  Nuclear Localisation of DNA Methylase
DNA methylase activity measured in cell nuclei varies markedly during the cell- 
cycle. In resting cells DNA methylase activity is essentially absent Entrance into S- 
phase correlates with an increase in activity which then falls off again in G2/M 
(Adams, 1990; |Szvf et al.. 1985). This cell-cycle variation in activity corresponds 
to variations in mRNA levels suggesting that the DNA methylase gene is 
transcriptionally regulated (jSzyf et al.. 1991; Adams et al.. 1992 in press). This 
cell-cycle variation also implies that DNA methylase must be transported into the 
nucleus at the commencement of S-phase. There is no evidence at present, 
however, to suggest whether this transport to the nucleus occurs by means of a
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nuclear localisation signal within the enzyme or is mediated by means of a "carrier 
protein".
An alternative mechanism to explain the perinuclear localisation of DNA 
methylase, therefore, could be that HSV infection inhibits the entry of newly 
synthesised DNA methylase into the nuclear interior causing it to accumulate around 
the nuclear periphery. However, the results of the DNA methylase assays in section 
3.1 showed that there is no alteration in DNA methylase activity in either the 0.2 M 
NaCl nuclear extract or in the nuclear residue fraction which suggests that the DNA 
methylase is still closely associated with the nucleus following HSV infection. 
Double labelling studies, for example using anti-DNA methylase antibodies in 
conjunction with a stain for DNA such as Hoescht or DAPI (4 ,6-diamidino-2- 
phenylindole) at early times after infection, may help to clarify the relationship 
between DNA methylase and cellular chromatin in HSV infected cells. In addition, 
it would be desirable to carry out an extensive study using mutants to pin-point the 
virus functions involved in the inhibition of DNA methylation and the relationship 
of this with the nuclear localisation of DNA methylase.
5 .4  Cellular Transformation with HSV-2
Transformation by HSV was first reported by Duff and Rapp in 1971 and 
1973. As well as transforming cells in culture, HSV has been associated with 
cervical carcinoma for over 3 decades. Early links between HSV and cevical 
carcinomas were made on the bases of seroepidemiological studies and HSV 
sequences have been identified in human genital preneoplastic and neoplastic 
diseases. However, more recent evidence suggests that the human papilloma virus 
(HPV) is a more likely candidate for the causative viral agent (reviewed by Macnab, 
1987; Galloway and McDougall, 1989)
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t :
The transfection assays performed in chapter 4 suggest that the transformation of 
RE cells is not directly caused by the inhibition of DNA methylation. This may not 
reflect the importance of the inhibition of methylation in oncogenesis in vivo. 
Carcinogenesis is thought to be a multistep, multifactorial, process involving both 
the activation of oncogenes and the inactivation of tumour supressor genes brought 
about by a combination of heritable genetic defects and environmental mutagenic 
factors. It is possible, therefore, that abortive infections which leave DNA 
methylation levels reduced may leave the cell more susceptible to other oncogenic 
agents. Zur Hausen (1982,1986) hypothesises that genital cancer may result from a 
synergistic interaction between HPV infection and other initiating factors. These 
factors, which zur Hausen speculates to include smoking and herpes simplex 
infection, may act by modifying cellular genes that would otherwise exert control 
over the integrated HPV viral genes and thereby also control tumour progression. 
Therefore, although not essential to bring about tumorogenesis HSV may be a 
contributory factor to the establishment of the transformed state.
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